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Abbreviation 
methicillin-resistant S. aureus strains MRSA 
phosphorylated ERM pERM 
intercellular adhesion molecule 1 ICAM-1 
sphingomyelin phosphodiesterase 1 Smpd1 
bone marrow-derived macrophages BMDMs 
alveolar macrophages AMs 
bronchoalveolar lavage BAL 
multiplicity of infection MOI 
colony-forming units CFUs 
tetramethylrhodamine isothiocyanate TMR  
fluorescein isothiocyanate FITC 
lysosome-associated membrane protein 1 Lamp1 
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Abstract 
Staphylococcus aureus plays an important role in sepsis, pneumonia, and wound 
infections. Acid sphingomyelinase (Asm) -deficient mice are highly susceptible to 
pulmonary S. aureus infections. We identified CD44 as a novel receptor for S. aureus in 
macrophages. CD44 activation by S. aureus stimulates Asm, resulting in ceramide 
release, clustering of CD44 in ceramide-enriched membrane platforms, a CD44/Asm-
dependent activation of Rho family GTPases, a translocation of phospho-
ezrin/radixin/moesin to the plasma-membrane, and a rapid rearrangement of the actin 
cytoskeleton with cortical actin polymerization. Genetic deficiency of CD44 or Asm 
abrogates these signaling events and thereby reduces internalization of S. aureus by 
macrophages by approximately 60% to 80%. Asm-deficient macrophages also exhibit 
reduced fusion of phagosomes with lysosomes, which prevents intracellular killing of S. 
aureus in macrophages and thereby allows internalized pathogen to replicate and cause 
severe pneumonia. Thus, the CD44-Asm-ceramide system plays an important role in 
the infection of macrophages with S. aureus. 
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1. Introduction 
1.1 Staphylococcus aureus (S. aureus) 
1.1.1 Epidemiology of S. aureus 
Staphylococcus aureus is a very common commensal bacterium which is a serious 
cause of morbidity and mortality worldwide (Wertheim et al., 2005a). S. aureus has 
remained a leading cause of healthcare issue and financial cost over the past decades. 
External acquisition of S. aureus could be the initiation of an infection into an open 
wound. Frequently, the human host is colonized with the bacteria on the skin and 
mucosae (von Eiff et al., 2001; Wertheim et al., 2004). Remarkably, about 20% of 
populations are persistent nasal carrier of S. aureus and approximately 30% are 
intermittent colonized (Eriksen et al., 1995; Hu et al., 1995; Kluytmans et al., 1997; 
Nouwen et al., 2004). Persistent nasal 
carriage is more frequent in children than 
adults (Armstrong-Esther, 1976), 
particularly, more than 70% of infants have 
been determined with at least one strain of 
S.aureus (Peacock et al., 2003).Extra-nasal 
infection of S. aureus includes the skin, 
perineum, pharynx (Ridley, 1959; Wertheim 
et al., 2005b; Williams, 1963). Other sites 
including gastrointestinal tract, vaginal wall, 
and axillae are less frequently colonized 
(Dancer and Noble, 1991; Guinan et al., 
1982; Williams, 1963). 
S. aureus is one of the most important 
causes of a broad array of clinical infections 
(Fig. 1.1.1) (Salgado-Pabon and Schlievert, 
2014). Skin and soft tissue infection such as 
boils, folliculitis, impetigo and cellulitis are 
Figure 1.1.1 Large diversities in S.aureus 
infection. S. aureus causes minor skin 
infection to life-threatening diseases 
(Salgado-Pabon and Schlievert, 2014). 
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the most frequent illness form of the bacteria, and the progression these infections can 
lead to bacteremia and severe invasive disease, including bloodstream infection, 
endocarditis or sepsis (David and Daum, 2010; Lowy, 1998; Talan et al., 2011). In 
addition, the organism can cause osteomyelitis, infectious arthritis, abscesses in many 
organ tissues, toxic-shock syndrome, surgical-site and prosthetic materials infections, 
and pneumonia (DeLeo et al., 2010; Fridkin et al., 2005; Klevens et al., 2007). The 
prevalence and incidence of S. aureus diseases range between 1-3% depends on age, 
race, and geographical location (David and Daum, 2010). The risk of S. aureus 
diseases elevates in early-born infants, children, elderly, and patients with 
immunosuppression, diabetes, and dialysis (Kluytmans et al., 1997). The recurrence is 
a key characteristic of the skin, soft tissue and blood infection, is found for 8-33% of all 
patients (Kallen et al., 2010). Many S. aureus strains are resistant to antibiotics (Corey, 
2009; Grundmann et al., 2006; Maskalyk, 2002); in particular, methicillin-resistant S. 
aureus strains (MRSA) have become an important clinical problem and are now 
recognized as serious pathogens in communities and hospitals worldwide (Marimuthu 
and Harbarth, 2014; Peyrani and Ramirez, 2015; Singer and Talan, 2014).  
S. aureus plays a predominant role in hospital-acquired infections: hospital-acquired 
pneumonia, ventilator-associated pneumonia, and health care-associated pneumonia 
(American Thoracic and Infectious Diseases Society of, 2005). Overall, S. aureus has 
been implicated as one of the most common pathogen which accounts for more than 40% 
culture-positive health care-associated pneumonia cases (Kollef et al., 2005). Recently, 
a distinct strain of S. aureus named USA 400, which is encoded with genes for Panton-
Valentine leukocidin (PVL), has emerged and causes a severe necrotizing pneumonia 
(1999; Gillet et al., 2002). PVL is a member of the family of bicomponent β-channel 
pore-forming toxins targeting phagocytic leukocytes in S. aureus necrotizing infections 
(Diep et al., 2010; Loffler et al., 2010). The success of S. aureus acting as a respiratory 
pathogen is in virtue of several features: substantial metabolism, genetic flexibility that 
acquires and mutates specific genetic elements, and the capability of exploiting the 
evoked immune responses (al-Ujayli et al., 1995; Parker and Prince, 2012). S. aureus is 
regularly recognized as extracellular aerobic pathogen; however the organism also 
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survives and replicates intracellular (da Silva et al., 2004; Kapral and Shayegani, 1959) 
and tolerates anaerobic conditions (Belay and Rasooly, 2002) which are connected to 
pulmonary infections. 
 
1.1.2 Components and Products of S. aurues 
S. aureus is a gram-positive bacterium belonging to the Micrococcaceae family (Fig. 
1.1.2) (Lowy, 1998). S. aureus is discriminated from other staphylococcal species on 
the appearance of the gold-yellow colonies, which are positive for coagulase, 
mannitolfermentation, and deoxyribonuclease tests. 
The genome of S. aureus consists of a circular chromosome of approximately 2.7–2.8 
Mbp plus an assortment of extrachromosomal accessory gene elements: prophages, 
plasmids, mobile elements, other variable elements (Baba et al., 2008; Mlynarczyk et al., 
1998). Genes carrying virulence and antibiotic resistance determinants that induce the 
development of clinical diseases was found on chromosome and extrachromosomal 
elements (Baba et al., 2002; Novick, 1991). 
The staphylococcal cell wall is constituted of peptidoglycan, teichoic acids, and proteins 
(Giesbrecht et al., 1976; Umeda et al., 1987). Over 70% of the cell wall is peptidoglycan 
by weight and teichoic acid binds to the peptidoglycan through a phosphodiester bond 
(Heptinstall et al., 1978). These polymers in the cell wall arranges circularly where the 
bacteriophage receptors on the bacterial surfaces are located (Umeda et al., 1980). The 
peptidoglycan chains are linked by pentaglycine cross-bridge and by tetrapeptide chains 
bound to N-acetylmuramic acid (Ton-That et al., 1997).Variation in the peptidoglycan 
structure is response to the differences in their ability to cause disseminated 
intravascular coagulation (DIC) (Kessler et al., 1991). 
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Capsule of S. aureus was first reported in 1931 (Gilbert, 1931). At least 18 strains of 
capsule of S. aureus have been described and partially characterized (O'Riordan and 
Lee, 2004). Most clinical isolates of S. aureus produces type 5 or type 8, which 
accounts for 75% of human infections. The capsule impedes the phagocytosis therefore 
enhancing virulence of the organism, finally the bacterial persistence in hosts (Thakker 
et al., 1998). 
Staphylococcal surface proteins are covalently attached to peptidoglycan. The structure 
of these proteins is composed of a signal sequence at the N terminal which is cleaved 
during secretion, and a wall-spanning region and sorting signal at the carboxyl terminal 
facilitating the covalent anchorage to peptidoglycan (Foster et al., 2014). Ligand-binding 
Figure 1.1.2 Structure of S. aureus (Lowy, 1998).  
Panel A: The surface and secreted proteins. The synthesis of these proteins is dependent on 
the growth phase and is controlled by regulatory genes such as agr. Panels B and C: Cross 
sections of the cell envelope. Many of the surface proteins and peptides have a similar 
structural organization as clumping factor, including repeated segments of amino acids. 
TSST-1 denotes toxic shock syndrome toxin 1. 
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domain at the N terminal on the bacterial surface functions as adhesins of some 
proteins (Foster and McDevitt, 1994). Protein A has an ability binds to the Fc region of 
immunoglobulin resulting antiphagocytic properties (Fig. 1.1.2). In addition, protein A 
mediates the activation of host intracellular signaling and increase of inflammation, 
leading severe pneumonia (Normark et al., 2004; Soong et al., 2011). Several surface 
proteins bind extracellular-matrix molecules and function in invasion of host cells and 
evasion of elimination of host cells, of which microbial surface component recognizing 
adhesive matrix molecules (MSCRAMMs) are the largest class (Patti et al., 1994). 
S. aureus produces numerous toxins which are classified into three families: pore-
forming toxins, exfoliative toxins and superantigens (Grumann et al., 2014). Pore-
forming toxins destruct the membranes of host cells, eventually induce the cell lysis. 
These pore-forming toxins potentially function as cell stressors at sublytic 
concentrations, synergically effect with signals such as lipoproteins and activating toll-
like receptor 2 (TLR2) and NALP3-inflammasomes, finally the release of cytokines 
(Franchi et al., 2012). Hemolysin-α (Hla, α-toxin), Panton-Valentine leukocidin (PVL) 
and hemolysin-γ (Hlg) have been shown strongly evoking the inflammatory responses 
(Holzinger et al., 2012; Kebaier et al., 2012; Perret et al., 2012). Exfoliative toxins are 
functionally isoforms of enzymes with high species-specificity. Exfoliative toxins have 
glutamate-specific serine protease activity and cause skin erythema and separation as 
“molecular scissors” (Nishifuji et al., 2008). The staphylococcal superantigens are 
considered as enterotoxins since they induce food poisoning syndrome such as 
vomiting and diarrhea after oral uptake (Harris et al., 1993). In addition, the 
superantigens interact with major histocompatibility complex (MHC) class II proteins by 
binding to the α-chain or to a conserved histidine in the β-domain, and trigger extensive 
T-cell proliferation and cytokine release (Fraser and Proft, 2008; Marrack and Kappler, 
1990). 
S. aureus produce various enzymes degrading molecules, interfering metabolic or 
signaling cascades of hosts. Several enzymes function as proteases which non-
specifically or specifically degrade host proteins and leads to tissue damage.  The 
protease aureolysin cleaves proteins with a preference of cleaving after hydrophobic 
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residues (Laarman et al., 2011). It can also inactivate phenol-soluble modulins thus 
triggering osteoblast cell death and bone destruction (Cassat et al., 2013). In addition, 
Aureolysin, glutamyl endopeptidase, and the cysteine proteases staphopain appear to 
be interfering with complement factors, leading to pathogen-mediated evasion of the 
human complement system (Jusko et al., 2014). The biological function of a series of S. 
aureus serine proteases is not well defined. Staphylokinase is known to convert 
plasminogen into plasmin which mediates fibrinolysis. This biological effect is to disrupt 
the function of fibrin meshwork thus localizing staphylococcal infection (Okada et al., 
2000). Further staphylokinase assists invasion of organism through the skin barrier 
(Kwiecinski et al., 2013). Two coagulases, staphylocoagulase and von Willebrand factor 
(vWF), mediates the activation of host prothrombin and formation of fibrin cables, thus 
facilitating S. aureus clot formation and establishment of infectious (Thomer et al., 2013). 
S. aureus produces nucleases, which may decrease the bactericidal capacity of 
neutrophil extracellular traps (NET), which consist of rocessed chromatin bound to 
granular and selected cytoplasmic proteins (Brinkmann and Zychlinsky, 2012). The 
function of staphylococcal lipases is not well understood, presumably these enzyme 
degrade triglycerides to release free fatty acids which involve in the bacteria growth. 
Importantly, S. aureus beta-toxin is a sphingomyelinase that hydrolyzes sphingomyelin 
to yield ceramide and phosphorylcholine, a key enzyme will be discussed in our study. 
The beta-toxin is a critical virulent factor contributing significantly to the pathogenesis of 
S. aureus, including lung injury (Hayashida et al., 2009). 
 
1.1.3 Pathogenesis of S. aureus 
S. aureus virulence genes are thought to be unregulated after exposure to the mucosal 
surface or skin of host (Novick, 2003). Bacterial products or signals from host immune 
response activate the resident phagocytes and epithelial cells in the localized skin or 
mucosal tissue. Host molecules such as TLR2 recognize staphylococcal peptidoglycan 
and lipoprotein (Fournier, 2012; Hashimoto et al., 2006); furthermore, hyaluronan (HA), 
a ubiquitously distributed extracellular matrix ligand for CD44, breakdowns into lower 
molecular weight fragments which can further facilitate pro-inflammatory signaling 
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resulting local immune cell activation, and recruitment  of neutrophil and macrophage 
(Scheibner et al., 2006). 
S. aureus has been generally recognized surviving both extracellular and intracellular 
organism of host cells. S. aureus escapes from opsonization by complement and 
antibodies which target the bacteria for uptake or elimination by phagocytes through Fc 
or complement receptors. This pathogen evades opsonophagocytosis by expressing on 
its surface a capsule, protein A, and variety of complement inhibitors, all of which serves 
to blocking and avoiding host opsonins from targeting the organism for destruction 
(Foster, 2005; Rooijakkers et al., 2005). 
S. aureus can survive within a variety of mammalian epithelial cells, endothelial cells, 
non-professional phagocytes, and professional phagocytes such as neutrophils and 
monocytes (Kubica et al., 2008). S. aureus employ several strategies to avoid 
formidable challenge by neutrophils. First, chemotaxis inhibitory protein (CHIP) and 
extracellular adherence protein (Eap) secreted by S. aureus abolish the recognition of 
chemotactic factors from neutrophils (de Haas et al., 2004), as well as interact with host 
adhesive proteins intercellular adhesion molecule 1 (ICAM-1) thus blocking neutrophil 
adhesion (Chavakis et al., 2002). Neutrophils release a series of products which serve 
to clear S. aureus, including antimicrobial peptides, reactive oxygen species (ROS), 
reactive nitrogen species (RNS), proteases, and lysozyme. However, S. aureus defense 
against ROS by secreting antioxidant enzymes, such as catalase, pigment, and 
superoxide dismutase which counteract ROS and RNS (Foster, 2005). S. aureus can 
also modify its own negatively charged bacteria surface thereby escaping targeting of 
antimicrobial peptides (Collins et al., 2002; Peschel et al., 2001). In addition, aureolysin 
(Sieprawska-Lupa et al., 2004) or staphylokinase (Jin et al., 2004) can degrade or 
neutralize antimicrobial peptides, respectively. Further, S. aureus produces a large 
amount of two-component toxins which lead to the neutrophils lysis (Tomita and Kamio, 
1997). Recently phenol soluble modulin (PSM) has emerged as a novel toxin family of 
aggressive S. aureus isolates which highly induce inflammation and neutrophil cytolysis 
(Peschel and Otto, 2013). 
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Iron is vital for the survival and proliferation of S. aureus within the human during 
infection (Hammer and Skaar, 2011). Most iron is employed as a cofactor in intracellular 
biochemical reactions, and free iron within the serum is almost always bound to high-
affinity iron binding proteins. In response of the iron acquisition, S. aureus has 
developed complex strategies to obtain iron needed to proliferate within hosts. Heme, 
representing most amount of iron within the host, is a important iron source of S. aureus 
(Skaar et al., 2004). During iron starvation, S. aureus dramatically change its protein 
expression which is mediated by the iron-dependent ferric uptake regulator (fur) 
(Friedman et al., 2006; Torres et al., 2006). Small molecules siderophores secreted by 
S. aureus have remarkably high affinity to iron. Two distinct siderophores produced by S. 
aureus named staphyloferrin A and staphyloferrin B are maximally synthesized in iron-
limiting environments for bacterial survival (Friedman et al., 2006; Lindsay and Riley, 
1994). 
The adaptive immune system consists of highly specific, systemic cells and 
bioprocesses that limit the ongoing pathogen infection and prevent future re-infections. 
However, one feature of S. aureus pathogenesis is the capacity of infecting human host 
repeatedly throughout life. Studies have revealed that staphylococcal extracellular 
adherence protein, toxic shock syndrome toxin, and enterotoxins could impede T cell 
functions by blocking T cell receptor activation (Lee et al., 2002; Llewelyn and Cohen, 
2002), which is the strategy of host developing long time memory of protect against S. 
aureus infection. Similarly, protein A induced preferential and prolonged deletion of 
innate-like B lymphocytes which are precursors of B cells (Goodyear and Silverman, 
2004). Manipulation of B cell and T cell responses, together with strategies described 
above, could be possible underlying reasons that S. aureus infect throughout host lives. 
The generation of biofilm by S. aureus plays a critical role in the persistence of chronic 
infections. The S. aureus biofilm matrix is composed of host factors, secreted and lysis-
derived proteins, polysaccharide, and eDNA (Lister and Horswill, 2014). Individual 
bacterial can spread out from the original biofilm and develop new sites of infections or 
mediate sepsis (Costerton et al., 1999). The biofilm dispersal mechanism can be 
regulated by protease (Bronner et al., 2004; O'Neill et al., 2008), nuclease (Hernandez 
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et al., 2014; Olson et al., 2013), and dispersin-B (Kaplan et al., 2004). Other virulence 
mechanisms including small colony variants are linked to chronic, recurrent, and 
antibiotic-resistant infections (Proctor et al., 2014). Changes in small colony variants are 
found, including stringent response (Gao et al., 2010), RNAIII metabolism (Kohler et al., 
2008), toxin-antitoxin,(Donegan and Cheung, 2009), and ribosomes (Lannergard et al., 
2011), all of these alterations are responsible for bacterial survival within the harsh host 
environment. 
 
1.1.4 S. aureus in pulmonary infection 
Adaption of S. aureus to the environment of respiratory tract has facilitated its 
emergence as a respiratory pathogen. Serious respiratory syndrome has been 
apparently increasing due to emerge of more virulent USA300 community acquired 
MRSA strains (Klevens et al., 2007; Montgomery et al., 2008). 
Accessory gene regulator (Agr), a regulatory system in the genome of S. aureus, 
coordinates the expression of both surface proteins and secreted toxins (Recsei et al., 
1986). Agr mutations are also found in clinical strains (Traber et al., 2008). The sensor 
histidine kinase (AgrC) and the response regulator (AgrA) are necessary for the 
coordination of invasive infection of the lungs (Heyer et al., 2002), as well in the animal 
models of pneumonia (Bubeck Wardenburg et al., 2007; Montgomery et al., 2010). 
Additionally, Agr plays an important role in pathogenesis of intracellular circle of S. 
aureus. Agr is necessary for these intracellular bacteria escaping from endosomes and 
contributing to pulmonary damage (Qazi et al., 2001; Shompole et al., 2003). S. aureus 
has been observed in non-phagocytic cells such as some epithelial cells lines (Bayles et 
al., 1998; Qazi et al., 2001) and is linked to the cell apoptosis (da Silva et al., 2004). In 
phagocytic cells macrophages, S. aureus is able to persist and survive intracellular 
several days without affecting the viability of these mobile cells, until the pathogens 
escape into the cytoplasm and induce the cell lysis (Kubica et al., 2008). Likewise, 
studies has shown small number of S. aureus survive prolonged periods of time within 
neutrophils and occasionally multiply within dying cells (Melly et al., 1960), a 
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mechanism which effect to a systemic dissemination of the pathogen (Gresham et al., 
2000). 
As mentioned above, iron is essential for bacterial survival. Ferric uptake regulator (Fur), 
a homologue of the iron regulatory protein secreted by S. aureus, alters the abundance 
of a large number of virulence factors including α-hemolysin and PVL thus protecting S. 
aureus against killing by neutrophils in the pathogenesis of pneumonia (Torres et al., 
2010). By coordinating the reciprocal expression of cytolysins and a subset of 
immunomodulatory proteins, Fur exhibit an impact on regulating the expression of 
virulent factors. 
Varieties of surface proteins specifically recognize host cell and tissues, such as 
collagen, fibrinogen, and fibronectin. Epithelial cell damage permits the binding of 
Panton-Valentine leukocidin-positive S. aureus to exposed collagens and laminin during 
severe lung injury (de Bentzmann et al., 2004). Fibronectin-binding protein plays a 
major role in the colonization of human airway epithelial cells in staphylococcal 
infectious process (Mongodin et al., 2002). Clumping factors A and B mediates the 
adherence of S. aureus to fibrinogen (Higgins et al., 2006; Palmqvist et al., 2004). 
Clumping factor B promotes adherence to human type I cytokeratin 10 on nasal 
epithelial cells (O'Brien et al., 2002). Further studies confirms Clumping factor B is a 
major determinant of nasal S. aureus colonization (Wertheim et al., 2008). 
The secretion of various toxins also contributes to pathogenesis of S. aureus. The α-
toxin is a major pore-forming toxin of S. aureus. Expression of α-toxin is increased, 
associated with calcium fluxes and pro-inflammatory response (Yun et al., 1999), and 
change of ciliary beat frequency (Rose et al., 2002) in epithelial cells during infection. 
Recently, studies have shown that α-toxin binds to a disintegrin and metalloprotease 10 
(ADAM10) with high-affinity, which is critical for causing cytotoxicity at low toxin 
concentrations (Wilke and Bubeck Wardenburg, 2010). ADAM10 is crucial for bacterial 
virulence and regulate acute and asthmatic inflammatory responses in lung injury 
(Dreymueller et al., 2015). α-toxin is involved in activating pyroptosis, inducing 
inflammasome via caspase-1 activation, targeting pro-IL-1β, and generation of  IL-1β 
13 
 
(Parker and Prince, 2012). Consistently, studies using mutants of α-toxin have shown 
connections between α-toxin expression and virulence in the lung (Bubeck Wardenburg 
and Schneewind, 2008). Development of antibodies against α-toxin identifies further 
therapeutic opportunities in preventing lung injuries (Ragle and Bubeck Wardenburg, 
2009; Ragle et al., 2010). Furthermore, β-toxin of S. aureus also contributes to the 
pulmonary infection. In airway epithelial cells β-toxin has been shown reduce ciliary 
activity (Kim et al., 2000). β-toxin is also associated with the increasing of airway 
permeability as well as a neutrophilic response in lung pathology (Hayashida et al., 
2009). Panton–Valentine leukocidin (PVL) is a toxin encoded by lukF-PV and lukS-PV 
(Prevost et al., 1995), and forms octomeric protein pores at the cell membranes (Diep et 
al., 2010), all of which contributes the inflammations in the lung. 
Protein A is an abundant surface protein which may be one of the most sophisticated 
staphylococcal components since its various interactions with host signaling including 
lung pathogenesis. Infection of protein A mutants significantly reduce the mortality of 
mice with pneumonia compared with the wild type (Bubeck Wardenburg et al., 2007). 
Protein A binds the Fab portion of V(H)3-type B cell receptors thus impedes the 
adaptive immune response (Hakoda et al., 1994). Tumor-necrosis factor-alpha receptor 
(TNFR1), a protein A receptor widely expressed on the airway epithelium, is activated 
and recruits polymorphonuclear leukocytes finally inducing pneumonia (Gomez et al., 
2004). Additionally, protein A ubiquitously and multifunctionally stimulates EGFR and 
ERK phosphorylation to regulate TNFR1 on mucosal cells (Gomez et al., 2007). 
Moreover, EGFR activation stimulates the increased wound closure and transepithelial 
resistance, which results from increased proliferation and survival of uninjured epithelial 
cells (Shaykhiev et al., 2008). 
In summary, S. aureus has deployed a series of mechanism surviving as a respiratory 
pathogen which not only success in persistence in the respiratory tract but also prosper 
as an invasive pulmonary pathogen. To prevent infection, multiples strategies should be 
considered, including virulence determinants, iron acquisition, biofilm production and 
immune evasion. 
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1.2 Acid sphingomyelinase and ceramide system 
1.2.1 Lipid rafts 
The fluid mosaic model, first introduced by Singer and Nicolson in 1972, is the major 
fundamental of our understanding of the structure of biological membranes (Singer and 
Nicolson, 1972). The theory is proposed as a basic framework model for cell 
membranes which could interprets studies on membrane proteins and structure and 
dynamics of lipids at the time. As originally described, the fluid mosaic model defined 
biological membranes as a matrix composed of fluid bilayer of phospholipids with 
mobile globular integral membrane proteins and glycoproteins that were intercalated 
into the fluid lipid bilayer, which is “protein icebergs floating in the sea of lipid” (Fig 1.2.1 
A) (Nicolson, 2014; Singer and Nicolson, 1972). However, considering numerous later 
studies on membranes those have been published, our view of biological membrane 
structure has been extended in these years. Studies have demonstrated that lipids are 
not uniformly distributed in the cell membrane, and the membrane microdomain „lipid 
rafts‟ was proposed (Lisanti et al., 
1988; van Meer et al., 1987). 
Biochemically, lipids are sorted within 
the cell (van Meer et al., 2008). Lipid 
rafts are defined as self-associative 
properties of sphingolipid and 
cholesterol which promotes selective 
lateral segregation in the membrane 
plane and serves as a basis for lipid 
sorting (Simons and Ikonen, 1997). 
Recently, the new concept is 
established in the consensus 
description of lipid rafts at the 
Keystone Symposium of Lipid Rafts 
and Cell Function: Lipid rafts are 
small (10–200 nm), heterogeneous, 
Figure 1.2.1 A. The fluid mosaic membrane 
model. In this cross-sectional structural view of 
a cell membrane the solid bodies with stippled 
cut surfaces represent globular integral 
membrane proteins, which at intermediate 
range are randomly distributed in the plane of 
the membrane. At short range, some integral 
membrane proteins form specific integral protein 
complexes (Nicolson, 2014). 
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highly dynamic, sterol- and sphingolipid-enriched domains that compartmentalize 
cellular processes. Small rafts can sometimes be stabilized to form larger platforms 
through protein-protein and protein-lipid interactions (Pike, 2006). The studies on lipid 
rafts is continuous developing, Fig. 1.2.1 B lists the timeline of pioneer studies in the 
lipid raft field (Varshney et al., 2016). 
 
Lipid rafts incorporate with multiple distinct classes of proteins: true resident proteins 
such as glycosylphosphatidylinositol (GPI)-linked proteins and caveolin (Brown and 
London, 1998; Hooper, 1999). signalling proteins such as doubly acylated proteins like 
Src family kinases, G-protein-coupled receptor (GPCR) proteins (Resh, 1999), 
cholesterol-linked and palmitoylated proteins such as hedgehog and myristoylated 
proteins (Brown and London, 1998; Rietveld et al., 1999). The mechanism that GPI-
anchored or hydrophobic modifications carried proteins possibly due to preferential 
packing of their saturated membrane anchors into rafts. The kinetics or partition 
coefficients of proteins associating with rafts can be distinct. For example, a monomeric 
Figure 1.2.1 B. Timeline of pioneer discoveries in the field of lipid rafts and signaling. 
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transmembrane protein residents most of time outside the rafts, but when crosslinked or 
oligomerized, its affinity to rafts increased and stay longer in rafts (Harder et al., 1998). 
Further, clustering of separate rafts recruits proteins to a new membrane environment 
and initiates signaling cascades through amplification. These evidences, which lipids 
driven by lipid–lipid, lipid–protein and protein–protein interactions, are crucial for the 
activation of many signal transduction pathways. 
Sphingolipids, cholesterol and (glycero)phospholipids are predominantly components of 
cell membranes. Particularly, sphingolipids and cholesterol seem to be not randomly 
distributed in the membrane. The interactions between these lipids result in 
spontaneous formation of distinct sphingolipid- and cholesterol-enriched very small 
membrane domains, termed rafts. Sphingolipids consist of a hydrophilic head group and 
a hydrophobic ceramide molecule. Sphingolipids, particularly the most abundant 
sphingolipid sphingomyelin, have a higher melting temperature compared with 
phospholipids in the cell membrane; tend to interact with each other through hydrophilic 
interactions of the hydrophilic sphingolipid head groups (Brown and London, 1998; 
Harder and Simons, 1997; Simons and Ikonen, 1997; Xu et al., 2001). Cholesterol 
functions as a spacer between the bulky head groups of sphingolipids head, coordinate 
with sphingolipids via hydrogen bonds and hydrophobic van der Waal interactions of the 
sterol ring system and the ceramide moiety of sphingolipids, thus interactions formed. 
The tight interactions induced stable domains exist in a liquid-ordered- or even gel-like 
phase, which are separated from other phospholipids in the cell membrane. Studies 
support the existence of these domains that cell membrane contains domains resistant 
to solubilization by non-ionic detergents (Brown and Rose, 1992). Powerful microscopy 
evidence further records the existence of lipid nanodomains rafts with a diameter of 20 
nm in living cells (Eggeling et al., 2009). It should be noted that lipid rafts may exist in 
the outer leaflet of the cell membrane, while the existence of lipid rafts or similar 
membrane domains in the inner/cytoplasmic leaflet of the plasma membrane is currently 
unknown. 
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1.2.2 Ceramide and ceramide enriched platforms 
Sphingomyelin is predominantly present in the outer leaflet of the cell membrane. 
Sphingomyelin can be hydrolyzed to ceramide, which dramatically alters the biophysical 
properties of the plasma membrane. Ceramide constitutes the hydrophobic backbone of 
all complex sphingolipids and are composed of D-erythro-sphingosine and a fatty acid 
containing 2–36 carbon atoms in the acyl chain (Sandhoff, 2010). The amino alcohol 
binds to fatty acid forming an amide ester. Generally, fatty acyl chains are saturated or 
monounsaturated and an OH group might link to C2 or to the terminal carbon atom. 
Among all, the most abundant amount of physiological ceramides are those with the 
long (C16–20) and very long (C22–24) acyl chains (Fahy et al., 2005; Sandhoff, 2010). 
Therefore, structure of ceramides determines their poor solubility in water and cannot 
exist in biological fluids or in the cytosol (Goni et al., 2005). Ceramide molecules have 
the tendency to spontaneously self-associate. With the hydroxyl functional group, the 
amide linkage and the OH group on the sphingosine backbone, ceramides form 
extensive hydrogen bonds, which contribute to their high bulk transition temperature 
and in-plane phase separation, finally promote the formation of ceramide-enriched 
domains, particularly solid-like condensed domains in bilayers and monolayers (Castro 
et al., 2014; Maula et al., 2011). Moreover, ceramide dramatically alters membrane 
properties with other lipids. Low concentration as 5 mol% ceramide is sufficient to 
spontaneously induce ceramide-enriched membrane domains formation in model 
membranes (Veiga et al., 1999). A large number of biophysical techniques have been 
used to detect complex phase behavior of lipid mixtures with ceramide, including 
nuclear magnetic resonance (Hsueh et al., 2002), atomic force microscopy (Chiantia et 
al., 2006), X-ray diffraction (Boulgaropoulos et al., 2012), fourier transform infrared 
spectroscopy (Boulgaropoulos et al., 2011), fluorescence spectroscopy (Castro et al., 
2007; Silva et al., 2007) and fluorescence microscopy (Staneva et al., 2009). 
Ceramides are generated from diverse pathways. Several enzymes located in specific 
subcellular compartments are involved in ceramide metabolism, and certain activation 
of molecule signaling can occure due to their sites of function. Various stimuli can 
activate different metabolic pathways resulting the formation of ceramides (Fig. 1.2.2 A) 
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(Ruvolo, 2003; Stancevic and Kolesnick, 2010). De novo pathway of ceramide synthesis 
is located in endoplasmic reticulum (Bartke and Hannun, 2009; Carpinteiro et al., 2008). 
Serine palmitoyltransferase, a rate limiting step of de novo pathway, condensates the 
serine and palmitate to form 3-keto-dihydroshingosine. 3-keto-dihydroshingosine is then 
reduced to dihydrosphingosine, a metabolite further acylated to dihydroceramide by 
ceramide synthase. Six isoforms of ceramide synthase are found in mammals and are 
responsible for synthesizing (dihydro)ceramides with distinct chain lengths (Pewzner-
Jung et al., 2006). Finally ceramide is synthesized from dihydroceramide by 
dihydroceramide desaturase. Ceramide can be delivered to the Golgi by vesicular 
trafficking or the ceramide transfer protein CERT for further structure modification to 
other sphingolipids (Hanada et al., 2007; Yamaoka et al., 2004).  
Sphingomyelinases (SMase) catalyze the breakdown of phosphodiester bond of 
sphingomyelin to ceramide and phosphorylcholine (Airola and Hannun, 2013; Gulbins et 
al., 2004). According to basis of optimal pH values required for their activation, 
sphingomyelinases can be distinguished to acid SMase (ASM), neutral SMase (NSM) 
and alkaline SMase (alk-SM) (Hannun and Obeid, 2008; Stancevic and Kolesnick, 
2010). It has been several years that only acid and neutral SMase are considered 
involved in cell signaling, however recent studies have summarized potential signaling 
roles for alkaline SMases (Duan, 2006). Acid SMase is encoded by SMPD1 gene which 
gives rise to lysosomal and secretory ASM (Marathe et al., 1998). Neutreal SMase are 
encoded by SMPD2–5 which are translated into NSM1, NSM2, NSM3, and 
mitochondria-associated SMase (MA-SMase) (Hofmann et al., 2000). Alk-SMase is 
encoded by the ENPP7 gene (Duan et al., 2003). Various stimulations can activate the 
SMase pathway of ceramide generation including cytokines, viral and bacterial 
infections, death receptor ligands, differentiation agents, and anti-cancer drugs 
(Carpinteiro et al., 2008; Tchikov et al., 2011; van Blitterswijk et al., 2003), resuting the 
ceramide enriched domain formation in the plasma membranes. 
The salvage pathway or sphingolipid recycling is also an important pathway for 
ceramide generation (Gillard et al., 1998; Kitatani et al., 2008). Ceramide generation 
from the catabolism of complex sphingolipids is finally broken down into sphingosine, 
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which is then re-synthesized to ceramide through re-acylation. Several enzymes 
including SMases, glucocerebrosidase, ceramidases and ceramide synthases are 
involved in this pathway. In addition, several specific hydrolases break down complex 
sphingolipids leading to the generation of glucosylceramide and galactosylceramide, 
which is hydrolyzed into ceramide by specific β-glucosidases and galactosidases 
(Bartke and Hannun, 2009; Hannun and Obeid, 2008).  
In general, the accumulation of ceramide within cellular membranes leads to the 
formation of ceramide-enriched membrane domains, which appears to sort proteins and 
to provide platform for the spatial recruiting receptors and intracellular signalling 
molecules upon various stimuli (Fig. 1.2.2 B) (Bollinger et al., 2005; Grassme et al., 
Figure 1.2.2 A. Ceramide structure and sphingolipid metabolism. Schematic representation 
of sphingolipid metabolism showing ceramide (Cer) as the central lipid. Ceramide is 
synthesized by de novo pathway, hydrolysis of sphingomyelin, salvage pathway and 
hydrolysis complex glycosphingolipids. The structures of sphingosine, C16-ceramide, C16-
sphingomyelin and C16-glucosylceramide are shown in right panel. Abberaviations: C1PP, 
ceramide 1-phosphate phosphatase; CDase, ceramidase; CerS, (dihydro)ceramide 
synthase; CK, ceramide kinase; DES, ceramide desaturase; GCase, glucosylceramidase; 
GCS, glucosylceramide synthase; KDS, ketosphinganine reductase; S1P lyase, sphingosine 
1-phosphate lyase; SK, sphingosine kinase; SMase, sphingomyelinase; SMS, sphingomyelin 
synthase; SPPase, sphingosine phosphate phosphatase; SPT, serine palmitoyl transferase. 
(Castro et al., 2014) 
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2007; Zhang et al., 2009). Ceramide plays important roles in a series of physiological 
and pathophysiological processes. First, the tightly packed ceramides strongly stabilize 
lipid rafts (Kolesnick et al., 2000; Xu et al., 2001). This stabilization of lipid rafts promote 
the formation of cell membrane domains into a lipid ordered state as mentioned above. 
Further, ceramide-enriched membrane domains serve the reorganization and clustering 
of receptor molecules, including CD95 (Grassme et al., 2001a; Grassme et al., 2001b), 
CD40 (Grassme et al., 2002), CD20 (Bezombes et al., 2004), FcγRII (Abdel Shakor et 
al., 2004), and CD28 (Boucher et al., 1995). Clustering of these receptors by ceramide 
may lead the very high receptor density, thus activating the downstream signaling 
molecules of the receptors, the exclusion of inhibitory molecules, conformational change 
Figure 1.2.2 B. Ceramide action in biological membranes.  
Biological membranes consist of sphingolipids (mainly sphingomyelin), cholesterol, and 
phosphoglycerides. Sphingolipids and cholesterol spontaneously interact with each other 
and separate from other phospholipids into distinct microdomains named rafts. The 
accumulation of ceramide, which is present ten times less abundant than sphingomyelin 
under normal conditions, changes the biophysical properties of these domains in the 
biological membranes. Ceramide molecules tend to self-associate and form ceramide-
enriched microdomains, which can further fuse to large ceramide-enriched platforms. 
These ceramide-enriched membrane platforms function in recruiting and clustering of 
receptor molecules (Kornhuber et al., 2014). 
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of the receptor, and stabilization of the interaction of the receptor with its ligand 
(Grassme et al., 2007). In addition, ceramide also function as second messenger. 
Ceramide has been shown interacting and activating different enzymes such as 
cathepsin D (Heinrich et al., 1999; Zebrakovska et al., 2011), phospholipase A2 
(Bharath et al., 2015; Huwiler et al., 2001), kinase suppressor of Ras (Zhang et al., 
1997), ceramide-activated protein serine–threonine phosphatases (Dobrowsky and 
Hannun, 1993), and protein kinase C isoforms (Hage-Sleiman et al., 2016). Recent 
studies have identified an important function of ceramide in infectious biology. Basically, 
ceramides seem to be involved in the interaction of pathogens with host receptors, 
receptor clustering, and intracellular signaling molecules. Several studies have shown 
the ceramide interaction of pathogens with host, Pseudomonas aeruginosa (Becker et 
al., 2010; Pewzner-Jung et al., 2014), Staphylococcus aureus (Peng et al., 2015), 
Neisseriae gonorrhoeae (Grassme et al., 1997), and viruses (Aktepe et al., 2015; Dai et 
al., 2015; Mueller et al., 2014). In summary, ceramide and ceramide-enriched 
membrane domains might act as a crucial motif to reorganize the topology of a given 
signalosome, thus permit the stress stimulation and receptors to transmit 
biophysiological signals into the cell. 
 
1.2.3 Acid sphingomyelinase 
Acid sphingomyelinase (ASM), a hydrolase first identified by Gatt and colleagues in 
1963 (Gatt, 1963), plays an important role in sphingolipids metabolism breaking down 
the sphingomyelin to ceramide and phosphorycholine. Acid sphingomyelinase (EC 
3.1.4.12; gene symbol SMPD1 for human and Smpd1 for murine) is 5-6 kb long and 
localizes to chromosome 11p15.1–11p15.4 containing six exons and five introns (da 
Veiga Pereira et al., 1991; Schuchman et al., 1992), which is cloned and sequenced 
from human placenta (Quintern et al., 1989). Human ASM cDNA codes a polypeptide of 
629 amino acids (Quintern et al., 1989; Schuchman et al., 1991) which shares 
approximately 82% amino acid identities to mouse acid sphingomyelinase (Newrzella 
and Stoffel, 1992). ASM is composed of three main domains: the N-terminal saposin 
domain, the proline-rich connector, and the catalytic domain (Gorelik et al., 2016; Xiong 
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et al., 2016). Deficiency of ASM results in the accumulation of sphingomyelin and 
causes lysosomal storage diseases, which are fatal neuropathic and visceral disease 
Niemann-Pick type A and a visceral anomalies disease Niemann-Pick type B (Brady et 
al., 1966; Schuchman, 2007; Schuchman et al., 1992). 
Originally studies have reported that ASM effects solely lysosomal at an optima pH of 
4.5-5.0 (Fowler, 1969), however recent studies suggest ASM catalyze the hydrolysis of 
LDL-sphingomyelin at a higher even neutral pH on the plasma membrane (Schissel et 
al., 1998a; Schissel et al., 1998b). The possible mechanism for the activity of different 
pH is that one single ASM gene generates two distinct enzymes: a lysosomal form ASM 
(L-ASM) and a secretory form ASM (S-ASM). The generation of two forms of ASM 
results from alternative modification and trafficking. First, the mutation of N-glycosylation 
sites affects the L-ASM and S-ASM catalytic activity and intracellular process (Ferlinz et 
al., 1997). The lysosomal trafficking of ASM is regulated by mannose-6-phosphorylation 
(M6P) receptor system in studies using fibroblasts with I-cell disease (Ferlinz et al., 
1997; Takahashi et al., 2005). Other mechanisms have been reported that a trans-Golgi 
network (TGN) transmembrane protein sortilin is suggested to play a critical role in L-
ASM trafficking along a Golgi-dependent route (Ni and Morales, 2006; Vazquez et al., 
2016; Wahe et al., 2010). The pre-pro-form of ASM with a 75kDa (65 kDa protein core) 
molecular weight enter in the Golgi thereby generating the pro-form of ASM with a 72-
75 kDa (63-64 kDa protein core) (Kornhuber et al., 2015). The S-ASM is released onto 
the outer leaflet of plasma membrane of a 75-80 kDa (64kDa protein core) protein 
molecular weight via the Golgi secretory pathway (Jenkins et al., 2010; Jenkins et al., 
2011), whereas the L-ASM matures and traffics to lysosome as a 57 kDa (43 kDa 
protein core) enzyme (Edelmann et al., 2011) or a 65 kDa (55 kDa protein core) enzyme 
(Jenkins et al., 2011). Further, activation of S-ASM is dependent of exogenous Zn2+ 
while L-ASM binds to Zn2+ ions on its way to lysosomal compartments resulting the 
independence of exogenous Zn2+ (Schissel et al., 1998b). Although several groups 
have studied the ASM, only a few of them discuss about the precise molecular 
mechanism in the regulation of lysosomal form of ASM and secretory form of ASM. It is 
23 
 
still unclear whether L-ASM and S-ASM hydrolyze differently from sphingomyelin pools, 
how it would cause different signaling in the cell. 
Various stimulations can regulate the activation of ASM. The enzyme can be directly 
activated by oxidation (Zhang and Li, 2010). Studies have shown oxidation of purified 
ASM by hydrogen peroxide at C-terminal residue (Cys629) resulting in enzyme 
dimerization and activation (Qiu et al., 2003). Activation of ASM by DR5 or Cu2+ is 
inhibited by reactive oxygen radical scavengers (Dumitru et al., 2007; Lang et al., 2007), 
although these studies do not conclude whether ASM activity is directly modulated by 
reactive oxygen species or by unknown intermediates. In addition, protease involves in 
the ASM activation. Inhibition of caspases by Ac-YVAD-chloromethylketone blocks the 
activation of ASM by CD95 (Brenner et al., 1998). Studies have demonstrated TNF-α 
initiates the interaction of the TNF-receptor with caspase-7, which mediates the 
proteolytic cleavage as a mode of ASM activation (Edelmann et al., 2011). Furthermore, 
isoforms of preotein kinase C (PKC) has been also shown to mediate the ASM 
activation. PKC δ serves as a key upstream kinase mediated phosphorylation of ASM at 
serine 508 (Zeidan and Hannun, 2007), which is recently confirmed by PKC δ-specific 
inhibitor abolishs the activation of ASM (Tsukamoto et al., 2012). Moreover, receptors 
such as CD95 (Dumitru and Gulbins, 2006; Grassme et al., 2001a; Grassme et al., 
2001b) or DR5 (Carpinteiro et al., 2008), infection with bacteria (Grassme et al., 2003) 
or viruses (Avota et al., 2011; Grassme et al., 2005; Shivanna et al., 2015), induce the 
translocation and activation of ASM onto extracellular leaflet. Upon CD95 stimulation, 
vesicles containing ASM traffic to plasma membrane which is mediated by SNARE 
protein syntaxin 4, thus ASM is exposed to outer leaflet of plasma membrane (Perrotta 
et al., 2010). Finally, ASM is activated upon stress stimuli such as, UVA light (Charruyer 
et al., 2007; Zeidan et al., 2008b), radiations and chemotherapeutic drugs (Garcia-
Barros et al., 2003; Lovat et al., 2004; Perrotta et al., 2007). Overall, although molecular 
mechanisms regarding regulation of acid sphingomyelinase are still partially known, the 
above studies elucidate several possible mechanisms of ASM activation.  
Among these above mechanisms of ASM regulation, the interaction of ASM with 
reactive oxygen species (ROS) is one of the best studied. Our group has recently 
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shown hydrogen peroxide induces the activation and translocation of ASM in different 
cells (Li et al., 2012; Manago et al., 2015; Zhang et al., 2008). On the other hand, 
studies suggest the inhibition of ROS by several ROS scavenger TIRON, N-
acetylcysteine (NAC), superoxide dismutase (SOD), catalase blocks the activation of 
ASM induced by different stimulation (Dumitru and Gulbins, 2006; Grammatikos et al., 
2007; Lang et al., 2007; Zhang et al., 2008). Mechanically, the superoxide production 
induced activation of ASM is inhibited by a nicotinamide adenine dinucleotide 
phosphate (NADPH)-oxidase inhibitor diphenyleneiodonium chloride (DPI) (Zhang et al., 
2008). Genetic silence of a NADPH oxidase subunit gp91phox inhibits lipid raft formation 
induced by ASM activation (Boini et al., 2010). Another possible mechanism is that the 
direct oxidation of ASM at C-terminal cysteine residue 629 results in the activation of 
enzyme (Qiu et al., 2003). These evidences indicate ROS is required for the activation 
of ASM, although it is still unclear whether ROS regulates the enzyme activity directly or 
indirectly with other unknown mechanisms. 
 
1.2.4 ASM and ceramide system in bacterial infection 
Several reviews have shown ASM-ceramide system plays critical role in a wide range of 
cellular bioprocesses, such as cell death, proliferation, growth and differentiation 
(Beckmann et al., 2014; Henry et al., 2013; Perrotta et al., 2015; Wasserstein and 
Schuchman, 1993; Zeidan and Hannun, 2010). The alteration of ASM-ceramide system 
is involved in several pathological processes, such as genetic diseases (Aykut et al., 
2013; Ranganath et al., 2016), tumor development (Carpinteiro et al., 2015; Carpinteiro 
et al., 2016), brain function and behavior (Grassme et al., 2015; Gulbins et al., 2016a; 
Gulbins et al., 2016b; Gulbins et al., 2013), atherosclerosis (Deevska et al., 2012; 
Kobayashi et al., 2013), and pathogenic infections (Avota et al., 2011; Gassert et al., 
2009; Grassme et al., 1997; Grassme et al., 2005; Peng et al., 2015). Particularly, the 
interaction of bacterial infection and ASM-ceramide emerges as a novel research 
direction. Since ASM is located intracellular in lysosome and extracellular on the plasma 
membrane, and ceramide contribute to the formation of the plasma membrane, it is 
reasonable to expect ASM-ceramide system to be associated in the bioprocess of 
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bacteria invasion and killing. The studies related to ASM-ceramide sysyem and bacteria 
as well as bacteria generated toxin are listed in table 1. 
Bacteria/toxin Mechanism References 
P. aeruginosa IL-1 released, septic death (Grassme et al., 2003) 
 NADPH oxidase activation, ROS production (Zhang et al., 2008) 
 gp91phox clustering, ROS production (Zhang et al., 2010) 
 IL-8 release (Yu et al., 2009) 
 Pulmonary inflammation, cells death (Teichgraber et al., 2008) 
 CD95 clustering, epithelial cell death (Becker et al., 2012) 
S. aureus Cytochrome C release, cell apoptosis (Esen et al., 2001) 
 ROS formation, tight junction degradation (Peng et al., 2015) 
M. avium Granuloma formation (Utermohlen et al., 2008) 
M. marinum Macrophage necrosis (Roca and Ramakrishnan, 
2013) 
M. tuberculosis Phagosome maturation (Vazquez et al., 2016) 
L. monocytogenes Fusion of late phagosomes with lysosomes (Schramm et al., 2008) 
 Cytokine release, reactive nitrogen release (Utermohlen et al., 2003) 
N. gonorrhoeae CEACAM receptor-mediated phagocytosis (Hauck et al., 2000) 
 Activation of PC-PLC (Grassme et al., 1997) 
N. meningitidis Internalization of bacteria (Simonis et al., 2014) 
E. coli Dendritic cells apoptosis (Falcone et al., 2004) 
 Cytokine release (Hedlund et al., 1998) 
Salmonella ROS generation (McCollister et al., 2007) 
P.acnes Hijacking host ASM (Nakatsuji et al., 2011) 
LPS Dendritic cells apoptosis (Falcone et al., 2004) 
 TNF-α and MIP-2 release (Jozefowski et al., 2010) 
 Pulmonary inflammation (McCollister et al., 2007) 
 Endothelial cell apoptosis (Haimovitz-Friedman et al., 
1997) 
Pyocyanin Neutrophil cell death, ROS release (Manago et al., 2015) 
α-toxin α-toxin binding, host cell necrosis (Brauweiler et al., 2013) 
  
It was firstly shown in 2001 that S. aureus infection triggers ASM activation and 
ceramide production in human endothelial cells (Esen et al., 2001). Genetic deficiency 
of ASM significantly inhibits the cell death of human fibroblasts triggered by S. aureus, 
which regulates the stimulation of JNK signaling pathway and alteration of mitochondrial 
function. The functional inhibition of JNK by Tam67 gene transfection prevents the S. 
aureus induced cell apoptosis. These results are consistent with the finding that ASM 
and ceramide enriched platforms mediate macrophage apoptosis via stimulation of JNK 
upon P. aeruginosa infection (Zhang et al., 2008).  
Table 1 Bacterial infection and acid sphingomyelinase/ceramide system. 
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Recently, it was found that genetic deficiency or pharmacological inhibition of ASM 
protects mice against pneumonia and lethal S. aureus sepsis (Peng et al., 2015). ASM 
is activated by S. aureus in endothelial cells thereby the ceramide enriched platforms 
are generated. ASM activation triggers the release of superoxide whereas the ASM is 
inhibited by antioxidants. The ASM-ceramide system and ROS acts as a positive 
feedback loop mechanism upon S. aureus infection which is similar to the findings of 
previous studies (Zhang et al., 2008). ASM-ceramide triggered superoxide production 
induces degradation of tight junction proteins ZO1, ZO2, occluding and E-cadherin upon 
S. aureus infection in vitro or in vivo, which was reduced by inhibition of ASM by 
amitriptyline or antioxidants. Several evidences have demonstrated that the superoxide 
is responsible for the degradation of tight junctions via proteolytic enzymes matrix 
metalloproteinases (MMP) (Abdul-Muneer et al., 2015; Gu et al., 2011; Rochfort et al., 
2014). Moreover, ASM has been shown positively regulating the transcription of MMP 
mRNA and expression of protein (Bauer et al., 2009a; Bauer et al., 2009b; Butler et al., 
2007). 
S. aureus is a primary cause of sepsis and lethal lung edema even with the treatments 
of antibiotics clinically. A series of antibiotics were used to clear the bacteria burden in 
the mice however the mice still died because of lung edema. Mice with ASM inhibitor 
amitriptyline treatments or ASM gene deficiency reduces the lung edema by reducing 
the degradation of tight junction and preventing the myeloid cell trafficking (Peng et al., 
2015). However, the bactericidal capacity is also reduced since dysfunction of ASM 
results the fail of clustering and activating NADPH oxidase, resulting the susceptibility 
and high mortality of mice to the S. aureus infection. A combination of antibiotics with 
ASM deficiency or pharmacological inhibition successfully rescues the mice from 
lethality of S. aureus infection. This combination is sufficient to clear the bacteria with a 
protection of tight junction protein degradation which suggesting a novel therapeutic 
approach to treat lung edema and bacteremia in S. aureus induced sepsis. 
Staphylococcal alpha-toxin (α-toxin) appears to function by forming pores in cell 
membranes, damaging the membrane permeability, eventually triggering the cell death. 
α-toxin is secreted as water soluble monomer protein, once they reach the targets they 
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are capable of binding and oligomerization into a heptameric structure, therefore 
inserting or translocating across the cell membrane of the host (Gouaux et al., 1994; 
Song et al., 1996). ASM-ceramide system is found protecting against staphylococcal α-
toxin induced keratinocyte death (Brauweiler et al., 2013). Filaggrin is a protein critical 
for epidermal skin barrier function (Irvine et al., 2011). α-toxin targets and damages the 
filaggrin deficient or undifferentiated keratinocytes. The differentiation process leads to a 
significant increase of expression of ASM mRNA and protein. Gene silence of filaggrin 
reduces the both the amount and activity of secreted ASM but not the intracellular ASM 
activity. ASM is sufficient to protect cell death against α-toxin by reducing expression of 
α-toxin receptors and the binding of α-toxin with receptors (Brauweiler et al., 2013). 
ASM-ceramide system is also involved in several other host bacteria infection. Upon 
Pseudomonas aeruginosa (P. aeruginosa ) infection, ASM is activated and translocated 
to the extracellular leaflet of the plasma membrane which stumilates the ceramide 
generation and platform formation, thus mediates the bacteria internalization and killing, 
cytokine such as IL-1β release, cell death, inflammatory response, and susceptibility to 
bacteria challenge (Grassme et al., 2003; Teichgraber et al., 2008; Yu et al., 2009; 
Zhang et al., 2008; Zhang et al., 2010).  Further, ASM generated ceramide promotes 
bacteria killing and cell death in the infection of macrophages with pathogenic 
mycobacteria (Roca and Ramakrishnan, 2013; Vazquez et al., 2016). ASM deficiency 
highly impairs the bactericidal capacity of mice challenging the Listeria Monocytogenes  
(L. Monocytogenes), which due to the fail of macrophages intracellular bacteria killing 
involving the listeriocidal proteases cathepsin D, B and L (Utermohlen et al., 2003). In 
addition, ASM generated ceramide mediates interaction of pathogenic Neisseria with 
host receptors carcinoembryonic antigen related cellular adhesion molecule (CEACAM) 
or tyrosine kinase ErbB2 regulated phagocytosis in phagocytic or non-phagocytic cells 
(Grassme et al., 1997; Hauck et al., 2000; Simonis et al., 2014). The activation of ASM 
and generation of ceramide and their exposure to NO depend on the cGMP formation 
during the infection process of Escherichia coli (E. coli) (Falcone et al., 2004). 
Salmonella triggers a significant increase in the secreted fraction of ASM (McCollister et 
al., 2007). Recent studies have shown host ASM also involves in the P. acnes virulence 
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Figure 1.2.4 ASM-ceramide system in the bacteria-host interaction.  
1. Overview of ASM in the bioprocess of infection. Bacteria induce activation of ASM and 
release of ceramide, which recruit signaling molecules and receptors, such as NADPH 
oxidase, ErbB2, JNK, CFTR, CD95, JNK, and p38 kinase, therefore modulating ROS 
generation, cytokine release, host cell death, and bacterial killing. 2. ASM generated 
ceramide recruit molecules and receptor and mediate bacteria internalization. 3. 
Inflammatory cytokines including TNF-α and IL-1β stimulates the secretion of ASM. 4. 
ASM-ceramide system is needed for phagolysosome maturation. 5. ASM-ceramide system 
is involved in mitochondria induced cell death upon infection. 
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induced inflammation (Nakatsuji et al., 2011). 
ASM-ceramide system has been shown to be crucially in the regulation of host 
interaction with bacteria, including P. aeruginosa, S. aureus, mycobacteria, L 
monocytogenes, Neisseria, E. coli, Salmonella, P. acnes and bacteria toxins. Fig. 1.2.4 
shows the presumable role of ASM-ceramide system in the bacterial infection process 
on the cells. The infection of mammalian cells with bacteria triggers the activation of 
ASM and secretion of ASM onto membrane and extracellular environment. The ASM 
generated ceramide initiate the lipid raft organization thereby mediating the bacteria 
acting on host cells. ASM facilitates the activation of NADPH oxidases which involves 
generating of superoxide, known to be responsible for bacteria killing and regulate the 
cell apoptosis. The ceramide platforms critically mediate the internalization of bacteria 
into host cells. Moreover, ASM generated ceramide modifies the membrane biophysical 
properties and recruits receptor molecules, thereby modulating the fusion of phagosome 
and lysosome. In addition, ASM have an influence on the cytokine release, 
inflammatory response, and the susceptibility of mice. Taken together, although the 
detail mechanism of ASM-ceramide system acting on bacterial infection remains to be 
further studied, strong evidences shows the central role of this system in bacteria host 
interactions. Targeting the ASM-ceramide system is a novel potential therapeutic 
approach for treating bacterial infection. 
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1.3 CD44 
1.3.1 Structure of CD44  
CD44 is a widely expressed glycoprotein on the surface of a diverse variety of cell types, 
including endothelial cells, epithelial cells, chondrocytes, fibroblasts, keratinocytes, 
neural cells and leukocytes (Orian-Rousseau and Ponta, 2015; Sherman et al., 1994). 
CD44 is a transmembrane hyaluronan-binding protein which mediates the cell adhesion 
and migration in multiple physiological and pathophysiological processes, such as tumor 
development and metastasis (Karousou et al., 2016; Misra et al., 2015), wound healing 
(Prosdocimi and Bevilacqua, 2012; Tolg et al., 2014), inflammatory diseases (Johnson 
and Ruffell, 2009), leukocyte extravasation (McDonald and Kubes, 2015), neurological 
disorders (Dzwonek and Wilczynski, 2015), bacterial and viral infections (Abe et al., 
2012; Garay et al., 2016). 
The CD44 proteins range in molecular weight from 80 to 250 kDa and encoded by a 
single highly conserved gene (Screaton et al., 1992). The variation of CD44 protein 
forms is partially resulted from post-translational modifications, which depends on the 
cell type and growing status. Moreover, alternative splicing, the regulated alternative 
usage of exons during pre-mRNA splicing, affects the CD44 transcription mainly of 
extracellular, membrane-proximal stem structure of CD44 proteins (Gunthert et al., 1991; 
Stamenkovic et al., 1991). 
Structurally, the protein consists of three regions, an amino-terminal domain, a stem 
structure, and a transmembrane and cytoplasmic-tail region (Fig. 1.3.1). The 
hyaluronan-binding amino-terminal globular protein domain is encoded by non-variable 
exons 1 to 5 of CD44, which is considerable conserved between mammalians and is 
recognized to fold into a globular tertiary structure by the forming disulphide bonds 
between three pairs of cysteine residues (Goodison et al., 1999). This domain serves as 
a docking site for multiple components of the extracellular matrix (ECM) and interacts 
with ECM such as hyaluronan (Evanko et al., 2015; Konopka et al., 2016), fibronectin 
(Pal et al., 2013; Viana et al., 2015), collagen and laminin (Damodarasamy et al., 2014; 
Garrett et al., 2007; Golan et al., 2016), although the binding mechanism has not been 
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studied precisely. Further, the domain, containing 90 amino acid residues from 32 to 
123, is considered as a link domain which enables the binding of CD44 with hyaluronan 
and other glycosaminoglycans (Sherman et al., 1994; Sleeman et al., 1997). This 
hyaluronan binding motif presents similar homology with both the cartilage link protein 
and with the proteoglycan core protein (Naor et al., 1997). 
Figure 1.3.1 CD44 transcripts and proteins. 
a. 20 exons encode the CD44 pre-mRNA, 10 of which are variant exons regulated by 
alternative splicing. b. The smallest CD44 isoform (CD44s) and largest variant isoforms 
CD44v1–10 shows that the sequences encoded by the variant exons are in the stem region. 
c. The amino-terminal domain of CD44 proteins contains the hyaluronan-binding motifs and 
a basic motif outside the link domain. The interchain disulphide formed by cysteine residues 
is important for the stability of the link module. d. The stem structure of CD44s is composed 
of 46 or up to 381 variant-exon-encoded amino acids in human or 423 in mouse amino acids, 
as shown for CD44v1–10. e. The cytoplasmic domain supports the binding of proteins which 
is critical for cytoskeletal organization and signalling. Amino acids 292–300 are binding sites 
for Ezrin, radixin, moesin (ERM) proteins and amino acids 304–318 are for ankyrin. 
Basolateral distribution of CD44 is related to amino acids 331 and 332 (Ponta et al., 2003).  
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The stem structure of CD44 contains 46 amino acids and separates the amino-terminal 
globular domain of the smallest CD44 isoform (the standard isoform or CD44s) from cell 
membrane. This stem contains putative proteolytic cleavage sites for 
metalloproteinases ADAM-10 and ADAM-17, or membrane type 1-matrix 
metalloproteinase (Nagano and Saya, 2004; Okamoto et al., 1999). The stem structure 
can be enlarged to 381 amino acids in human by sequences which are encoded by 
alternatively spliced variant (v) exons of CD44. The inclusion of variant exons is partially 
dependent on mitogenic signals which modulate alternative splicing (Konig et al., 1998; 
Weg-Remers et al., 2001). For example, sequence encoded by exon v3 contains a 
heparan-sulphate site interacting with heparin-binding protein (Suga et al., 2012). 
The highly conserved cytoplasmic region is encoded by part of C-terminal exon 18, 19 
and 20 (Goldstein and Butcher, 1990). The hydrophobic transmembrane domain is 
encoded by conserved exon 18 and is composed of 23 hydrophobic amino acids and a 
cysteine residue. Importantly, the transmembrane region is critically involved in lipid raft-
mediated regulation of Hyaluronan-CD44 Interactions (Murai, 2015; Neame et al., 1995). 
Binding of intracellular proteins with cytoplasmic tail regulates the interaction of CD44 
with the cytoskeleton. The first identified CD44 binding protein ankyrin mediates contact 
with the cytoskeletal component spectrin (Lokeshwar and Bourguignon, 1991; Wang et 
al., 2014). In addition, ezrin, radixin and moesin proteins (ERM), importantly for 
regulation of cell shape and migration, interact with a basic-amino-acid motif in the 
cytoplasmic tail of CD44. Recent studies have implicated Smad1 interactions with 
activated CD44 bound to ERM protein and linked to actin cytoskeletons (Mori et al., 
2008). Phosphorylation of Ser291 modulates the interaction between CD44 and ezrin in 
vivo which is critical for CD44-dependent directional cell motility (Legg et al., 2002). 
Cytoplasmic tail of CD44 also regulates the activation of Rho family of GTPase 
(Bourguignon, 2008; Bourguignon et al., 2010; Ohata et al., 2012). 
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1.3.2 Mechanism of CD44 function 
CD44 independently or in collaboration with other cell surface or intracellular molecules 
induces multiple biological activities, including inflammatory response, cell death and 
proliferation, and cytoskeleton reorganization. The signaling output of CD44-involved 
pathway is shown in Fig. 1.3.2 (Naor et al., 2002). Presumably, function of CD44 can be 
proposed as three parts: First, CD44 serves as a ligand-binding receptor by interacting 
with ECM or presents as a specialized 'platform' for growth factors and matrix 
metalloproteinases (MMPs). Second, CD44 can function as a co-receptor to activate 
growth factor receptors. Third, CD44 is involved in reorganization of cortical actin 
cytoskeleton (Ponta et al., 2003). 
CD44 functions as a ligand-binding surface protein and interact with soluble 
extracellular components as well as ECM. These interactions trigger cellular responses 
and a passive adhesive function, or represented as a cell-surface protein that binds 
enzymes and their substrates. The binding affinity of CD44 with hyaluronan is regulated 
intracellular demonstrated by mitogenic stimulated upregulation of binding affinity and 
by phosphorylation of serine residues in the cytoplasmic tail of CD44 (Orian-Rousseau 
and Ponta, 2015; Vigetti et al., 2014). Regulation of binding affinity is critical for 
leukoctye migration and rolling. Studies have shown proteolytic cleavage might be 
another mechanism of regulated CD44–hyaluronan binding (Okamoto et al., 1999; 
Okamoto et al., 2002). The inhibition of CD44 cleavage leads to the block of tumor cell 
migration on a hyaluronan substrate. In addition, CD44 is implicated in several passive 
functions which possibly do not require direct activation of signalling cascades. For 
instance, hyaluronan can function as an adhesive bridging molecule between cells. 
CD44 is also involved in axon pathfinding. 
CD44 proteins can function in trapping and concentrating molecule relevant for growth, 
and bringing substrates and enzymes into interacting with one and another. CD44 
recruits MMP9, an enzyme which facilitates degradation of collagen IV and regulates 
tumor cell invasion on the plasma membrane (Miletti-Gonzalez et al., 2012). Activating 
of precursor pro-form of transforming growth factor (TGF)-beta by MMP9 requires its 
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FIGURE 1.3.2 CD44-involved signal transduction pathway and function.  
CD44 either independently or in collaboration with other signal transduction molecules 
(shadowed boxes and the bold, non-framed abbreviations) regulates multiple biological 
signaling pathways. The broken lines implicate the coupling mechanism between this 
receptor and the signaling elements need to be elucidated. CD44 connected TCR with 
double-headed arrow shows the structural and functional association between these two 
receptors. Abbreviations: Cdc42, homologous to yeast cell division cycle gene 42; ERK, 
extracellular signal regulated kinase; GEF, guanine exchange factor; HA, hyaluronic acid; 
IκB, inhibitor of NK-κB; IKK, IκB kinase; MAPK, mitogen-activated protein kinase; MAPKAPK, 
mitogen-activated protein kinase activated protein kinase; MEK, MAPK/ERK kinase; MEKK, 
MEK kinase; NIK, NF-κB-inducing kinase; OPN, osteopontin; PAK, p21-activated kinase; 
PI3-K, phosphatidylinositol 3-OH-kinase; PKC, protein kinase C; PLC, phospholipase C ;Ptd 
Ins 4,5 P2, phosphatidylinositol-4,5-biphosphate; Ptd Ins 3,4,5 P3, phosphatidylinositol-3,4,5-
triphosphate; Rac, Ras-related C3-botulinum toxin substrate; Ras, rat sarcoma virus; Rho, 
Ras homologous; ROK, Rho-kinase; SAPK, stress-activated protein kinase; SEK, SAPK/ERK 
kinase; TCR, T cell receptor. (Naor et al., 2002) 
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binding to CD44 on the cell surface, thereafter the TGF-beta triggers  
neovascularization (Yu and Stamenkovic, 2000). Moreover, CD44 recruits MMP7 to the 
cell surface, a signaling pathway accounts for the suppression of apoptosis in tumor 
cells (Okayama et al., 2009). The isoforms of CD44 proteins containing exon v6- and 
v7-encoded sequences interact with phosphorylated acidic glycoprotein osteopontin 
(OPN) which has been shown in involving inflammation (Higashi et al., 2015; Liu et al., 
2015). Deficiency in exons v6 and v7 results in significantly reduced inflammation on 
induction of experimental colitis (Denhardt et al., 2001). 
CD44 can function as co-receptors in signal transduction. CD44 isoforms containing 
exon v6 sequences serve as a co-receptor for the activation of mesenchymal–epithelial 
transition factor (Met) (Ghatak et al., 2014; Taher et al., 1999). Activation of Met is 
dependent on CD44 variants with exon-v6-encoded sequences experession. CD44 also 
act as a co-receptor for the ErbB receptor tyrosine kinase family (Palyi-Krekk et al., 
2008; Sherman et al., 2000). For example, v3 isoform of CD44 interferes with the CD44-
EGFR/ErbB2 interaction, alters the ERK1/2 and p38 MAPK thereby regulating cell 
proliferation and migration (Hernandez et al., 2011). CD44 cytoplasmic tail interacts with 
multiple intracellular proteins which are function in signaling transduction. These 
proteins include Src, small Rho GTPase, Rho GDP-dissociation inhibitor (GDI), proto-
oncogene protein-tyrosine kinases LCK and FYN and PKC (Naor et al., 1997). The 
platform and co-receptor functions together and are responsible for the action of CD44 
in tumor development, inflammation and autoimmune disease. 
CD44 interacting with proteins linked to actin cytoskeleton is crucial for actin dynamics. 
One of these proteins is ERM protein, which is required for the internalization of Met 
mediated by CD44 (Hasenauer et al., 2013). Met-mediated signaling from the 
endosomes depends on its collaboration with CD44v6 and the link to the cytoskeleton 
provided by ERM proteins. Cytoplasmic tail recruits ERM proteins to the complex of 
CD44v6, c-Met, and HGF, a process initiated by ERM interacting with coreceptor which 
is absolutely necessary for mediating the HGF-dependent activation of Ras (Orian-
Rousseau et al., 2007). In addition, Hyaluronidase-2 (Hyal2), the major enzyme for 
hyaluronan metabolism, directly interacts with CD44 and inhibits the formation of 
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glycocalyx thereby suppressing ERM-related cytoskeletal interactions and diminishes 
cell motility (Duterme et al., 2009). These data implicate that the actin cytoskeleton 
linked ERM proteins plays an important role in the signal transduction regulated by 
CD44. 
 
1.3.3 CD44 in bacterial infection 
CD44 has been implicated in a variety of diseases, including cancer, arthritis, 
cardiovascular disease, wound healing and infections (Jordan et al., 2015; Orian-
Rousseau and Ponta, 2015). Recent studies have demonstrated CD44 emerges as a 
new role in physiological and pathological processes of bacterial infection. 
CD44 is crucially involved in host pathogen interaction, particularly in activation and 
migration of lymphocytes (Siegelman et al., 1999). CD44 has also been shown 
connected to generation of antimicrobial peptides (Hill et al., 2013). In addition, 
pathogens can utilize the CD44-HA signaling for progression of infections and resulting 
severe consequences. CD44 is required for the activation, homing, and extravasation of 
lymphocytes into inflammatory sites (DeGrendele et al., 1997; Denning et al., 1990). 
Hyaluronan derived from human milk induces generation of human β-defensin 2 (HβD2) 
which enhances resistance to infection in the intestinal epithelium (Hill et al., 2013). 
These studies have suggested that CD44–HA signaling stimulates protective 
antimicrobial defense during early infancy. Similarly, studies have implicated the 
contribution of CD44-HA to innate defense response which is TLR4-dependent (Hill et 
al., 2012). 
Several studies have implicated CD44 directly or indirectly interacting with bacteria and 
host cells. For instance, capsular polysaccharide of group A Streptococcus (GAS) which 
has a similar size to mammalian cells adheres to human keratinocytes through its 
hyaluronan-rich polysaccharide capsule (Schrager et al., 1998). In vivo studies have 
shown transgenic mice with reduced CD44 expression significantly inhibits binding of 
CD44 with GAS and colonization (Cywes et al., 2000). In addition, molecular mass 
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difference of HA for macrophage-mediated phagocytosis of GAS can influence the GAS 
virulence. High molecular mass HA facilitates GAS deep tissue infections, whereas the 
generation of short-chain HA can be protective (Schommer et al., 2014). 
CD44 is involved in pneumonia caused by Escherichia coli. Deficiency of CD44 results 
in increasing of several inflammation related mRNA expression and neutrophil 
accumulation (Wang et al., 2002). However, this is not observed in Streptococcus 
pneumoniae-induced pneumonia which may due to the latter expressing of 
hyaluronidase, in turn decreasing CD44–HA regulated signaling and the downstream 
induction of inflammation. Further studies have demonstrated CD44 facilitates bacterial 
outgrowth and dissemination during pneumococcal pneumonia, which in lethal infection 
results in a prolonged survival of CD44 KO mice (van der Windt et al., 2011). CD44 has 
been previously shown to play a critical role in resolving lung inflammation (Teder et al., 
2002).  
CD44 has been implicated interacting with infection process of several other bacteria 
including Helicobacter pylori (Khurana et al., 2013), Listeria monocytogenes (Jung et al., 
2009), and Shigella (Lafont et al., 2002). CD44 deficiency or inhibition by a peptide 
PEP-1 generates significantly less proliferating isthmus stem cells than wild type after 
infection with Helicobacter pylori. CD44 is required for the entry of bacteria and localizes 
at the plasma membrane of cellular extensions induced by Shigella (Lafont et al., 2002). 
In addition, the collaboration of c-Met and CD44 contributes to the invasion of L. 
monocytogenes into host cells by the binding of a secreted bacterial protein IpaB. Once 
invaded intracellular, CD44 and ezrin become localized at the site of the membrane 
before protrusion formation (Sechi et al., 1997).  
Taken together these studies implicate that CD44 signaling plays a central role in 
bacterial infection and host inflammatory response, which helps to develop various 
strategies for targeting of CD44 and CD44-based therapeutic interventions. 
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1.4 Aim of study 
Staphylococcus aureus is one of the major human pathogen which causes a variety of 
clinical infections including pulmonary infections (Lowy, 1998; Tong et al., 2015). S. 
aureus has evolved multiple comprehensive mechanisms to avoid the killing by human 
immune system, thus to survive extreme conditions and replicate within the host (Liu, 
2009). Antibiotics are preferred and effective treatment for S. aureus infections for a 
long time, however, antibiotic resistance becomes a severe threaten to this pathogen 
infection. Lack of efficacious ways treating staphylococcal infection leads to an 
increasing for clinical outcome even death and financial cost. It is important and urgent 
to find more therapeutic target for fighting against S.aureus infection. 
Recent studies have implicated diverse functions of ceramide in infections, which 
suggest ASM-ceramide system plays an important role in the regulation of balance of 
the host and the microbe (Grassme and Becker, 2013). Our group has revealed that 
ASM-ceramide system regulates the interaction of several pathogens with host cell. In 
particular, our group firstly demonstrated in 2001 that S. aureus infection triggers ASM 
activation and ceramide production in human endothelial cells (Esen et al., 2001). 
Further, we identified that genetic deficiency or pharmacological inhibition of ASM 
protects mice against pneumonia and lethal S. aureus sepsis (Peng et al., 2015). In the 
study, ASM-ceramide triggered superoxide production induces degradation of tight 
junction protein in endothelial cells in vitro and in vivo. ASM deficiency or 
pharmacological inhibition prevents the myeloid cell trafficking. However, the 
mechanism of ASM-ceramide system interacting with macrophages in S. aureus 
induced lung injury even host death is still unknown. Macrophages are the most 
numerous immune-cells present in the lung environment which play a critical role in 
innate immunity and the clearance of S. aureus infection (Foster, 2005; Pozzi et al., 
2015). 
The present study was performed to investigate the role of the Asm-ceramide system in 
the infection of macrophages with S. aureus. We identified CD44 as a novel receptor for 
S. aureus binding. CD44 is intimately connected with the Asm, clusters in ceramide-
enriched domains after infection, which amplifies CD44 signaling and results in further 
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activation of the Asm and thereby in a positive forward feedback loop between CD44 
and the Asm. CD44 activation by S. aureus stimulates small-G proteins, a re-
organization of the cytoskeleton, internalization of the pathogen and fusion of 
phagosomes with lysosomes, a process that requires again Asm. Deletion of CD44 or 
the Asm prevents internalization of S. aureus. 
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2. Materials 
2.1 Chemicals 
Acetic acid Merck KGaA, Darmstadt, Germany 
Acetone Merck KGaA, Darmstadt, Germany 
Acrylamide (C3H5NO) Carl-Roth GmbH & Co, Karlsruhe 
Agarose  Gibco, Invitrogen,Karlsruhe, Germany 
Ammonium persulfate (APS) Carl-Roth GmbH & Co, Karlsruhe 
Bovine serum albumin (BSA) Sigma-Aldrich Chemie GmbH, Steinheim 
β-mercaptoethanol Sigma-Aldrich Chemie GmbH, Steinheim 
Bromphenol blue Sigma-Aldrich Chemie GmbH, Steinheim 
Calcium chloride  (CaCl2) Sigma-Aldrich Chemie GmbH, Steinheim 
Cardiolipin Sigma-Aldrich Chemie GmbH, Steinheim 
Chloroform (CHCl3) Applichem GmbH, Darmstadt, Germany 
CDP-STAR with Nitro-Block II enhancer PerkinElmer, Boston, USA 
Dithiothreitol Carl-Roth GmbH & Co, Karlsruhe 
Dimethylsulfoxid (DMSO) Sigma-Aldrich Chemie GmbH, Steinheim 
Enhanced chemiluminescence (ECL) Thermo Scientific, USA 
Ethanol (C2H5OH) Sigma-Aldrich Chemie GmbH, Steinheim 
Ethylenediamine Tetraacetic Acid Serva Electrophoresis GmbH, Heidelberg 
Fetal calf serum (FCS) Gibco, Invitrogen, Karlsruhe 
Formamide Sigma-Aldrich Chemie GmbH, Steinheim 
Gentamycin Sigma-Aldrich Chemie GmbH, Steinheim 
Glucose (C6H12O6) Sigma-Aldrich Chemie GmbH, Steinheim 
Glycerol (C3H8O3) Fluka Chemie GmbH, Buchs 
Glycine (C2H5NO2) Applichem, GmbH, Darmstadt, Germany 
HEPES Carl-Roth GmbH & Co, Karlsruhe 
Hydrochloric acid (HCl) Sigma-Aldrich Chemie GmbH, Steinheim 
Isopropanol  Sigma-Aldrich Chemie GmbH, Steinheim 
Ketamine Ceva Tiergesundheit GmbH, Duesseldorf 
Magnesium chloride (MgCl2) Sigma-Aldrich Chemie GmbH, Steinheim 
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Magnesium sulphate (MgSO4) Sigma-Aldrich Chemie GmbH, Steinheim 
Methanol Fluka Chemie GmbH, Buchs 
Monopotassium phosphate (KH2PO4) Merck KGaA, Darmstadt, Germany 
Mowiol Kuraray Specialities GmbH, Frankfurt 
NP-40 (Igepal) Sigma-Aldrich Chemie GmbH, Steinheim 
Paraformaldehyde (PFA) Sigma-Aldrich Chemie GmbH, Steinheim 
Pepsin Invitrogen, Frederick, USA 
Potassium chloride (KCl) Sigma-Aldrich Chemie GmbH, Steinheim 
Protease inhibitor Carl-Roth GmbH & Co, Karlsruhe 
Saponin Serva Electrophoresis GmbH, Heidelberg 
Sodium acetate (CH3COONa) Sigma-Aldrich Chemie GmbH, Steinheim 
Sodium chloride (NaCl) Carl-Roth GmbH & Co, Karlsruhe 
Sodium dodecyl sulphate (SDS) Serva Electrophoresis GmbH, Heidelberg 
Sodium fluoride (NaF) Sigma-Aldrich Chemie GmbH, Steinheim 
Sodium hydroxide (NaOH) Sigma-Aldrich Chemie GmbH, Steinheim 
Sodium phosphate (Na2HPO4) Merck, Darmstadt 
Sodium pyrophosphate (Na4P2O7) Sigma-Aldrich Chemie GmbH, Steinheim 
Tryptic soy broth (TSB) BD Biosciences, Heidelberg, Germany 
Tris-HCl and Tris-Base Carl-Roth GmbH & Co, Karlsruhe 
Triton X-100 Sigma-Aldrich Chemie GmbH, Steinheim 
Tween-20 Sigma-Aldrich Chemie GmbH, Steinheim 
Xylazin Ceva Tiergesundheit GmbH, Duesseldorf 
Xylene Applichem GmbH, Darmstadt, Germany 
 
2.2 Antibodies 
Goat anti-Armenian hamster 
immunoglobulin G 
Jackson ImmunoResearch, USA 
Rabbit anti-S. aureus antibody IgG Abcam, USA 
Mouse anti-S. aureus antibody IgG Abcam, USA 
Rabbit anti-phospho-ERM antibody IgG Cell Signaling Technology, USA 
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Rabbit anti-Ezrin antibody IgG Cell Signaling Technology, USA 
Rat anti-CD44 antibody IgG Abcam, USA 
Mouse anti-ceramide antibody IgM Glycobiotech, Germany 
FITC-phalloidin Sigma, USA 
Fluorescent secondary antibodies Jackson ImmunoResearch, USA 
Mouse anti-RhoA antibody Cytoskeleton inc., USA 
Mouse anti-Rac1 antibody Cytoskeleton inc., USA 
Mouse anti-Rac1 antibody Cytoskeleton inc., USA 
Beta-actin Santa Cruz, USA 
 
2.3 Tissue culture materials 
MEM Gibco/Invitrogen, Karlsruhe 
Fetal Calf Serum (FCS) Gibco/Invitrogen, Karlsruhe 
L-Glutamine Gibco/Invitrogen, Karlsruhe 
Penicilin/Streptomycin Gibco/Invitrogen, Karlsruhe 
Sodium pyruvate Gibco/Invitrogen, Karlsruhe 
 
2.4 Equipments 
Cell culture incubator ThermoFisher Scientific, MA, USA 
Cell culture flask Corning Inc., NY, USA 
Cell culture, 6, 24 and 96 well plate Corning Inc., NY, USA 
Cell scraper TPP, Trasadingen, Switzerland 
Cell strainer Becton Dickinson Labware, France 
Conical centrifuge tubes BD Falcon, USA 
Cover slips Carl-Roth GmbH & Co, Karlsruhe 
Cuvettes Sarstedt, Nümbrecht, Germany 
Hybond ECL nitrocellulose membrane GE Healthcare, USA 
Leica DMI-4000 fluorescence microscope Leica Microsystem, Mannheim, Germany 
Leica TCS SP5 confocal microscope Leica Microsystem, Mannheim, Germany 
Microscopic slides Engelbrecht Medizin und labortechnik 
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GmbH, Germany 
Parafilm Peckiney, Chicago, IL, USA 
Rotary agitator Neolab Migge Laborbedarf-Vertriebs 
GmbH,Germany 
Silica G60 TLC plates Merck, Darmstadt, Germany 
SpeedVac ThermoFisher Scientific, MA, USA 
Thermomixer Eppendorf, Germany 
Typhoon FLA 9500 laser scanner GE Healthcare Life Sciences, USA 
X-ray films FUJIFILM Medical Systems, USA 
 
2.5 Buffers 
Agarose gel (0.8%) 0.8 g agarose 
100 ml TAE buffer 
Alcaline phosphatase wash buffer 100 mM Tris/HCl pH 9.5 
100 mM NaCl 
Anesthesia cocktail 10% Ketamin 2 ml 
2% Xylazin 0.5 ml 
ddH2O 10 ml 
HEPES 132 mM NaCl 
20 mM Hepes pH 7.4 
5 mM KCl 
1 mM CaCl2 
0.7 mM MgCl2 
0.8 mM MgSO4 
Mowiol 6 g Glycerol 
2.4 g Mowiol 
6 ml ddH2O 
12 ml 0.2 M Tris-Base, pH 8.5 
0.1% DABCO 
Phosphate buffered saline (PBS), pH 7.4 137 mM NaCl 
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2.7 mM KCl 
10 mM Na2HPO4 
1.8 mM KH2PO4 
PBS-T 137 mM NaCl 
2.7 mM KCl 
10 mM Na2HPO4 
1.8 mM KH2PO4 
0.05 % Tween 20 
Running buffer 25 mM Tris 
192 mM glycine 
0.1 % SDS 
Sample buffer (5X) 250 mM Tris pH 6.8 
20 % Glycine 
4 % SDS 
8 % β-mercaptoethanol 
0.2 % bromophenol blue 
TBS-T 20 mM Tris 
150 mM NaCl 
0.05 % Tween 20 
Transfer buffer 10 mM NaHCO3 
3 mM Na2CO3 
10 % Methanol 
Trypsin 0.25% Trypsin 
5 mM Glucose 
1.3 mM EDTA 
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3 Methods 
3.1 Mice and cells 
Acid sphingomyelinase (Asm)-deficient mice and wild-type (WT) littermates (Horinouchi 
et al., 1995) (sphingomyelin phosphodiesterase 1 knockout; Smpd1−/−) and CD44-
deficient mice and wild type littermates WT mice (Olaku et al., 2011; Orian-Rousseau et 
al., 2002) were maintained on a C57BL/6J background. The genotype was verified by 
polymerase chain reaction (PCR). We used Asm-deficient mice and WT littermates 
aged 6 to 8 weeks to avoid sphingomyelin accumulation (Carpinteiro et al., 2015). Mice 
were bred in the animal facility of the University of Duisburg-Essen under specific 
pathogen-free (SPF) conditions according to the criteria of the Federation of Laboratory 
Animal Science. All procedures performed on mice were approved by the 
Bezirksregierung Düsseldorf, Düsseldorf, Germany.  
The culture of bone marrow-derived macrophages (BMDMs) has been previously 
described in detail (Zhang et al., 2011). Briefly, mice were sacrificed, femurs and tibias 
were flushed with minimum essential medium (MEM; Gibco, UK) supplemented with 10% 
fetal bovine serum (Gibco), 10 mM HEPES (Roth GmbH; pH 7.4), 2 mM L-glutamine, 1 
mM sodium pyruvate, 100 μM non-essential amino acids, 100 U/mL penicillin, and 100 
μg/mL streptomycin (Gibco). The samples were passed through a 23G needle to obtain 
single cells and cultured for 24 h in small tissue-culture flasks. Cells were washed and 3 
× 104 or 1.5 × 105 non-adherent cells were cultured in 24- or 6-well plates in MEM with 
20% L-cell supernatant as a source of macrophage colony-stimulating factor. Fresh 
MEM/L-cell supernatant media was applied after 4 days of culture. Macrophages 
mature within the next 6 days and were used on day 10 of culture. 
Alveolar macrophages (AMs) were isolated from bronchoalveolar lavage (BAL) fluid 
(Zhang et al., 2011). Mice were sacrificed; the trachea was exposed, catheterized, and 
lavaged with a total of 15 mL phosphate-buffered saline (PBS). Cells were centrifuged 
for 5 min at 300 × g at 4oC, supernatants were discarded, and the pellets were 
resuspended in MEM/HEPES. Cells were then seeded for further experiments. 
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3.2 Infection experiments 
The S. aureus strain used in the present study was isolated from a patient with sepsis. 
The strain produces alpha toxin and enterotoxin D but not the Panton-Valentine 
leukocidin or the toxic shock syndrome toxin (Peng et al., 2015). S. aureus was grown 
overnight on trypticase soy agar (TSA) plates with 5% sheep‟s blood (BD), resuspended 
in 40 mL tryptic soy broth (BD) at an optical density of 0.2 to 0.25, and incubated at 
37°C with shaking at 125 rpm for 75 min. Bacteria were pelleted by centrifugation at 
2800 rpm for 10 min and washed with RPMI 1640 (Gibco) supplemented with 10 mM 
HEPES (Roth GmbH). The bacteria were finally resuspended in HEPES/Saline (H/S) 
buffer consisting of 132 mM NaCl, 20 mM HEPES (pH 7.4), 5 mM KCl, 1 mM CaCl2, 0.7 
mM MgCl2, and 0.8 mM MgSO4. Cells or mice were then infected within the next 10 min. 
To determine Asm activity, ezrin/radixin/moesin (ERM) phosphorylation, and Rho family 
GTPase activity, we infected approximately 106 macrophages in a 6-well plate with S. 
aureus at a multiplicity of infection (MOI) of 100 bacteria per macrophage. For all 
immunofluorescence studies or intracellular bacteria killing assay in vitro, macrophages 
were cultured in 24-well plates, and cells were infected with S. aureus at an MOI of 100 
bacteria per BMDM or an MOI of 50 bacteria per AM. Macrophages were left uninfected 
or were infected with S. aureus indicated times below. 
For in vivo experiments, we infected mice intranasally with 8 × 108 colony-forming units 
(CFUs) per mouse (Grassme et al., 2000). The mice were observed for 5 days or were 
sacrificed at 6 h or 12 h to determine the number of CFUs in the lungs. 
To perform bacterial killing and phagocytosis assays in vitro, cells were infected as 
described above. The infection was terminated by gently washing the cells with sterile 
PBS followed by incubation of the macrophages with or without 100 µg/mL gentamycin 
(Sigma) for 1 h at 37°C in MEM/HEPES to determine the number of internalized 
bacteria or the total number of intra- and extracellular bacteria. The macrophages were 
then extensively washed, lysed in 5 mg/mL saponin dissolved in PBS for 10 min to 
release intracellular bacteria, pelleted by centrifugation at 3200 rpm, resuspended in 
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PBS, aliquots were plated on Luria broth (LB)-agar plates, and the CFUs were counted 
after growth overnight at 37°C.  
For in vivo assays mice were infected with S. aureus and sacrificed at 6 h or 12 h for 
detecting total bacteria in the lung. The lung tissue was collected, homogenized into 
very small pieces, lysed with 5 mg/mL saponin/PBS, and total bacteria were determined 
as described above. Mice were sacrificed at 6 h and lung homogenates were incubated 
with 100 µg/mL gentamycin in PBS for 1 h or left untreated for detecting intracellular 
bacteria in the lung. The samples were then extensively washed. Next, the lung tissue 
was lysed with 5 mg/mL saponin/PBS, and the CFU of internalized were determined as 
described above. 
 
3.3 Assay for acid sphingomyelinase activity  
Acid sphingomyelinase activity was measured with green fluorescent BODIPY-FLC12-
sphingomyelin (Thermo Fisher Scientific) as a substrate. Briefly, cells were infected or 
left untreated, harvested and lysed in 250 mM sodium acetate (Sigma) and 1% Nonidet 
P-40 (pH 5.0; Sigma) for 5 min on ice. Cells were further disrupted by sonification for 10 
min in an ice bath sonicator (Bandelin Electronic). The protein concentration was 
measured by a Bradford protein assay (BioRad), and 5 µg of protein in 20 μL lysis 
buffer was added to 250 mM sodium acetate (pH 5.0) containing 100 pmol BODIPY-
FLC12-sphingomyelin. The samples were incubated at 37°C for 1 h with shaking at 300 
rpm. The reaction was stopped by the addition of 1 mL chloroform:methanol (2:1, v/v) 
followed by centrifugation for 5 min at 14 000 rpm. The lower phase was dried in a 
SpeedVac Concentrator (Thermo Fisher Scientific) and resuspended in 
chloroform:methanol (2:1, v/v). The samples were spotted on a thin-layer 
chromatography (TLC) plate (Merck, Germany), separated with chloroform:methanol 
(80:20, v/v), scanned with a Typhoon FLA 9500 laser scanner (GE Healthcare Life 
Sciences, USA), and analyzed with ImageQuant software (GE Healthcare Life 
Sciences). 
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3.4 Immunocytochemistry 
Macrophages were grown on coverslips and were left uninfected or infected with S. 
aureus. Infection was stopped by adding 4% paraformaldehyde (PFA; Sigma) in PBS 
(pH 7.4) for 10 min. Cells were washed 3-times with H/S. For confocal microscopy 
macrophages were permeabilized with 0.1% Triton X-100/PBS for 5 min at room 
temperature. Cells were washed again with PBS and incubated for 1 h with goat anti-
Armenian hamster immunoglobulin G (IgG) antibodies (dilution 1:100; Jackson 
ImmunoResearch) to block non-specific binding. Samples were washed and incubated 
for 1 h with rabbit monoclonal IgG anti-phospho-ezrin (phospho Thr567)/anti-phospho-
radixin (phospho Thr564)/anti-phospho-moesin (phospho Thr558) antibodies (1:200; 
Cell Signaling Technology), rat monoclonal IgG2b anti-CD44 antibodies (1:200 diluted; 
Abcam), mouse monoclonal IgM anti-ceramide antibodies (1:100 diluted; Glycobiotech), 
rabbit polyclonal IgG anti-S. aureus antibody (1:200 diluted), mouse monoclonal IgG 
anti-S. aureus antibody (1:200 diluted), or fluorescein isothiocyanate-conjugated (FITC) 
phalloidin (25 μg/mL; Sigma). All antibodies were diluted in 5% FCS/PBS. Cells were 
then washed 3-times for 5 min each with 0.05% Tween-20/PBS and incubated with 
secondary antibodies corresponding to the primary antibodies: FITC-conjugated F(abʹ)2 
fragments of goat anti-rat IgG; Cy3-conjugated F(abʹ)2 fragments of donkey anti-rat IgG, 
donkey anti-mouse IgM, and donkey anti-rabbit IgG; DyLight 649-conjugated F(abʹ)2 
fragments of donkey anti-mouse IgG; and Alexa Fluor 647-conjugated F(abʹ)2 fragments 
of donkey anti-rabbit IgG for 45 min (all antibodies from Jackson ImmunoResearch; final 
concentration of all antibodies, 1.5 μg/mL; diluted in 5% FCS/PBS). The samples were 
then washed 3-times with PBS/0.05% Tween 20 and once in PBS and were then 
mounted with Mowiol (Kuraray Specialities Europe GmbH, Germany). Samples were 
visualized with a Leica TCS SP5 confocal microscope using a 100× oil lens, and images 
were analyzed with Leica LCS software (Leica Microsystems). 
For scanning electron microscopy, macrophages were treated as above. After fixation 
and washing with H/S cells were dehydrated in graded series of ethanol followed by 
critical-point drying (CPD 7501; Polaron) and were then sputtered with 
platinum/palladium (208HR high-resolution sputter coater; Cressington). Specimens 
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were analyzed with an S-4000 scanning electron microscope (SEM) (Hitachi), and 
images were obtained with a DISS5 (Point Electronics) analysis system. 
 
3.5 Western blots and pull-down assay 
Cells were lysed in 100 μL 0.1% sodium dodecyl sulfate (SDS), 25 mM HEPES, 0.5% 
deoxycholate, 0.1% Triton X-100, 10 mM ethylenediaminetetraacetic acid (EDTA), 10 
mM sodium pyrophosphate, 10 mM sodium fluoride, 125 mM NaCl, and 10 μg/mL 
aprotinin/leupeptin (Sigma). Samples were centrifuged at 14 000 rpm for 5 min at 4°C, 
and supernatants were collected. Proteins were separated by 10% SDS polyacrylamide 
gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes, followed 
by blocking with 5% bovine serum albumin (BSA) in Tris-buffered saline supplemented 
with 0.05% Tween 20. Blots were incubated overnight at 4°C with anti-phospho-ERM 
(1:2000; Cell Signaling Technology) or anti-Ezrin antibodies (1:1000; Cell Signaling 
Technology). Blots were washed and developed with alkaline phosphatase-coupled 
secondary antibodies (1:20,000; Santa Cruz Biotechnology Inc.) using the Tropix 
chemoluminescence system (Amersham Pharmacia Biotech Inc.). 
Rho family GTPase activity was detected using the RhoA/Rac1/Cdc42 Activation Assay 
Combo Biochem Kit (Cytoskeleton Inc.) according to the manufacturer‟s instructions. 
Briefly, cells were infected and lysed in 50 mM Tris (pH 7.5), 10 mM MgCl2, 0.5 M NaCl, 
and 2% Igepal. Equivalent amounts of protein were added to a pre-determined amount 
of rhotekin Rho binding domain (for RhoA activation assay) or PAK-PBD beads (for 
Rac1 and Cdc42 activation assays) and incubated at 4°C on a rotator for 1 h. Beads 
were washed with a buffer consisting of 25 mM Tris (pH 7.5), 30 mM MgCl2, and 40 mM 
NaCl. Finally, 20 μL of Laemmli sample buffer were added to each sample. Proteins 
were separated on a 10% SDS-PAGE gel and transferred to a nitrocellulose membrane. 
Blots were incubated with anti-RhoA monoclonal antibody (ARH04), anti-Rac1 
monoclonal antibody (ARC03), or anti-Cdc42 monoclonal antibody (ACD03) (all 
antibodies from Cytoskeleton Inc.) as described by the vendor and developed as 
described above. 
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3.6 Phagosome-lysosome-fusion 
For detection of phagosome-lysosome fusion, macrophages were pre-incubated with 1 
mg/mL tetramethylrhodamine isothiocyanate (TMR) dextran (10 kD, Sigma-Aldrich) for 
1 h in HEPES/MEM at 37°C. Cells were then washed with HEPES/MEM and infected 
with S. aureus as above. Cells were fixed and permeabilized as above. Lysosomes 
were stained with an anti-lysosome-associated membrane protein 1 (Lamp1) antibody 
(Abcam) followed by incubation with FITC-coupled anti-rat antibodies. For observation 
of intracellular acidic organelles, macrophages were incubated with 60 nM LysoTracker 
Red DND-99 or 1 μM LysoSensor DND-189 (ThermoFisher) in MEM. Macrophages 
were then infected with S. aureus, washed, and analyzed with confocal microscopy, as 
described above. 
 
3.7 Statistics 
Data are expressed as arithmetic means ± standard deviation (SD) unless otherwise 
indicated. One-way analysis of variance (ANOVA) followed by the Student-Newman-
Keuls test was used to test between-group and within-group differences; pairwise 
comparisons were performed with Student‟s t-test. Comparisons of survival variables 
were performed with log-rank tests. Statistical significance was set at the level of p < 
0.05. All data were obtained from independent measurements. The GraphPad Prism 
statistical software program (GraphPad Software, USA) was used for the analyses. 
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4 Results 
4.1 Acid sphingomyelinase is activated upon S. aureus infection and is crucially 
involved in internalization of the pathogen 
The engulfment of bacteria into macrophages is a crucial mechanism of the host-
defense system for eliminating pathogens, but it is also a mechanism used by the 
bacteria to escape the hostile extracellular environment and the immune system and 
thus to survive in infected cells. To determine whether Asm is involved in the uptake of 
S. aureus, we infected WT and Asm-deficient BMDMs with S. aureus for 30, 60, or 120 
min or left them uninfected and then determined Asm activity. The results show a rapid 
and strong activation of Asm in WT macrophages but no Asm activity in Asm-deficient 
macrophages (Fig. 4.1A and B). Wild-type macrophages rapidly internalized S. aureus, 
which was severely reduced in Asm-deficient macrophages (Fig. 4.1C). Asm deficiency 
did not affect the adhesion of S. aureus bacteria to macrophages (Fig. 4.1D). Taken 
together, these findings indicate that Asm is activated by and is crucial for S. aureus 
internalization in BMDMs. 
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Fig. 4.1: Staphylococcus aureus infection activates acid sphingomyelinase that 
mediates internalization of Staphylococcus aureus into macrophages 
(A) Bone marrow-derived macrophages (BMDMs) were infected and lysed, and the activity 
of acid sphingomelinase (Asm) was determined by the consumption of BODIPY-FLC12-
sphingomyelin. Samples were extracted and separated on thin-layer chromatography (TLC) 
plates, which were then scanned with a Typhoon laser scanner. Panel A shows a 
representative result. Panel B shows the mean ± standard deviation (SD) of 3 independent 
experiments using ImageQuant, *p < 0.05, t-test. (C, D) Wild-type (WT) and acid 
sphingomyelinase (Asm)-deficient bone marrow-derived macrophages (BMDMs) were 
infected with S. aureus for 30, 60, or 120 min or left uninfected. The colony forming units 
(CFUs) of internalized (C) or total number (extra- and intracellular) bacteria (D) were 
determined. Data are shown as mean ± SD of 3 independent experiments, *p < 0.05, one 
way ANOVA followed Student-Newman-Keuls test. 
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4.2 Acid sphingomyelinase is required for internalization induced actin 
polymerization 
Actin cytoskeleton dynamics in macrophages are essential for the recognition of 
pathogens and for phagocytosis (Kuwae et al., 2016; Man et al., 2014; Siegrist et al., 
2015). Infection of WT BMDMs with S. aureus resulted in dramatic changes of the cell 
shape, as determined by scanning electron microscopy (SEM) (Fig. 4.2A). Filopodia 
began to form as early as 30 min after S. aureus infection of WT macrophages and 
continued to extend at 60 and 120 min after infection. The formation and extension of 
filopodia were much less prominent and occurred much more slowly in Asm-deficient 
macrophages infected with S. aureus (Fig. 4.2A). Immunofluorescence staining of 
BMDMs (Fig. 4.2B) or of AMs (Fig. 4.2C) with phalloidin confirmed these results and 
showed that actin filaments reassemble and aggregate at the cell surface in WT 
macrophages after infection with S. aureus, but not in Asm-deficient macrophages.  
The ERM family of actin-binding proteins function as linkers between the plasma 
membrane and the actin cytoskeleton and transduce signals to mediate cytoskeleton 
remodeling (Fehon et al., 2010; Hamada et al., 2003). ERM proteins are activated by 
phosphorylation (Fukata et al., 1998; Nakamura et al., 1995; Ng et al., 2001). To 
determine whether Asm (indirectly) mediates the phosphorylation of ERM proteins upon 
S. aureus infection, we infected WT and Asm-deficient BMDMs with S. aureus. We then 
stained the cells with immunofluorescent anti-phospho-ERM antibodies or lysed them, 
performed Western blots, and measured ERM phosphorylation, respectively. S. aureus 
infection induced a rapid and marked phosphorylation of ERM proteins, whereas there 
was almost no induction of phosphorylation in Asm-deficient BMDMs or AMs (Fig. 4.2B-
E). Phosphorylated ERM proteins (pERM) rapidly co-localized with phalloidin, newly 
formed filopodia, and cell-associated bacteria in WT macrophages (Fig. 4.2B and C); in 
contrast, there were almost no changes of pERM in Asm-deficient BMDMs or AMs (Fig. 
4.2B and C).  
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Fig. 4.2: Acid sphingomyelinase controls actin cytoskeleton rearrangement and 
phosphorylation of ezrin/radixin/moesin after S. aureus infection of macropahges 
 (A) Wild-type (WT) and acid sphingomyelinase (Asm)-deficient bone marrow-derived 
macrophages (BMDMs) were left uninfected or infected with S. aureus and analyzed for cell 
morphology by scanning electron microscopy (SEM). Shown are representative images from 
3 independent experiments. B-E is shown in next pages. (B, C) Immunofluorescence studies 
using fluorescein isothiocyanate (FITC) phalloidin show a marked change of the actin 
cytoskeleton upon infection of WT BMDMs (B) and alveolar macrophages (AMs) (C) with S. 
aureus, a change that is absent from cells lacking Asm. (B-E) Rearrangement of the actin 
cytoskeleton is accompanied with the phosphorylation of ezrin/radixin/moesin, as determined 
by confocal microscopy (B, C) or Western blot studies (D, E). An ezrin antibody was used to 
confirm similar loading of all lanes. Shown are representative results (B-D) and mean ± SD 
of quantifications of the Western blot results of three independent experiments. * p < 0.05, 
ANOVA followed by Student-Newman-Keuls test.  
55 
 
 
56 
 
 
57 
 
 
 
 
4.3 Acid sphingomyelinase regulates the activation of Rho GTPase upon S. 
aureus infection  
RhoA, Rac1, and CDC42 are members of the Rho family of small GTPases, which 
regulate many aspects of intracellular actin dynamics (Ridley and Hall, 1992; Ridley et 
al., 1992; Schulz et al., 2015). To determine whether Asm regulates the activity of those 
Rho GTPases upon S. aureus infection, we determined their activity by pull-down 
assays. RhoA, Rac1, and Cdc42 were activated upon S. aureus infection in WT BMDMs 
(Fig. 4.3A-C), whereas their activation was almost completely abrogated by Asm 
deficiency (Fig. 4.3A-C). 
Collectively, these findings indicate that Asm in macrophages is necessary for S. 
aureus-induced morphology changes, actin cytoskeleton rearrangement, ERM 
phosphorylation, and Rho GTPase activation. 
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Figure 4.3: Acid sphingomyelinase mediates activation of Rho family GTPases upon 
S. aureus infection of macrophages  
(A-C) Top: RhoA (A)/Rac1 (B)/Cdc42 (C) activity was determined by a pull-down assay from 
lysates obtained from S. aureus-infected or non-infected BMDMs. Bottom: quantification of 
the results of RhoA/Rac1/Cdc42 activity as determined by ImageJ. Values are means ± SD 
of 3 independent experiments; * p< 0.05, ANOVA followed by Student-Newman-Keuls test. 
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4.4 CD44 interacts with Asm in the infection process of S. aureus 
CD44 is a glycoprotein that interacts with ERM and links the actin cytoskeleton to the 
plasma membrane and the extracellular matrix (Liu and Sy, 1997; Tsukita et al., 1994). 
We hypothesized that CD44 may serve as a receptor for S. aureus, linking the pathogen 
to the cytoskeleton and the Asm-ceramide signaling pathway. To study this hypothesis, 
we infected WT and Asm-deficient BMDMs with S. aureus and stained them with 
specific antibodies to CD44. The results reveal that infection with S. aureus leads to a 
translocation of CD44 to the plasma membrane and co-localization with actin filaments, 
which were recruited to the infection site at the cell surface. These translocation and co-
localization events were almost completely absent in Asm-deficient BMDMs or AMs (Fig. 
4.4A and C). Furthermore, upon infection with S. aureus, CD44 clustered within 
ceramide-enriched membrane platforms in WT BMDMs or AMs, events that were again 
absent in Asm-deficient cells (Fig. 4.4B and D).  
 
 
Figure 4.4: Acid sphingomyelinase regulates CD44 co-aggregation with phalloidin and 
ceramide  
Figures are shown in bellowing pages. Wild-type (WT) and acid sphingomyelinase (Asm)-
deficient bone marrow-derived macrophages (BMDMs) (A, B) or alveolar macrophages 
(AMs) (C, D) were left uninfected or were infected with S. aureus for 30, 60, or 120 min or 
15, 30, 60 min. Cells were then fixed and stained with anti-phalloidin, anti-CD44, and anti-S. 
aureus antibodies or with anti-CD44, anti-ceramide, and anti-S. aureus antibodies and 
corresponding fluorescent secondary antibodies. The samples were analyzed by confocal 
microscopy. Shown are representative results from 3 independent studies. 
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4.5 S. aureus binds to CD44 which acts as upstream of Asm 
To determine whether CD44 links to the Asm-ceramide system, we infected WT and 
CD44-deficient BMDMs with S. aureus and determined Asm activity. Our results show a 
marked activation of Asm after infection of WT macrophage with S. aureus (Fig. 4.5 and 
B). CD44 deficiency reduced and delayed the activation of Asm but did not completely 
prevent the stimulation of the enzyme (Fig. 4.5A and 5B). 
These findings suggest that CD44 functions upstream of Asm. Therefore, we 
investigated whether CD44 is also involved in the uptake of S. aureus, the 
rearrangement of the cytoskeleton, and the phosphorylation of ERM proteins. The 
results show that CD44-deficiency in macrophages prevents S. aureus internalization, 
whereas adhesion is unaffected (Fig. 4.5C and 5D). Like Asm-deficient cells, S. aureus-
infected CD44-deficient BMDMs did not rearrange the cytoskeleton to polymerize 
cortical actin, to cluster actin at ceramide-enriched membrane platforms, or to 
phosphorylate and translocate ERM proteins (Fig. 4.5E-G). Infection with S. aureus 
triggered a clustering of CD44 in ceramide-enriched membrane domains. Formation of 
these domains was abrogated by CD44 deficiency (Fig. 4.5H).  
These findings strongly suggest that the Asm-ceramide system serves as a downstream 
target of CD44 during infection with S. aureus and mediates clustering of CD44 and 
thereby amplify signaling via the receptor. 
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Figure 4.5: Acid sphingomyelinase activation upon S. aureus infection requires CD44 
(A, B) Wild-type (WT) and CD44-deficient bone marrow-derived macrophages (BMDMs) 
were left uninfected or infected with S. aureus for 30, 60, or 120 min. Acid sphingomyelinase 
(Asm) activity was determined by the consumption of BODIPY-FLC12-sphingomyelin. Panel 
A shows representative results; panel B the mean ± SD of 3 independent studies; * p < 0.05, 
ANOVA followed by Student-Newman-Keuls test. (C, D) WT and CD44-deficient BMDMs 
were infected with S. aureus and the number of intracellular (C) or total (D) S. aureus was 
determined. Shown are the means ± SD of the number of colony forming units (CFUs) from 
at least 3 independent experiments; * p < 0.05, ANOVA followed by Student-Newman-Keuls 
test. (E, F) Levels of phosphorylated ezrin/radixin/moesin (pERM) were determined in 
BMDMs left untreated or infected with S. aureus for 30, 60, or 120 min by Western blotting 
using phospho-specific anti-ERM antibodies (E). Aliquots were blotted with an anti-ezrin 
antibody to confirm similar loading of all lanes (E). Shown are representative results from 3 
independent experiments. Panel F shows the quantification of the phosphorylation of ERM 
by ImageJ. Results are given as mean ± SD, n=3, * p < 0.05, ANOVA followed by Student-
Newman-Keuls test. (G) Confocal studies of the actin cytoskeleton using FITC-phalloidin and 
staining with Cy3-coupled anti-pERM antibodies demonstrate that CD44 is necessary for 
cortical rearrangement of actin filaments and pERM translocation/phosphorylation of 
macrophages with S. aureus. (H) Confocal microscopy studies using FITC-coupled anti-
CD44 and Cy3-anti-ceramide antibodies show that CD44 clusters in ceramide-enriched 
membrane domains after infection. CD44 deficiency prevents the formation of ceramide-
enriched membrane platforms. Panels G and H show representative results from 3 
independent experiments. 
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4.6 Asm-deficient mice are highly susceptible to pulmonary S. aureus infections 
To study the role of Asm in pulmonary S. aureus infections in vivo, we intranasally 
infected WT and Asm-deficient mice with S. aureus. Most WT mice rapidly cleared the 
infection, and almost all WT mice survived (Fig. 4.6A). In contrast, 80% of Asm-deficient 
mice died within 5 days (Fig. 4.6A). To determine bacteria killing in the lung, we again 
intranasally infected WT and Asm-deficient mice with S. aureus and determined the 
total number of CFUs in the lung 6 and 12 h after infection. Bacterial numbers were 
substantially higher in Asm-deficient mice than in WT mice after 6 h and 12 h infection 
(Fig. 4.6B). 
The failure of Asm-deficient mice to kill S. aureus in the lung could be explained by the 
findings that S. aureus internalization is reduced by 60% to 80% in these mice (see 
above) and that Asm-deficiency reduces the release of reactive oxygen species that kill 
extracellular pathogens, as previously shown (Peng et al., 2015; Zhang et al., 2008). 
Thus, to determine whether Asm-deficient mice die by an accumulation of extracellular 
S. aureus, we intranasally infected WT and Asm-deficient mice with S. aureus for 6 h, 
sacrificed the mice, homogenized the lung tissue without compromising the cell integrity, 
and incubated the lung homogenates with gentamycin for 1 h. Cells are impermeable to 
gentamicin, at least for this short time, allowing extracellular bacteria to be killed by 
gentamycin without affecting intracellular bacteria. The results surprisingly showed that 
the number of CFUs is still higher in Asm-deficient mice than in WT mice 6 h after 
infection (Fig. 4.6C), a finding indicating that S. aureus accumulates within lung cells in 
Asm-deficient mice. Thus, to determine whether Asm is involved in intracellular killing of 
S. aureus, we cultured WT and Asm-deficient AMs and BMDMs and determined the 
killing of intracellular S. aureus 2 h to 8 h after infection via CFU assay. WT BMDMs and 
AMs efficiently killed S. aureus (Fig. 4.6D and E). In contrast, S. aureus survived and 
replicated in Asm-deficient macrophages (Fig. 4.6D and 6E).  
These findings indicate that intracellular bacteria, although initially lower in numbers 
because the ability of Asm-deficient macrophages to internalize S. aureus is reduced, 
are not killed by macrophages; instead, they proliferate and finally cause severe and 
even lethal pneumonia. 
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Figure 4.6: Acid sphingomyelinase-deficient mice fail to clear S. aureus  
(A) Wild-type (WT) and acid sphingomyelinase (Asm)-deficient mice were intranasally 
infected with 8 × 108 colony-forming units (CFUs) of S. aureus. Mice were observed for 5 
days for survival experiments. The graph represents 10 mice from each group. Comparisons 
of survival variables were performed with the log-rank test. (B) WT and Asm-deficient mice 
were infected with S. aureus, sacrificed at 6 or 12 h after infection, lungs were homogenized 
and total CFU of S. aureus bacteria in the lung were determined. Results are shown as 
means ± SD; * p < 0.05, ANOVA followed by Student-Newman-Keuls test. (C) WT and Asm-
deficient mice were infected with S. aureus for 6 h, sacrificed, lungs were homogenized and 
incubated with gentamycin for 1 h to kill extracellular bacteria. The numbers of bacterial 
CFUs is given as mean ± SD of 4 independent experiment; * p < 0.05, t-test. (D, E) Bone 
marrow-derived macrophages (BMDMs) and alveolar macrophages (AMs) from WT and 
Asm-deficient mice were exposed to S. aureus for the indicated times. After infection, 
gentamicin was added, and cells were incubated for 1 h to kill extracellular bacteria. CFU 
derived from lysates were determined. Data are expressed as means ± SD of 3 experiments, 
p < 0.05, ANOVA followed by Student-Newman-Keuls test. 
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4.7 Asm-deficiency leads to a failure in phagosome-lysosome fusion 
To understand the mechanisms that allow intracellular S. aureus to survive in Asm-
deficient macrophages, we investigated whether the fusion of phagosomes and 
lysosomes is altered in Asm-deficient macrophages. To this end, we incubated BMDMs 
with TMR-labeled dextran and stained the cells after fixation with antibodies to Lamp1, a 
lysosomal marker protein. Lamp1 staining and dextran fluorescence did not differ 
between WT and Asm-deficient BMDMs before infection. Instead infection with S. 
aureus induced the fusion of TMR-dextran-positive phagosomes with anti-Lamp1-
labelled lysosomes in WT BMDMs (Fig. 4.7A) whereas this fusion event was abrogated 
by Asm-deficiency (Fig 4.7A).  
We further stained the macrophages with anti-S. aureus antibody and Lysotracker Red, 
a fluorescent dye for labeling and tracking acidic organelles in living cells. S. aureus co-
localized with Lysotracker-labeled acidic compartments in WT macrophages. Although 
most bacteria localized to lysosomes in WT macrophages, the fusion of phagosomes 
and lysosomes was defective in Asm-deficient BMDMs, and intracellular pathogens 
remained separated from lysosomes (Fig. 4.7B and C). In addition, staining of 
macrophages with Lysosensor Green, a method to measure the pH of intracellular 
vesicles, revealed accumulation of Lysosensor Green in intracellular compartments of 
WT macrophages, whereas the accumulation of Lysosensor Green was reduced in 
Asm-deficient macrophages (Fig. 4.7D). This indicates a failure of acidification of 
lysosomes in Asm-deficient macrophages upon infection. 
Taken together, these findings suggest that Asm regulates phagocytosis, phagosome-
lysosome fusion, and intracellular vesicle pH to mediate the killing of bacteria. 
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Figure 4.7: Acid sphingomyelinase expression is required for lysosomal acidification 
and phagosome-lysosome fusion upon infection of macrophages with S. aureus  
(A) Wild-type (WT) or Asm-deficient bone marrow-derived macrophages (BMDMs)  were left 
untreated or were infected with S. aureus. Cells were stained with FITC-labeled anti-Lamp1 
antibodies and TMR-dextran and were analyzed by fluorescence microscopy. 
Representative fluorescence images from four independent experiments are shown. (B, C) 
Samples were stained with LysoTracker and Cy5-labeled S. aureus for confocal microscopy 
studies (B). Panel C shows the measurement of the percentage of localizing bacteria as 
determined by LysoTracker DND-99. Results are means ± SD of 4 independent experiments; 
at least 100 cells were used for calculation; * p < 0.05, t test. (D) Macrophages were stained 
with LysoSensor DND-189 for detection of the pH of intracellular acidic compartments. 
Shown are representative fluorescence microscopy studies from four independent 
experiments. 
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5 Discussion 
The present results identify CD44 as a novel macrophage receptor for Staphylococcus. 
aureus that is linked via activation of the Asm-ceramide system to internalization of the 
pathogen, fusion of phagosomes with lysosomes and intracellular killing of the pathogen. 
CD44 and Asm seem to act in a positive feedback loop with Asm activation induced by 
CD44 binding as an initial event that is then amplified by clustering of CD44 in 
ceramide-enriched membrane platforms. Additional activation of Asm by the clustered 
receptor and further clustering of CD44 finally lead to amplification of intracellular 
signaling as a positive feedback cycle. The generation of a strong signal by CD44 within 
a small, defined area of the cell membrane may allow the receptor to transmit the signal 
into macrophages, resulting in the activation of small G proteins and the rearrangement 
of the cytoskeleton, an event that finally mediates the uptake of S. aureus and 
intracellular killing in WT macrophages. The absence of Asm prevents this cascade of 
events.  
5.1 Asm-ceramide system mediated phagocytosis of S. aureus 
Internalization of bacteria into host cells may allow the pathogen to attack the host 
organism, if the pathogen can survive in the infected cells. On the other hand, 
internalization may also allow the host to target a pathogen to phagolysosomes, thereby 
killing the invading pathogen. Our lab has demonstrated Asm generated ceramide 
enriched platforms are essential for the internalization of P. aeruginosa into mammalian 
cells, which can be prevented by disruption of these platforms by pharmacological 
inhibitor or Asm gene deficiency (Grassme et al., 2003). Similar results have 
demonstrated the crucial role of Asm-ceramide system in non-phagocytic and 
phagocytic cells internalizing bacteria, which are N. gonorrhoeae and N. meningitidis 
(Grassme et al., 1997; Hauck et al., 2000; Simonis et al., 2014). However, the precise 
mechanism that how ASM-ceramide system mediates intracellular bacteria survival and 
replication within the host cell is poorly known. 
The present studies show that the internalization of S. aureus is an important part of the 
defense against the pathogen: Asm-deficient macrophages that exhibit a reduced rate 
of internalization in vivo and in vitro are also unable to kill internalized S. aureus. Our 
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studies in which we used gentamycin to kill extracellular bacteria in lung homogenates 
of Asm-deficient and WT mice showed that S. aureus accumulates in vivo within Asm-
deficient cells, because the pathogen is not killed within Asm-deficient macrophages 
even if these cells primarily internalize fewer bacteria. In addition, our results showed 
Asm-deficient mice is highly susceptible to pulmonary S. aureus infections in vivo. 
These findings strongly suggest that internalization and subsequent killing of the 
pathogen is an important part of the host defense in WT macrophages and lungs, 
respectively. The results of recent studies are consistent with this concept, showing that 
blocking the phagocytosis of S. aureus contributes to increased bacterial survival in 
human blood, bacterial persistence, and abscess formation both in pneumonia and after 
intravenous infection in vivo (Jongerius et al., 2012; Ko et al., 2013). 
 
5.2 Asm-ceramide system mediated elimination of S. aureus 
5.2.1 Asm and reactive oxygen species 
The current study has implicated that Asm-deficient mice are highly susceptible to 
pulmonary S. aureus infections in vitro and in vivo. Multiple mechanisms can be 
proposed to explain the function of Asm taking into account the susceptibility. Our group 
has previously demonstrated that genetic deficiency of Asm abolishes the extracellular 
release of reactive oxygen species (ROS) after the infection of macrophages with P. 
aeruginosa (Zhang et al., 2008). In freshly isolated macrophages Asm generated 
ceramide enriched platforms are required for the activation of nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase and release of ROS. ROS is critical 
components of the antimicrobial repertoire of mammalian cells (Slauch, 2011). Two 
subunits of NADPH oxidase p47phox and gp91phox have been shown critically involved in 
Asm-ceramide regulated signaling (Reinehr et al., 2006; Zhang et al., 2008). Further, 
we have shown Asm is activated by S. aureus thereby the ceramide enriched platforms 
are generated in endothelial cells, this signaling triggers the release of superoxide 
(Peng et al., 2015). However, although this mechanism may contribute to the 
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extracellular killing of S. aureus in the lung, our findings show that intracellular killing of 
the pathogen is also required for its elimination. 
Our previous work has shown that Asm-deficient mice are more susceptible than WT 
mice to systemic, septic S. aureus infections (Peng et al., 2015). These studies 
demonstrated that systemic infection with S. aureus destroys tight junctions of 
endothelial cells in the lung, thereby inducing lung edema. Whether destruction of 
endothelial tight junctions is mediated by intra- or extracellular S. aureus or toxins is 
presently unknown. 
 
5.2.2 Asm and phagosome-lysosome fusion 
Our findings have revealed a mechanism that deficiency of Asm allows the survival and 
replication of intracellular S. aureus in macrophages, which is Asm-deficiency leads to a 
failure in phagosome-lysosome fusion. No difference of Lamp1-staining and dextran 
fluorescence between WT and Asm-deficient BMDMs before infection indicates that 
Asm deficiency does not lead a phenotype, whereas the fusion of TMR-dextran-positive 
phagosomes with anti-Lamp1-labelled lysosomes is blocked by Asm-deficiency after 
infection of S. aureus. Furthermore, internalized S. aureus localized to lysosomes in WT 
macrophages but not in Asm deficient macrophages. In addition, Asm deficiency 
reduces the accumulation of Lysosensor Green marked intracellular acidic 
compartments. All of these findings implicates that Asm-ceramide system regulates the 
phagocytosis by fusion of phagosome with lysosome and acidification of intracellular 
vesicles. Most bacteria are rapidly eliminated and degraded in the phagolysosome, thus, 
the failure of bioprocess of phagolysosome formation by Asm deficiency leads to the 
intracellular bacteria survival. 
It has been demonstrated that Asm deficiency highly impairs the bactericidal capacity of 
mice challenging the L. monocytogenes, which due to the fail of macrophages 
intracellular bacteria killing (Utermohlen et al., 2003). The dose of LD50 with L. 
monocytogenes infection for Asm deficient mice was 100 times lower than WT mice, an 
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effect may account from reduced intracellular listeriocidal activity in Asm deficient 
macrophages. Further the same group extended the study and demonstrated the Asm 
is required for efficient phago-lysosomal fusion in L. monocytogenes infection 
(Schramm et al., 2008). L. monocytogenes rapidly escape from phagosome into the 
cytosol in Asm deficient macrophages. The Asm deficiency reduces the co-localization 
of intracellular L. monocytogenes with the late endosome/lysosome marker Lamp1. The 
mechanism is that ASM does not impair the maturation of phagosome in the early stage 
but delays fusion of lysosomes with phagosomes in the late stage in macrophages. In 
Asm deficient macrophages, the existence of listeriocidal proteases cathepsin D, B and 
L in L. monocytogenes contained phagosomes significantly decreased upon infection. 
Asm generated ceramide targets and enhances the activation of the lysosomal 
cathepsin D (Heinrich et al., 1999). 
Recent studies have shown Asm interacting with proneurotrophin receptor sortilin 
mediates the infection process of M. tuberculosis in macrophages (Vazquez et al., 
2016). Sortilin mediates the Asm trafficking from Golgi complex into mycobacterial 
containing phagosomes. Once delivered to phagosome, Asm localizing with lysosomal-
associated membrane protein (Lamp) 2 serves to the growth restriction and elimination 
of M. tuberculosis in bone marrow derived macrophages. Moreover, depleting ASM by a 
pharmacological inhibitor desipramine increases the survival of M. tuberculosis. Similar 
with this notion, addition of ceramide is found facilitating the clearance of M. 
tuberculosis and M. avium, by significantly increasing the fraction of acidified 
phagosomes in macrophages (Anes et al., 2003).  
Thus it is very likely Asm regulate the killing of S. aureus by host cells via modulating 
the bioprocess of phagocytosis, in particular the fusion and maturation of 
phagolysosome. 
 
5.2.3 Asm and cytokine and chemokine release 
Asm-ceramide system has been demonstrated in regulation of cytokines and 
chemokines release upon several bacteria. When exposed to bacterial infection, 
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macrophage secretes inflammatory cytokines such as TNF-α and IL-1β, and 
chemokines which drive an immune reaction (Turner et al., 2014). Abnormities of 
cytokine and chemokine release is involved in multiple infectious diseases. 
Our group has demonstrated that P. aeruginosa infection leads to the increased mRNA 
transcription of IL-1β as well as uncontrolled released of IL-1β from infected cells or 
lungs of Asm deficiency (Grassme et al., 2003). Adding of exogenous ceramide is 
sufficient to rescue the uncontrolled release of IL-1β in Asm deficient epithelial cells. 
More studies has implicated blocking of Asm with a multiple approaches, i.e. silencing 
of Asm, pharmacological Asm inhibitor, or adding Asm antibody significantly increased 
the IL-8 release with P. aeruginosa infection in epithelial cells (Yu et al., 2009). 
Asm can involve in the bacterial toxin induced cytokine and chemokine release, such as 
LPS. Inhibiting of NF-kB pathway by a cell penetrating peptide sufficiently suppresses 
the Asm activation upon LPS stiumulation. The ceramide mediated production of TNF-α, 
IL-6, CXC chemokine CXCL8, and MCP-1, these key regulators of inflammation are 
also found reduced by NF-kB inhibition (von Bismarck et al., 2012). Studies also show 
the effect of LPS on Asm activation is involving the production of IL-1β (Wong et al., 
2000).  This is similar that LPS leads to the production of TNF-α and other cytokines 
which stimulates the hydrolysis of sphingomyelin to ceramide by Asm (Haimovitz-
Friedman et al., 1997). Vice versa, the Asm activation by LPS is required for the release 
of TNF-α (Cuschieri et al., 2007). 
 
5. 3 Asm activation and CD44 
Previous studies have shown that the Asm-ceramide system is involved in infection with 
several pathogenic bacteria, such as Neisseria gonorrhoeae, N. meningitides, 
Pseudomonas aeruginosa, S. aureus, and Salmonella species (Hauck et al., 2000; 
McCollister et al., 2007; Peng et al., 2015; Simonis et al., 2014; Zhang et al., 2008). 
However, the molecular mechanisms of Asm activation by bacteria are still poorly 
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understood. Our current studies identify for the first time a receptor, i.e., CD44 that 
couples a pathogen with activation of Asm.  
Our results has shown CD44 and Asm seem to act in a positive feedback loop with Asm 
activation induced by CD44 binding as an initial event that is then amplified by 
clustering of CD44 in ceramide-enriched membrane platforms. Recent studies have 
shown hyaluronan tetrasaccharides, the smallest unit of hyaluronan, bind to its receptor 
CD44; thereby stimulate ceramide production through upregulated mRNA expression of 
Asm (Kage and Tokudome, 2016). 
Our findings do not show a complete absence of Asm activation, ceramide formation, 
cytoskeletal changes, and internalization in CD44-deficient cells. This result may be 
explained by the binding of the pathogen to additional receptors, such as intercellular 
adhesion molecule 1 (ICAM-1), that may also couple with Asm (Olaku et al., 2011). 
Cells lacking Asm activity was found an increased expression of ICAM-1 (Lopes 
Pinheiro et al., 2016). Asm-ceramide system coordinating with ICAM-1 functions in T 
cell transmigration. 
Similarly, Asm deficiency does not completely abrogate the internalization of S. aureus. 
Because cells contain only a single Asm gene, it may be possible that other pathways 
independent of Asm are also involved in the uptake of the pathogen.  
Asm hydrolyzes sphingomyelin to ceramide, which has been shown to spontaneously 
form ceramide-enriched platforms in the plasma membrane (Grassme et al., 2001a). 
These platforms trap and cluster specific proteins, thereby inducing and amplifying 
signaling transduction (Bock and Gulbins, 2003; Grassme et al., 2001b). This 
mechanism may also apply to the positive feedback between CD44 and Asm activation. 
CD44 consists of three regions: an extracellular domain, a transmembrane domain, and 
a C-terminal cytoplasmic domain (Goodison et al., 1999). The results of structural 
studies of CD40 indicated that the transmembranous domain of CD40 determines 
clustering within ceramide-enriched membrane domains (Bock and Gulbins, 2003). It is 
tempting to speculate that a similar mechanism applies to CD44, although the exact 
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mechanisms by which receptors cluster in ceramide-enriched membrane domains are 
unknown.  
 
5. 4 Asm and cytoskeleton reorganization 
Our findings have demonstrated Asm mediates the phosphorylation of ERM proteins in 
the infection process of S. aureus. Asm deficiency reduces the co-localization of 
phosphorylated ERM (pERM) with phalloidin and filopodia. Additionally, Asm deficiency 
abolished the activation of Rho GTPase RhoA, Rac1, and Cdc42 upon S. aureus 
infection. 
5.4.1 Asm and ezrin/radixin/moesin (ERM) proteins 
ERM proteins have been implicated as critical organizers of actin dynamics (Fehon et 
al., 2010; Tsukita and Yonemura, 1999). ERM proteins are able to interact with 
transmembrane proteins such as CD44, lipids, membrane associated cytoplasmic 
proteins and cytoskeleton. Phosphorylation of ERM proteins leads to their structure 
conformational change and activation. Our group recently observed that exogenous 
adding of Asm resulted in phosphorylation of ezrin in B16F10 or human melanoma cells 
(Carpinteiro et al., 2016). However, the phosphorylation of ezrin also was found after 
the co-incubation of B16F10 melanoma cells with Asm-deficient platelets, which 
indicates that ezrin phosphorylation can be induced not only Asm but also different 
pathway independent of this enzyme. The author proposed a mechanism that both 
exogenous adding of Asm (Canals et al., 2010) and physiological contact of platelets 
(Yatomi et al., 1995) with tumor cells induces the generation of sphingosine-1-
phosphate (S1P). Therefore, S1P then leads to the phosphorylation of ezrin (Canals et 
al., 2010). 
Similar to our result, a study has shown Asm is required for the phosphorylation of ezrin 
and formation of microvilli, ultimately induce T cell mobility and transmigration (Lopes 
Pinheiro et al., 2016). Furthermore, ERM proteins were also less phosphorylated upon 
ICAM-1 clustering in Asm-deficient cells. 
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Interestingly, other studies have also implicated that phosphorylation of ERM proteins 
can be regulated by ASM-ceramide system (Zeidan et al., 2008a). In that study, 
chemotherapeutic agent cisplatin leads to an activation of Asm activity and translocation 
of Asm to the cell membrane, which induces dephosphorylation of ezrin and loss of 
lamellipodia/filopodia in breast cancer cells. Reconstitution of Asm or exogenous 
delivery of ceramide recapitulates the morphotropic effects of cisplatin. Collectively, 
these results indicate a suppressor characteristic of Asm-ceramide system in ERM 
protein phosphorylation.  
Our result shows a marked increase of pERM proteins upon S. aureus infection in 
macropahges. The discrepancy may be because of the type of cells used. Macrophages 
are phagocyte and serve for pathogen killing in our study whereas cancer cells are 
highly proliferative in comparison with macrophages. Further, we studied specific 
bacteria-host interaction as opposed to cancer cell migration, these interaction are more 
individual and related to their specialized function. 
Further, ERM proteins can be activated and phosphorylated to a wide variety of 
signaling pathways, for example, protein kinase C (PKC) (Ng et al., 2001). This would 
be a potential mechanism in Asm-ceramide induced ERM phosphorylation upon S. 
aureus infection. Asm-ceramide system has been shown plays an important role in 
regulating activation of PKC isoforms in a variety of studies (Cuschieri et al., 2007; 
Gilbert et al., 2016; Kasai and Tanabe, 2014; Parent et al., 2011). 
The precise mechanism regarding how exactly ERM phosphorylation is controlled and 
in what cellular and developmental contexts is regulated by Asm-ceramide system 
remains to be elucidated. Detecting the precipitation of ceramide with ERM proteins 
would be strong evidence which confirms the interaction this signaling in the infection 
process of S. aureus.  
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5.4.2 Asm and Rho GTPase 
Our studies have demonstrated Asm is critically required for the activation of Rho 
GTPase upon S. aureus infection. The Rho family of GTPase is a subfamily of Ras 
superfamily and consists of 20 members in human, of which Rho, Rac and Cdc42 
remain the best studied (Hodge and Ridley, 2016; Jaffe and Hall, 2005). Once activated, 
Rho GTPases bind to a variety of effectors including protein kinases and some actin-
binding proteins, regulate cytoskeletal and cell adhesion dynamics and thereby 
coordinate a wide range of cellular processes. 
The association of Rho GTPase with plasma membranes is modified by lipids (Hodge 
and Ridley, 2016). The G domain of Rho GTPase is highly conserved whereas the C 
terminal contains a hypervariable motif. Rho GTPase is specified through the 
hypervariable domain at the carboxyl terminus which contains several important 
sequences. For example, the CAAX motif of RhoA at C terminus is modified by a variety 
of post-translational lipid modifications including farnesylation, geranylgeranylation and 
palmitoylation. These lipid moiety connect the Rho GTPase to the cell membrane avoids 
diffusing through the cytoplasm. Thus, the Rho GTPase can localize to distinct 
membrane compartments on lipid bilayer. However, the existence of lipid rafts or similar 
membrane domains in the inner leaflet of cell membrane is not known currently. 
Resolving how cholesterol and sphingolipid dependent lipids rafts interact with Rho 
GTPase promises to be a difficult but rewarding undertaking. 
It has been shown that depletion of sphingolipids decreases targeting of RhoA and 
Cdc42 to the cell membrane, a process which could be partially recovered by 
exogenous adding of sphingomyelin (Cheng et al., 2006). Sphingomyelin is critically 
required for in vivo membrane targeting and in vitro binding to artificial lipid vesicles of 
RhoA and Cdc42. This study may suggest sphingomyelin, a component of lipid rafts, 
plays important in Rho GTPase signaling. In addition, RhoA bounding to cell membrane 
is found significant reduced in Asm deficient cell, which in term impairs function of 
membrane remodeling.  
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5.5 CD44 and S. aureus infection 
In several cases, CD44 isoforms were shown to participate in the host infections 
(Gunthert et al., 1991). CD44v6 was for example shown to promote the internalization of 
the food-born pathogen Lysteria monocytogenes upon binding of the virulence factor 
Internalin B to the receptor tyrosine kinase MET (Jung et al., 2009). CD44 was also 
described to interact with IpaB, a protein secreted by Shigella (Skoudy et al., 2000). The 
formation of this complex appeared important for invasion of epithelial cells. Later on, 
the interaction between CD44 and IpaB was described to take place within lipid rafts 
thereby promoting infection (Lafont et al., 2002). More recently peptides targeting CD44 
were shown to block Helicobacter pylori-induced proliferation and subsequent gastritis 
(Bertaux-Skeirik et al., 2015). A collaboration between CD44 and MET was required in 
that case. Whether similar mechanisms link CD44 to the Asm remains to be determined.  
 
Taken together, our studies describe a novel mechanism by which S. aureus infects 
macrophages: Binding of the pathogen to CD44 on macrophages activates the Asm-
ceramide system, resulting in the formation of ceramide-enriched membrane platforms 
that in turn cluster and amplify CD44 signaling and thereby act as a positive feedback 
loop. CD44 and Asm are crucially involved in the activation of small G-proteins, the 
phosphorylation of ERM proteins, and the re-arrangement of the cytoskeleton, 
culminating in the phagocytosis of S. aureus. Phagosomes containing the pathogen 
fuse with acidified lysosomes in an Asm-dependent manner to kill intracellular 
pathogens, which is a requirement for successful host defense in the lungs. Asm 
deficiency reduces or prevents all of these events, allowing the intracellular survival of 
internalized pathogens. 
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6 Summary 
Staphylococcus aureus is a very common commensal opportunistic bacterium that 
causes severe and life-threatening diseases such as pneumonia, endocarditis, sepsis, 
osteomyelitis, and toxic shock syndrome. In addition, some S. aureus strains have 
developed resistance to almost all antibiotics. Thus, S. aureus infections are a major 
clinical problem and mechanisms that mediate infection with S. aureus need to be 
identified to facilitate the development of novel treatments. Here, we demonstrate that 
CD44 serves as a receptor for S. aureus in macrophages. CD44 activates the acid 
sphingomyelinase upon infection and triggers the release of ceramide. Ceramide forms 
distinct domains in the plasma membrane that serve to cluster CD44 and thereby 
Figure 6 Asm-ceramide system regulates S. aureus infections 
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amplify CD44 signaling, which results in activation of small Rho family GTPases, 
reorganization of the actin cytoskeleton, internalization of S. aureus by macrophages, 
fusion of phagosomes with lysosomes and intracellular killing of the pathogen. Genetic 
deficiency of CD44 or acid sphingomyelinase abrogates these events. Accordingly, acid 
sphingomyelinase-deficient macrophages fail to kill intracellular S. aureus and are 
highly susceptible to pulmonary S. aureus infections. Thus, our data identify an 
important role of the CD44-Asm-ceramide system in the infection of macrophages with 
S. aureus. 
 
  
88 
 
7 References 
(1999). From the Centers for Disease Control and Prevention. Four pediatric deaths from community-
acquired methicillin-resistant Staphylococcus aureus--Minnesota and North Dakota, 1997-1999. Jama 
282, 1123-1125. 
Abdel Shakor, A.B., Kwiatkowska, K., and Sobota, A. (2004). Cell surface ceramide generation precedes 
and controls FcgammaRII clustering and phosphorylation in rafts. The Journal of biological chemistry 279, 
36778-36787. 
Abdul-Muneer, P.M., Chandra, N., and Haorah, J. (2015). Interactions of oxidative stress and 
neurovascular inflammation in the pathogenesis of traumatic brain injury. Molecular neurobiology 51, 
966-979. 
Abe, T., Fukuhara, T., Wen, X., Ninomiya, A., Moriishi, K., Maehara, Y., Takeuchi, O., Kawai, T., Akira, S., 
and Matsuura, Y. (2012). CD44 participates in IP-10 induction in cells in which hepatitis C virus RNA is 
replicating, through an interaction with Toll-like receptor 2 and hyaluronan. Journal of virology 86, 6159-
6170. 
Airola, M.V., and Hannun, Y.A. (2013). Sphingolipid metabolism and neutral sphingomyelinases. 
Handbook of experimental pharmacology, 57-76. 
Aktepe, T.E., Pham, H., and Mackenzie, J.M. (2015). Differential utilisation of ceramide during replication 
of the flaviviruses West Nile and dengue virus. Virology 484, 241-250. 
al-Ujayli, B., Nafziger, D.A., and Saravolatz, L. (1995). Pneumonia due to Staphylococcus aureus infection. 
Clinics in chest medicine 16, 111-120. 
American Thoracic, S., and Infectious Diseases Society of, A. (2005). Guidelines for the management of 
adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. American 
journal of respiratory and critical care medicine 171, 388-416. 
Anes, E., Kuhnel, M.P., Bos, E., Moniz-Pereira, J., Habermann, A., and Griffiths, G. (2003). Selected lipids 
activate phagosome actin assembly and maturation resulting in killing of pathogenic mycobacteria. 
Nature cell biology 5, 793-802. 
Armstrong-Esther, C.A. (1976). Carriage patterns of Staphylococcus aureus in a healthy non-hospital 
population of adults and children. Annals of human biology 3, 221-227. 
Avota, E., Gulbins, E., and Schneider-Schaulies, S. (2011). DC-SIGN mediated sphingomyelinase-
activation and ceramide generation is essential for enhancement of viral uptake in dendritic cells. PLoS 
pathogens 7, e1001290. 
Aykut, A., Karaca, E., Onay, H., Ucar, S.K., Coker, M., Cogulu, O., and Ozkinay, F. (2013). Analysis of the 
sphingomyelin phosphodiesterase 1 gene (SMPD1) in Turkish Niemann-Pick disease patients: mutation 
profile and description of a novel mutation. Gene 526, 484-486. 
Baba, T., Bae, T., Schneewind, O., Takeuchi, F., and Hiramatsu, K. (2008). Genome sequence of 
Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: 
polymorphism and evolution of two major pathogenicity islands. Journal of bacteriology 190, 300-310. 
Baba, T., Takeuchi, F., Kuroda, M., Yuzawa, H., Aoki, K., Oguchi, A., Nagai, Y., Iwama, N., Asano, K., Naimi, 
T., et al. (2002). Genome and virulence determinants of high virulence community-acquired MRSA. 
Lancet 359, 1819-1827. 
Bartke, N., and Hannun, Y.A. (2009). Bioactive sphingolipids: metabolism and function. Journal of lipid 
research 50 Suppl, S91-96. 
Bauer, J., Huy, C., Brenmoehl, J., Obermeier, F., and Bock, J. (2009a). Matrix metalloproteinase-1 
expression induced by IL-1beta requires acid sphingomyelinase. FEBS letters 583, 915-920. 
Bauer, J., Liebisch, G., Hofmann, C., Huy, C., Schmitz, G., Obermeier, F., and Bock, J. (2009b). Lipid 
alterations in experimental murine colitis: role of ceramide and imipramine for matrix 
metalloproteinase-1 expression. PloS one 4, e7197. 
89 
 
Bayles, K.W., Wesson, C.A., Liou, L.E., Fox, L.K., Bohach, G.A., and Trumble, W.R. (1998). Intracellular 
Staphylococcus aureus escapes the endosome and induces apoptosis in epithelial cells. Infection and 
immunity 66, 336-342. 
Becker, K.A., Grassme, H., Zhang, Y., and Gulbins, E. (2010). Ceramide in Pseudomonas aeruginosa 
infections and cystic fibrosis. Cellular physiology and biochemistry : international journal of experimental 
cellular physiology, biochemistry, and pharmacology 26, 57-66. 
Becker, K.A., Henry, B., Ziobro, R., Tummler, B., Gulbins, E., and Grassme, H. (2012). Role of CD95 in 
pulmonary inflammation and infection in cystic fibrosis. Journal of molecular medicine 90, 1011-1023. 
Beckmann, N., Sharma, D., Gulbins, E., Becker, K.A., and Edelmann, B. (2014). Inhibition of acid 
sphingomyelinase by tricyclic antidepressants and analogons. Frontiers in physiology 5, 331. 
Belay, N., and Rasooly, A. (2002). Staphylococcus aureus growth and enterotoxin A production in an 
anaerobic environment. Journal of food protection 65, 199-204. 
Bertaux-Skeirik, N., Feng, R., Schumacher, M.A., Li, J., Mahe, M.M., Engevik, A.C., Javier, J.E., Peek, R.M., 
Jr., Ottemann, K., Orian-Rousseau, V., et al. (2015). CD44 plays a functional role in Helicobacter pylori-
induced epithelial cell proliferation. PLoS pathogens 11, e1004663. 
Bezombes, C., Grazide, S., Garret, C., Fabre, C., Quillet-Mary, A., Muller, S., Jaffrezou, J.P., and Laurent, G. 
(2004). Rituximab antiproliferative effect in B-lymphoma cells is associated with acid-sphingomyelinase 
activation in raft microdomains. Blood 104, 1166-1173. 
Bharath, L.P., Ruan, T., Li, Y., Ravindran, A., Wan, X., Nhan, J.K., Walker, M.L., Deeter, L., Goodrich, R., 
Johnson, E., et al. (2015). Ceramide-Initiated Protein Phosphatase 2A Activation Contributes to Arterial 
Dysfunction In vivo. Diabetes 64, 3914-3926. 
Bock, J., and Gulbins, E. (2003). The transmembranous domain of CD40 determines CD40 partitioning 
into lipid rafts. FEBS letters 534, 169-174. 
Boini, K.M., Zhang, C., Xia, M., Han, W.Q., Brimson, C., Poklis, J.L., and Li, P.L. (2010). Visfatin-induced 
lipid raft redox signaling platforms and dysfunction in glomerular endothelial cells. Biochimica et 
biophysica acta 1801, 1294-1304. 
Bollinger, C.R., Teichgraber, V., and Gulbins, E. (2005). Ceramide-enriched membrane domains. 
Biochimica et biophysica acta 1746, 284-294. 
Boucher, L.M., Wiegmann, K., Futterer, A., Pfeffer, K., Machleidt, T., Schutze, S., Mak, T.W., and Kronke, 
M. (1995). CD28 signals through acidic sphingomyelinase. The Journal of experimental medicine 181, 
2059-2068. 
Boulgaropoulos, B., Arsov, Z., Laggner, P., and Pabst, G. (2011). Stable and unstable lipid domains in 
ceramide-containing membranes. Biophysical journal 100, 2160-2168. 
Boulgaropoulos, B., Rappolt, M., Sartori, B., Amenitsch, H., and Pabst, G. (2012). Lipid sorting by 
ceramide and the consequences for membrane proteins. Biophysical journal 102, 2031-2038. 
Bourguignon, L.Y. (2008). Hyaluronan-mediated CD44 activation of RhoGTPase signaling and 
cytoskeleton function promotes tumor progression. Seminars in cancer biology 18, 251-259. 
Bourguignon, L.Y., Wong, G., Earle, C., Krueger, K., and Spevak, C.C. (2010). Hyaluronan-CD44 interaction 
promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, 
leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion. The Journal of 
biological chemistry 285, 36721-36735. 
Brady, R.O., Kanfer, J.N., Mock, M.B., and Fredrickson, D.S. (1966). The metabolism of sphingomyelin. II. 
Evidence of an enzymatic deficiency in Niemann-Pick diseae. Proceedings of the National Academy of 
Sciences of the United States of America 55, 366-369. 
Brauweiler, A.M., Bin, L., Kim, B.E., Oyoshi, M.K., Geha, R.S., Goleva, E., and Leung, D.Y. (2013). Filaggrin-
dependent secretion of sphingomyelinase protects against staphylococcal alpha-toxin-induced 
keratinocyte death. The Journal of allergy and clinical immunology 131, 421-427 e421-422. 
90 
 
Brenner, B., Ferlinz, K., Grassme, H., Weller, M., Koppenhoefer, U., Dichgans, J., Sandhoff, K., Lang, F., 
and Gulbins, E. (1998). Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspases. Cell death 
and differentiation 5, 29-37. 
Brinkmann, V., and Zychlinsky, A. (2012). Neutrophil extracellular traps: is immunity the second function 
of chromatin? The Journal of cell biology 198, 773-783. 
Bronner, S., Monteil, H., and Prevost, G. (2004). Regulation of virulence determinants in Staphylococcus 
aureus: complexity and applications. FEMS microbiology reviews 28, 183-200. 
Brown, D.A., and London, E. (1998). Functions of lipid rafts in biological membranes. Annual review of 
cell and developmental biology 14, 111-136. 
Brown, D.A., and Rose, J.K. (1992). Sorting of GPI-anchored proteins to glycolipid-enriched membrane 
subdomains during transport to the apical cell surface. Cell 68, 533-544. 
Bubeck Wardenburg, J., Patel, R.J., and Schneewind, O. (2007). Surface proteins and exotoxins are 
required for the pathogenesis of Staphylococcus aureus pneumonia. Infection and immunity 75, 1040-
1044. 
Bubeck Wardenburg, J., and Schneewind, O. (2008). Vaccine protection against Staphylococcus aureus 
pneumonia. The Journal of experimental medicine 205, 287-294. 
Butler, A., Gordon, R.E., Gatt, S., and Schuchman, E.H. (2007). Sperm abnormalities in heterozygous acid 
sphingomyelinase knockout mice reveal a novel approach for the prevention of genetic diseases. The 
American journal of pathology 170, 2077-2088. 
Canals, D., Jenkins, R.W., Roddy, P., Hernandez-Corbacho, M.J., Obeid, L.M., and Hannun, Y.A. (2010). 
Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation: probing 
sphingolipid signaling at the outer plasma membrane. The Journal of biological chemistry 285, 32476-
32485. 
Carpinteiro, A., Becker, K.A., Japtok, L., Hessler, G., Keitsch, S., Pozgajova, M., Schmid, K.W., Adams, C., 
Muller, S., Kleuser, B., et al. (2015). Regulation of hematogenous tumor metastasis by acid 
sphingomyelinase. EMBO molecular medicine 7, 714-734. 
Carpinteiro, A., Beckmann, N., Seitz, A., Hessler, G., Wilker, B., Soddemann, M., Helfrich, I., Edelmann, B., 
Gulbins, E., and Becker, K.A. (2016). Role of Acid Sphingomyelinase-Induced Signaling in Melanoma Cells 
for Hematogenous Tumor Metastasis. Cellular physiology and biochemistry : international journal of 
experimental cellular physiology, biochemistry, and pharmacology 38, 1-14. 
Carpinteiro, A., Dumitru, C., Schenck, M., and Gulbins, E. (2008). Ceramide-induced cell death in 
malignant cells. Cancer letters 264, 1-10. 
Cassat, J.E., Hammer, N.D., Campbell, J.P., Benson, M.A., Perrien, D.S., Mrak, L.N., Smeltzer, M.S., Torres, 
V.J., and Skaar, E.P. (2013). A secreted bacterial protease tailors the Staphylococcus aureus virulence 
repertoire to modulate bone remodeling during osteomyelitis. Cell host & microbe 13, 759-772. 
Castro, B.M., de Almeida, R.F., Silva, L.C., Fedorov, A., and Prieto, M. (2007). Formation of 
ceramide/sphingomyelin gel domains in the presence of an unsaturated phospholipid: a quantitative 
multiprobe approach. Biophysical journal 93, 1639-1650. 
Castro, B.M., Prieto, M., and Silva, L.C. (2014). Ceramide: a simple sphingolipid with unique biophysical 
properties. Progress in lipid research 54, 53-67. 
Charruyer, A., Jean, C., Colomba, A., Jaffrezou, J.P., Quillet-Mary, A., Laurent, G., and Bezombes, C. 
(2007). PKCzeta protects against UV-C-induced apoptosis by inhibiting acid sphingomyelinase-dependent 
ceramide production. The Biochemical journal 405, 77-83. 
Chavakis, T., Hussain, M., Kanse, S.M., Peters, G., Bretzel, R.G., Flock, J.I., Herrmann, M., and Preissner, 
K.T. (2002). Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by 
inhibiting the recruitment of host leukocytes. Nature medicine 8, 687-693. 
91 
 
Cheng, Z.J., Singh, R.D., Sharma, D.K., Holicky, E.L., Hanada, K., Marks, D.L., and Pagano, R.E. (2006). 
Distinct mechanisms of clathrin-independent endocytosis have unique sphingolipid requirements. 
Molecular biology of the cell 17, 3197-3210. 
Chiantia, S., Kahya, N., Ries, J., and Schwille, P. (2006). Effects of ceramide on liquid-ordered domains 
investigated by simultaneous AFM and FCS. Biophysical journal 90, 4500-4508. 
Collins, L.V., Kristian, S.A., Weidenmaier, C., Faigle, M., Van Kessel, K.P., Van Strijp, J.A., Gotz, F., 
Neumeister, B., and Peschel, A. (2002). Staphylococcus aureus strains lacking D-alanine modifications of 
teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. 
The Journal of infectious diseases 186, 214-219. 
Corey, G.R. (2009). Staphylococcus aureus bloodstream infections: definitions and treatment. Clinical 
infectious diseases : an official publication of the Infectious Diseases Society of America 48 Suppl 4, 
S254-259. 
Costerton, J.W., Stewart, P.S., and Greenberg, E.P. (1999). Bacterial biofilms: a common cause of 
persistent infections. Science 284, 1318-1322. 
Cuschieri, J., Bulger, E., Billgrin, J., Garcia, I., and Maier, R.V. (2007). Acid sphingomyelinase is required 
for lipid Raft TLR4 complex formation. Surgical infections 8, 91-106. 
Cywes, C., Stamenkovic, I., and Wessels, M.R. (2000). CD44 as a receptor for colonization of the pharynx 
by group A Streptococcus. The Journal of clinical investigation 106, 995-1002. 
da Silva, M.C., Zahm, J.M., Gras, D., Bajolet, O., Abely, M., Hinnrasky, J., Milliot, M., de Assis, M.C., 
Hologne, C., Bonnet, N., et al. (2004). Dynamic interaction between airway epithelial cells and 
Staphylococcus aureus. American journal of physiology Lung cellular and molecular physiology 287, 
L543-551. 
da Veiga Pereira, L., Desnick, R.J., Adler, D.A., Disteche, C.M., and Schuchman, E.H. (1991). Regional 
assignment of the human acid sphingomyelinase gene (SMPD1) by PCR analysis of somatic cell hybrids 
and in situ hybridization to 11p15.1----p15.4. Genomics 9, 229-234. 
Dai, L., Trillo-Tinoco, J., Bai, A., Chen, Y., Bielawski, J., Del Valle, L., Smith, C.D., Ochoa, A.C., Qin, Z., and 
Parsons, C. (2015). Ceramides promote apoptosis for virus-infected lymphoma cells through induction of 
ceramide synthases and viral lytic gene expression. Oncotarget 6, 24246-24260. 
Damodarasamy, M., Johnson, R.S., Bentov, I., MacCoss, M.J., Vernon, R.B., and Reed, M.J. (2014). 
Hyaluronan enhances wound repair and increases collagen III in aged dermal wounds. Wound repair and 
regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair 
Society 22, 521-526. 
Dancer, S.J., and Noble, W.C. (1991). Nasal, axillary, and perineal carriage of Staphylococcus aureus 
among women: identification of strains producing epidermolytic toxin. Journal of clinical pathology 44, 
681-684. 
David, M.Z., and Daum, R.S. (2010). Community-associated methicillin-resistant Staphylococcus aureus: 
epidemiology and clinical consequences of an emerging epidemic. Clinical microbiology reviews 23, 616-
687. 
de Bentzmann, S., Tristan, A., Etienne, J., Brousse, N., Vandenesch, F., and Lina, G. (2004). 
Staphylococcus aureus isolates associated with necrotizing pneumonia bind to basement membrane 
type I and IV collagens and laminin. The Journal of infectious diseases 190, 1506-1515. 
de Haas, C.J., Veldkamp, K.E., Peschel, A., Weerkamp, F., Van Wamel, W.J., Heezius, E.C., Poppelier, M.J., 
Van Kessel, K.P., and van Strijp, J.A. (2004). Chemotaxis inhibitory protein of Staphylococcus aureus, a 
bacterial antiinflammatory agent. The Journal of experimental medicine 199, 687-695. 
Deevska, G.M., Sunkara, M., Morris, A.J., and Nikolova-Karakashian, M.N. (2012). Characterization of 
secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr-/- mice 
fed on a high-fat diet. Bioscience reports 32, 479-490. 
92 
 
DeGrendele, H.C., Estess, P., and Siegelman, M.H. (1997). Requirement for CD44 in activated T cell 
extravasation into an inflammatory site. Science 278, 672-675. 
DeLeo, F.R., Otto, M., Kreiswirth, B.N., and Chambers, H.F. (2010). Community-associated meticillin-
resistant Staphylococcus aureus. Lancet 375, 1557-1568. 
Denhardt, D.T., Noda, M., O'Regan, A.W., Pavlin, D., and Berman, J.S. (2001). Osteopontin as a means to 
cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. The 
Journal of clinical investigation 107, 1055-1061. 
Denning, S.M., Le, P.T., Singer, K.H., and Haynes, B.F. (1990). Antibodies against the CD44 p80, 
lymphocyte homing receptor molecule augment human peripheral blood T cell activation. Journal of 
immunology 144, 7-15. 
Diep, B.A., Chan, L., Tattevin, P., Kajikawa, O., Martin, T.R., Basuino, L., Mai, T.T., Marbach, H., Braughton, 
K.R., Whitney, A.R., et al. (2010). Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-
Valentine leukocidin-induced lung inflammation and injury. Proceedings of the National Academy of 
Sciences of the United States of America 107, 5587-5592. 
Dobrowsky, R.T., and Hannun, Y.A. (1993). Ceramide-activated protein phosphatase: partial purification 
and relationship to protein phosphatase 2A. Advances in lipid research 25, 91-104. 
Donegan, N.P., and Cheung, A.L. (2009). Regulation of the mazEF toxin-antitoxin module in 
Staphylococcus aureus and its impact on sigB expression. Journal of bacteriology 191, 2795-2805. 
Dreymueller, D., Uhlig, S., and Ludwig, A. (2015). ADAM-family metalloproteinases in lung inflammation: 
potential therapeutic targets. American journal of physiology Lung cellular and molecular physiology 308, 
L325-343. 
Duan, R.D. (2006). Alkaline sphingomyelinase: an old enzyme with novel implications. Biochimica et 
biophysica acta 1761, 281-291. 
Duan, R.D., Bergman, T., Xu, N., Wu, J., Cheng, Y., Duan, J., Nelander, S., Palmberg, C., and Nilsson, A. 
(2003). Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to 
the nucleotide phosphodiesterase family. The Journal of biological chemistry 278, 38528-38536. 
Dumitru, C.A., Carpinteiro, A., Trarbach, T., Hengge, U.R., and Gulbins, E. (2007). Doxorubicin enhances 
TRAIL-induced cell death via ceramide-enriched membrane platforms. Apoptosis : an international 
journal on programmed cell death 12, 1533-1541. 
Dumitru, C.A., and Gulbins, E. (2006). TRAIL activates acid sphingomyelinase via a redox mechanism and 
releases ceramide to trigger apoptosis. Oncogene 25, 5612-5625. 
Duterme, C., Mertens-Strijthagen, J., Tammi, M., and Flamion, B. (2009). Two novel functions of 
hyaluronidase-2 (Hyal2) are formation of the glycocalyx and control of CD44-ERM interactions. The 
Journal of biological chemistry 284, 33495-33508. 
Dzwonek, J., and Wilczynski, G.M. (2015). CD44: molecular interactions, signaling and functions in the 
nervous system. Frontiers in cellular neuroscience 9, 175. 
Edelmann, B., Bertsch, U., Tchikov, V., Winoto-Morbach, S., Perrotta, C., Jakob, M., Adam-Klages, S., 
Kabelitz, D., and Schutze, S. (2011). Caspase-8 and caspase-7 sequentially mediate proteolytic activation 
of acid sphingomyelinase in TNF-R1 receptosomes. The EMBO journal 30, 379-394. 
Eggeling, C., Ringemann, C., Medda, R., Schwarzmann, G., Sandhoff, K., Polyakova, S., Belov, V.N., Hein, 
B., von Middendorff, C., Schonle, A., et al. (2009). Direct observation of the nanoscale dynamics of 
membrane lipids in a living cell. Nature 457, 1159-1162. 
Eriksen, N.H., Espersen, F., Rosdahl, V.T., and Jensen, K. (1995). Carriage of Staphylococcus aureus 
among 104 healthy persons during a 19-month period. Epidemiology and infection 115, 51-60. 
Esen, M., Schreiner, B., Jendrossek, V., Lang, F., Fassbender, K., Grassme, H., and Gulbins, E. (2001). 
Mechanisms of Staphylococcus aureus induced apoptosis of human endothelial cells. Apoptosis : an 
international journal on programmed cell death 6, 431-439. 
93 
 
Evanko, S.P., Potter-Perigo, S., Petty, L.J., Workman, G.A., and Wight, T.N. (2015). Hyaluronan Controls 
the Deposition of Fibronectin and Collagen and Modulates TGF-beta1 Induction of Lung Myofibroblasts. 
Matrix biology : journal of the International Society for Matrix Biology 42, 74-92. 
Fahy, E., Subramaniam, S., Brown, H.A., Glass, C.K., Merrill, A.H., Jr., Murphy, R.C., Raetz, C.R., Russell, 
D.W., Seyama, Y., Shaw, W., et al. (2005). A comprehensive classification system for lipids. Journal of 
lipid research 46, 839-861. 
Falcone, S., Perrotta, C., De Palma, C., Pisconti, A., Sciorati, C., Capobianco, A., Rovere-Querini, P., 
Manfredi, A.A., and Clementi, E. (2004). Activation of acid sphingomyelinase and its inhibition by the 
nitric oxide/cyclic guanosine 3',5'-monophosphate pathway: key events in Escherichia coli-elicited 
apoptosis of dendritic cells. Journal of immunology 173, 4452-4463. 
Fehon, R.G., McClatchey, A.I., and Bretscher, A. (2010). Organizing the cell cortex: the role of ERM 
proteins. Nature reviews Molecular cell biology 11, 276-287. 
Ferlinz, K., Hurwitz, R., Moczall, H., Lansmann, S., Schuchman, E.H., and Sandhoff, K. (1997). Functional 
characterization of the N-glycosylation sites of human acid sphingomyelinase by site-directed 
mutagenesis. European journal of biochemistry 243, 511-517. 
Foster, T.J. (2005). Immune evasion by staphylococci. Nature reviews Microbiology 3, 948-958. 
Foster, T.J., Geoghegan, J.A., Ganesh, V.K., and Hook, M. (2014). Adhesion, invasion and evasion: the 
many functions of the surface proteins of Staphylococcus aureus. Nature reviews Microbiology 12, 49-62. 
Foster, T.J., and McDevitt, D. (1994). Surface-associated proteins of Staphylococcus aureus: their 
possible roles in virulence. FEMS microbiology letters 118, 199-205. 
Fournier, B. (2012). The function of TLR2 during staphylococcal diseases. Frontiers in cellular and 
infection microbiology 2, 167. 
Fowler, S. (1969). Lysosomal localization of sphingomyelinase in rat liver. Biochimica et biophysica acta 
191, 481-484. 
Franchi, L., Munoz-Planillo, R., and Nunez, G. (2012). Sensing and reacting to microbes through the 
inflammasomes. Nature immunology 13, 325-332. 
Fraser, J.D., and Proft, T. (2008). The bacterial superantigen and superantigen-like proteins. 
Immunological reviews 225, 226-243. 
Fridkin, S.K., Hageman, J.C., Morrison, M., Sanza, L.T., Como-Sabetti, K., Jernigan, J.A., Harriman, K., 
Harrison, L.H., Lynfield, R., Farley, M.M., et al. (2005). Methicillin-resistant Staphylococcus aureus 
disease in three communities. The New England journal of medicine 352, 1436-1444. 
Friedman, D.B., Stauff, D.L., Pishchany, G., Whitwell, C.W., Torres, V.J., and Skaar, E.P. (2006). 
Staphylococcus aureus redirects central metabolism to increase iron availability. PLoS pathogens 2, e87. 
Fukata, Y., Kimura, K., Oshiro, N., Saya, H., Matsuura, Y., and Kaibuchi, K. (1998). Association of the 
myosin-binding subunit of myosin phosphatase and moesin: dual regulation of moesin phosphorylation 
by Rho-associated kinase and myosin phosphatase. The Journal of cell biology 141, 409-418. 
Gao, W., Chua, K., Davies, J.K., Newton, H.J., Seemann, T., Harrison, P.F., Holmes, N.E., Rhee, H.W., Hong, 
J.I., Hartland, E.L., et al. (2010). Two novel point mutations in clinical Staphylococcus aureus reduce 
linezolid susceptibility and switch on the stringent response to promote persistent infection. PLoS 
pathogens 6, e1000944. 
Garay, J., Piazuelo, M.B., Majumdar, S., Li, L., Trillo-Tinoco, J., Del Valle, L., Schneider, B.G., Delgado, A.G., 
Wilson, K.T., Correa, P., et al. (2016). The homing receptor CD44 is involved in the progression of 
precancerous gastric lesions in patients infected with Helicobacter pylori and in development of mucous 
metaplasia in mice. Cancer letters 371, 90-98. 
Garcia-Barros, M., Paris, F., Cordon-Cardo, C., Lyden, D., Rafii, S., Haimovitz-Friedman, A., Fuks, Z., and 
Kolesnick, R. (2003). Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 
300, 1155-1159. 
94 
 
Garrett, Q., Simmons, P.A., Xu, S., Vehige, J., Zhao, Z., Ehrmann, K., and Willcox, M. (2007). 
Carboxymethylcellulose binds to human corneal epithelial cells and is a modulator of corneal epithelial 
wound healing. Investigative ophthalmology & visual science 48, 1559-1567. 
Gassert, E., Avota, E., Harms, H., Krohne, G., Gulbins, E., and Schneider-Schaulies, S. (2009). Induction of 
membrane ceramides: a novel strategy to interfere with T lymphocyte cytoskeletal reorganisation in 
viral immunosuppression. PLoS pathogens 5, e1000623. 
Gatt, S. (1963). Enzymic Hydrolysis and Synthesis of Ceramides. The Journal of biological chemistry 238, 
3131-3133. 
Ghatak, S., Bogatkevich, G.S., Atnelishvili, I., Akter, T., Feghali-Bostwick, C., Hoffman, S., Fresco, V.M., 
Fuchs, J.C., Visconti, R.P., Markwald, R.R., et al. (2014). Overexpression of c-Met and CD44v6 receptors 
contributes to autocrine TGF-beta1 signaling in interstitial lung disease. The Journal of biological 
chemistry 289, 7856-7872. 
Giesbrecht, P., Wecke, J., and Reinicke, B. (1976). On the morphogenesis of the cell wall of staphylococci. 
International review of cytology 44, 225-318. 
Gilbert, I. (1931). Dissociation in an Encapsulated Staphylococcus. Journal of bacteriology 21, 157-160. 
Gilbert, S., Loranger, A., Omary, M.B., and Marceau, N. (2016). Keratin impact on PKCdelta- and ASMase-
mediated regulation of hepatocyte lipid raft size - implication for FasR-associated apoptosis. Journal of 
cell science 129, 3262-3273. 
Gillard, B.K., Clement, R.G., and Marcus, D.M. (1998). Variations among cell lines in the synthesis of 
sphingolipids in de novo and recycling pathways. Glycobiology 8, 885-890. 
Gillet, Y., Issartel, B., Vanhems, P., Fournet, J.C., Lina, G., Bes, M., Vandenesch, F., Piemont, Y., Brousse, 
N., Floret, D., et al. (2002). Association between Staphylococcus aureus strains carrying gene for Panton-
Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. 
Lancet 359, 753-759. 
Golan, M., Feinshtein, V., Polyak, D., Scomparin, A., Satchi-Fainaro, R., and David, A. (2016). Inhibition of 
Gene Expression and Cancer Cell Migration by CD44v3/6-Targeted Polyion Complexes. Bioconjugate 
chemistry 27, 947-960. 
Goldstein, L.A., and Butcher, E.C. (1990). Identification of mRNA that encodes an alternative form of H-
CAM(CD44) in lymphoid and nonlymphoid tissues. Immunogenetics 32, 389-397. 
Gomez, M.I., Lee, A., Reddy, B., Muir, A., Soong, G., Pitt, A., Cheung, A., and Prince, A. (2004). 
Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. 
Nature medicine 10, 842-848. 
Gomez, M.I., Seaghdha, M.O., and Prince, A.S. (2007). Staphylococcus aureus protein A activates TACE 
through EGFR-dependent signaling. The EMBO journal 26, 701-709. 
Goni, F.M., Contreras, F.X., Montes, L.R., Sot, J., and Alonso, A. (2005). Biophysics (and sociology) of 
ceramides. Biochemical Society symposium, 177-188. 
Goodison, S., Urquidi, V., and Tarin, D. (1999). CD44 cell adhesion molecules. Molecular pathology : MP 
52, 189-196. 
Goodyear, C.S., and Silverman, G.J. (2004). Staphylococcal toxin induced preferential and prolonged in 
vivo deletion of innate-like B lymphocytes. Proceedings of the National Academy of Sciences of the 
United States of America 101, 11392-11397. 
Gorelik, A., Illes, K., Heinz, L.X., Superti-Furga, G., and Nagar, B. (2016). Crystal structure of mammalian 
acid sphingomyelinase. Nature communications 7, 12196. 
Gouaux, J.E., Braha, O., Hobaugh, M.R., Song, L., Cheley, S., Shustak, C., and Bayley, H. (1994). Subunit 
stoichiometry of staphylococcal alpha-hemolysin in crystals and on membranes: a heptameric 
transmembrane pore. Proceedings of the National Academy of Sciences of the United States of America 
91, 12828-12831. 
95 
 
Grammatikos, G., Teichgraber, V., Carpinteiro, A., Trarbach, T., Weller, M., Hengge, U.R., and Gulbins, E. 
(2007). Overexpression of acid sphingomyelinase sensitizes glioma cells to chemotherapy. Antioxidants 
& redox signaling 9, 1449-1456. 
Grassme, H., and Becker, K.A. (2013). Bacterial infections and ceramide. Handbook of experimental 
pharmacology, 305-320. 
Grassme, H., Gulbins, E., Brenner, B., Ferlinz, K., Sandhoff, K., Harzer, K., Lang, F., and Meyer, T.F. (1997). 
Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells. Cell 91, 605-615. 
Grassme, H., Jekle, A., Riehle, A., Schwarz, H., Berger, J., Sandhoff, K., Kolesnick, R., and Gulbins, E. 
(2001a). CD95 signaling via ceramide-rich membrane rafts. The Journal of biological chemistry 276, 
20589-20596. 
Grassme, H., Jendrossek, V., Bock, J., Riehle, A., and Gulbins, E. (2002). Ceramide-rich membrane rafts 
mediate CD40 clustering. Journal of immunology 168, 298-307. 
Grassme, H., Jendrossek, V., Riehle, A., von Kurthy, G., Berger, J., Schwarz, H., Weller, M., Kolesnick, R., 
and Gulbins, E. (2003). Host defense against Pseudomonas aeruginosa requires ceramide-rich 
membrane rafts. Nature medicine 9, 322-330. 
Grassme, H., Jernigan, P.L., Hoehn, R.S., Wilker, B., Soddemann, M., Edwards, M.J., Muller, C.P., 
Kornhuber, J., and Gulbins, E. (2015). Inhibition of Acid Sphingomyelinase by Antidepressants 
Counteracts Stress-Induced Activation of P38-Kinase in Major Depression. Neuro-Signals 23, 84-92. 
Grassme, H., Kirschnek, S., Riethmueller, J., Riehle, A., von Kurthy, G., Lang, F., Weller, M., and Gulbins, E. 
(2000). CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa. 
Science 290, 527-530. 
Grassme, H., Riehle, A., Wilker, B., and Gulbins, E. (2005). Rhinoviruses infect human epithelial cells via 
ceramide-enriched membrane platforms. The Journal of biological chemistry 280, 26256-26262. 
Grassme, H., Riethmuller, J., and Gulbins, E. (2007). Biological aspects of ceramide-enriched membrane 
domains. Progress in lipid research 46, 161-170. 
Grassme, H., Schwarz, H., and Gulbins, E. (2001b). Molecular mechanisms of ceramide-mediated CD95 
clustering. Biochemical and biophysical research communications 284, 1016-1030. 
Gresham, H.D., Lowrance, J.H., Caver, T.E., Wilson, B.S., Cheung, A.L., and Lindberg, F.P. (2000). Survival 
of Staphylococcus aureus inside neutrophils contributes to infection. Journal of immunology 164, 3713-
3722. 
Grumann, D., Nubel, U., and Broker, B.M. (2014). Staphylococcus aureus toxins--their functions and 
genetics. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics 
in infectious diseases 21, 583-592. 
Grundmann, H., Aires-de-Sousa, M., Boyce, J., and Tiemersma, E. (2006). Emergence and resurgence of 
meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368, 874-885. 
Gu, Y., Dee, C.M., and Shen, J. (2011). Interaction of free radicals, matrix metalloproteinases and 
caveolin-1 impacts blood-brain barrier permeability. Frontiers in bioscience 3, 1216-1231. 
Guinan, M.E., Dan, B.B., Guidotti, R.J., Reingold, A.L., Schmid, G.P., Bettoli, E.J., Lossick, J.G., Shands, K.N., 
Kramer, M.A., Hargrett, N.T., et al. (1982). Vaginal colonization with Staphylococcus aureus in healthy 
women: a review of four studies. Annals of internal medicine 96, 944-947. 
Gulbins, A., Grassme, H., Hoehn, R., Kohnen, M., Edwards, M.J., Kornhuber, J., and Gulbins, E. (2016a). 
Role of Janus-Kinases in Major Depressive Disorder. Neuro-Signals 24, 71-80. 
Gulbins, A., Grassme, H., Hoehn, R., Wilker, B., Soddemann, M., Kohnen, M., Edwards, M.J., Kornhuber, 
J., and Gulbins, E. (2016b). Regulation of Neuronal Stem Cell Proliferation in the Hippocampus by 
Endothelial Ceramide. Cellular physiology and biochemistry : international journal of experimental 
cellular physiology, biochemistry, and pharmacology 39, 790-801. 
Gulbins, E., Dreschers, S., Wilker, B., and Grassme, H. (2004). Ceramide, membrane rafts and infections. 
Journal of molecular medicine 82, 357-363. 
96 
 
Gulbins, E., Palmada, M., Reichel, M., Luth, A., Bohmer, C., Amato, D., Muller, C.P., Tischbirek, C.H., 
Groemer, T.W., Tabatabai, G., et al. (2013). Acid sphingomyelinase-ceramide system mediates effects of 
antidepressant drugs. Nature medicine 19, 934-938. 
Gunthert, U., Hofmann, M., Rudy, W., Reber, S., Zoller, M., Haussmann, I., Matzku, S., Wenzel, A., Ponta, 
H., and Herrlich, P. (1991). A new variant of glycoprotein CD44 confers metastatic potential to rat 
carcinoma cells. Cell 65, 13-24. 
Hage-Sleiman, R., Hamze, A.B., El-Hed, A.F., Attieh, R., Kozhaya, L., Kabbani, S., and Dbaibo, G. (2016). 
Ceramide inhibits PKCtheta by regulating its phosphorylation and translocation to lipid rafts in Jurkat 
cells. Immunologic research 64, 869-886. 
Haimovitz-Friedman, A., Cordon-Cardo, C., Bayoumy, S., Garzotto, M., McLoughlin, M., Gallily, R., 
Edwards, C.K., 3rd, Schuchman, E.H., Fuks, Z., and Kolesnick, R. (1997). Lipopolysaccharide induces 
disseminated endothelial apoptosis requiring ceramide generation. The Journal of experimental 
medicine 186, 1831-1841. 
Hakoda, M., Hayashimoto, S., Yamanaka, H., Terai, C., Kamatani, N., and Kashiwazaki, S. (1994). 
Molecular basis for the interaction between human IgM and staphylococcal protein A. Clinical 
immunology and immunopathology 72, 394-401. 
Hamada, K., Shimizu, T., Yonemura, S., Tsukita, S., Tsukita, S., and Hakoshima, T. (2003). Structural basis 
of adhesion-molecule recognition by ERM proteins revealed by the crystal structure of the radixin-ICAM-
2 complex. The EMBO journal 22, 502-514. 
Hammer, N.D., and Skaar, E.P. (2011). Molecular mechanisms of Staphylococcus aureus iron acquisition. 
Annual review of microbiology 65, 129-147. 
Hanada, K., Kumagai, K., Tomishige, N., and Kawano, M. (2007). CERT and intracellular trafficking of 
ceramide. Biochimica et biophysica acta 1771, 644-653. 
Hannun, Y.A., and Obeid, L.M. (2008). Principles of bioactive lipid signalling: lessons from sphingolipids. 
Nature reviews Molecular cell biology 9, 139-150. 
Harder, T., Scheiffele, P., Verkade, P., and Simons, K. (1998). Lipid domain structure of the plasma 
membrane revealed by patching of membrane components. The Journal of cell biology 141, 929-942. 
Harder, T., and Simons, K. (1997). Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol 
microdomains. Current opinion in cell biology 9, 534-542. 
Harris, T.O., Grossman, D., Kappler, J.W., Marrack, P., Rich, R.R., and Betley, M.J. (1993). Lack of 
complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins. 
Infection and immunity 61, 3175-3183. 
Hasenauer, S., Malinger, D., Koschut, D., Pace, G., Matzke, A., von Au, A., and Orian-Rousseau, V. (2013). 
Internalization of Met requires the co-receptor CD44v6 and its link to ERM proteins. PloS one 8, e62357. 
Hashimoto, M., Tawaratsumida, K., Kariya, H., Kiyohara, A., Suda, Y., Krikae, F., Kirikae, T., and Gotz, F. 
(2006). Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active 
compounds in Staphylococcus aureus. Journal of immunology 177, 3162-3169. 
Hauck, C.R., Grassme, H., Bock, J., Jendrossek, V., Ferlinz, K., Meyer, T.F., and Gulbins, E. (2000). Acid 
sphingomyelinase is involved in CEACAM receptor-mediated phagocytosis of Neisseria gonorrhoeae. 
FEBS letters 478, 260-266. 
Hayashida, A., Bartlett, A.H., Foster, T.J., and Park, P.W. (2009). Staphylococcus aureus beta-toxin 
induces lung injury through syndecan-1. The American journal of pathology 174, 509-518. 
Hedlund, M., Duan, R.D., Nilsson, A., and Svanborg, C. (1998). Sphingomyelin, glycosphingolipids and 
ceramide signalling in cells exposed to P-fimbriated Escherichia coli. Molecular microbiology 29, 1297-
1306. 
Heinrich, M., Wickel, M., Schneider-Brachert, W., Sandberg, C., Gahr, J., Schwandner, R., Weber, T., 
Saftig, P., Peters, C., Brunner, J., et al. (1999). Cathepsin D targeted by acid sphingomyelinase-derived 
ceramide. The EMBO journal 18, 5252-5263. 
97 
 
Henry, B., Ziobro, R., Becker, K.A., Kolesnick, R., and Gulbins, E. (2013). Acid sphingomyelinase. 
Handbook of experimental pharmacology, 77-88. 
Heptinstall, J., Coley, J., Ward, P.J., Archibald, A.R., and Baddiley, J. (1978). The linkage of sugar 
phosphate polymer to peptidoglycan in walls of Micrococcus sp. 2102. The Biochemical journal 169, 
329-336. 
Hernandez, D., Miquel-Serra, L., Docampo, M.J., Marco-Ramell, A., Cabrera, J., Fabra, A., and Bassols, A. 
(2011). V3 versican isoform alters the behavior of human melanoma cells by interfering with CD44/ErbB-
dependent signaling. The Journal of biological chemistry 286, 1475-1485. 
Hernandez, F.J., Huang, L., Olson, M.E., Powers, K.M., Hernandez, L.I., Meyerholz, D.K., Thedens, D.R., 
Behlke, M.A., Horswill, A.R., and McNamara, J.O., 2nd (2014). Noninvasive imaging of Staphylococcus 
aureus infections with a nuclease-activated probe. Nature medicine 20, 301-306. 
Heyer, G., Saba, S., Adamo, R., Rush, W., Soong, G., Cheung, A., and Prince, A. (2002). Staphylococcus 
aureus agr and sarA functions are required for invasive infection but not inflammatory responses in the 
lung. Infection and immunity 70, 127-133. 
Higashi, A., Dohi, Y., Uraoka, N., Sentani, K., Uga, S., Kinoshita, H., Sada, Y., Kitagawa, T., Hidaka, T., 
Kurisu, S., et al. (2015). The Potential Role of Inflammation Associated with Interaction between 
Osteopontin and CD44 in a Case of Pulmonary Tumor Thrombotic Microangiopathy Caused by Breast 
Cancer. Internal medicine 54, 2877-2880. 
Higgins, J., Loughman, A., van Kessel, K.P., van Strijp, J.A., and Foster, T.J. (2006). Clumping factor A of 
Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes. FEMS 
microbiology letters 258, 290-296. 
Hill, D.R., Kessler, S.P., Rho, H.K., Cowman, M.K., and de la Motte, C.A. (2012). Specific-sized hyaluronan 
fragments promote expression of human beta-defensin 2 in intestinal epithelium. The Journal of 
biological chemistry 287, 30610-30624. 
Hill, D.R., Rho, H.K., Kessler, S.P., Amin, R., Homer, C.R., McDonald, C., Cowman, M.K., and de la Motte, 
C.A. (2013). Human milk hyaluronan enhances innate defense of the intestinal epithelium. The Journal 
of biological chemistry 288, 29090-29104. 
Hodge, R.G., and Ridley, A.J. (2016). Regulating Rho GTPases and their regulators. Nature reviews 
Molecular cell biology 17, 496-510. 
Hofmann, K., Tomiuk, S., Wolff, G., and Stoffel, W. (2000). Cloning and characterization of the 
mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase. Proceedings of the National 
Academy of Sciences of the United States of America 97, 5895-5900. 
Holzinger, D., Gieldon, L., Mysore, V., Nippe, N., Taxman, D.J., Duncan, J.A., Broglie, P.M., Marketon, K., 
Austermann, J., Vogl, T., et al. (2012). Staphylococcus aureus Panton-Valentine leukocidin induces an 
inflammatory response in human phagocytes via the NLRP3 inflammasome. Journal of leukocyte biology 
92, 1069-1081. 
Hooper, N.M. (1999). Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid 
rafts and caveolae (review). Molecular membrane biology 16, 145-156. 
Horinouchi, K., Erlich, S., Perl, D.P., Ferlinz, K., Bisgaier, C.L., Sandhoff, K., Desnick, R.J., Stewart, C.L., and 
Schuchman, E.H. (1995). Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick 
disease. Nature genetics 10, 288-293. 
Hsueh, Y.W., Giles, R., Kitson, N., and Thewalt, J. (2002). The effect of ceramide on phosphatidylcholine 
membranes: a deuterium NMR study. Biophysical journal 82, 3089-3095. 
Hu, L., Umeda, A., Kondo, S., and Amako, K. (1995). Typing of Staphylococcus aureus colonising human 
nasal carriers by pulsed-field gel electrophoresis. Journal of medical microbiology 42, 127-132. 
Huwiler, A., Johansen, B., Skarstad, A., and Pfeilschifter, J. (2001). Ceramide binds to the CaLB domain of 
cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release. FASEB 
journal : official publication of the Federation of American Societies for Experimental Biology 15, 7-9. 
98 
 
Irvine, A.D., McLean, W.H., and Leung, D.Y. (2011). Filaggrin mutations associated with skin and allergic 
diseases. The New England journal of medicine 365, 1315-1327. 
Jaffe, A.B., and Hall, A. (2005). Rho GTPases: biochemistry and biology. Annual review of cell and 
developmental biology 21, 247-269. 
Jenkins, R.W., Canals, D., Idkowiak-Baldys, J., Simbari, F., Roddy, P., Perry, D.M., Kitatani, K., Luberto, C., 
and Hannun, Y.A. (2010). Regulated secretion of acid sphingomyelinase: implications for selectivity of 
ceramide formation. The Journal of biological chemistry 285, 35706-35718. 
Jenkins, R.W., Idkowiak-Baldys, J., Simbari, F., Canals, D., Roddy, P., Riner, C.D., Clarke, C.J., and Hannun, 
Y.A. (2011). A novel mechanism of lysosomal acid sphingomyelinase maturation: requirement for 
carboxyl-terminal proteolytic processing. The Journal of biological chemistry 286, 3777-3788. 
Jin, T., Bokarewa, M., Foster, T., Mitchell, J., Higgins, J., and Tarkowski, A. (2004). Staphylococcus aureus 
resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. Journal 
of immunology 172, 1169-1176. 
Johnson, P., and Ruffell, B. (2009). CD44 and its role in inflammation and inflammatory diseases. 
Inflammation & allergy drug targets 8, 208-220. 
Jongerius, I., von Kockritz-Blickwede, M., Horsburgh, M.J., Ruyken, M., Nizet, V., and Rooijakkers, S.H. 
(2012). Staphylococcus aureus virulence is enhanced by secreted factors that block innate immune 
defenses. Journal of innate immunity 4, 301-311. 
Jordan, A.R., Racine, R.R., Hennig, M.J., and Lokeshwar, V.B. (2015). The Role of CD44 in Disease 
Pathophysiology and Targeted Treatment. Frontiers in immunology 6, 182. 
Jozefowski, S., Czerkies, M., Lukasik, A., Bielawska, A., Bielawski, J., Kwiatkowska, K., and Sobota, A. 
(2010). Ceramide and ceramide 1-phosphate are negative regulators of TNF-alpha production induced 
by lipopolysaccharide. Journal of immunology 185, 6960-6973. 
Jung, C., Matzke, A., Niemann, H.H., Schwerk, C., Tenenbaum, T., and Orian-Rousseau, V. (2009). 
Involvement of CD44v6 in InlB-dependent Listeria invasion. Molecular microbiology 72, 1196-1207. 
Jusko, M., Potempa, J., Kantyka, T., Bielecka, E., Miller, H.K., Kalinska, M., Dubin, G., Garred, P., Shaw, 
L.N., and Blom, A.M. (2014). Staphylococcal proteases aid in evasion of the human complement system. 
Journal of innate immunity 6, 31-46. 
Kage, M., and Tokudome, Y. (2016). Hyaluronan tetrasaccharides stimulate ceramide production 
through upregulated mRNA expression of ceramide synthesis-associated enzymes. Archives of 
dermatological research 308, 95-101. 
Kallen, A.J., Mu, Y., Bulens, S., Reingold, A., Petit, S., Gershman, K., Ray, S.M., Harrison, L.H., Lynfield, R., 
Dumyati, G., et al. (2010). Health care-associated invasive MRSA infections, 2005-2008. Jama 304, 641-
648. 
Kaplan, J.B., Velliyagounder, K., Ragunath, C., Rohde, H., Mack, D., Knobloch, J.K., and Ramasubbu, N. 
(2004). Genes involved in the synthesis and degradation of matrix polysaccharide in Actinobacillus 
actinomycetemcomitans and Actinobacillus pleuropneumoniae biofilms. Journal of bacteriology 186, 
8213-8220. 
Kapral, F.A., and Shayegani, M.G. (1959). Intracellular survival of staphylococci. The Journal of 
experimental medicine 110, 123-138. 
Karousou, E., Misra, S., Ghatak, S., Dobra, K., Gotte, M., Vigetti, D., Passi, A., Karamanos, N.K., and 
Skandalis, S.S. (2016). Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer. 
Matrix biology : journal of the International Society for Matrix Biology. 
Kasai, H., and Tanabe, F. (2014). Enhanced diacylglycerol production by phospholipase D activation is 
responsible for abnormal increase in concanavalin A cap formation in polymorphonuclear leukocytes 
from Chediak-Higashi syndrome (beige) mice. International immunopharmacology 21, 193-199. 
Kebaier, C., Chamberland, R.R., Allen, I.C., Gao, X., Broglie, P.M., Hall, J.D., Jania, C., Doerschuk, C.M., 
Tilley, S.L., and Duncan, J.A. (2012). Staphylococcus aureus alpha-hemolysin mediates virulence in a 
99 
 
murine model of severe pneumonia through activation of the NLRP3 inflammasome. The Journal of 
infectious diseases 205, 807-817. 
Kessler, C.M., Nussbaum, E., and Tuazon, C.U. (1991). Disseminated intravascular coagulation associated 
with Staphylococcus aureus septicemia is mediated by peptidoglycan-induced platelet aggregation. The 
Journal of infectious diseases 164, 101-107. 
Khurana, S.S., Riehl, T.E., Moore, B.D., Fassan, M., Rugge, M., Romero-Gallo, J., Noto, J., Peek, R.M., Jr., 
Stenson, W.F., and Mills, J.C. (2013). The hyaluronic acid receptor CD44 coordinates normal and 
metaplastic gastric epithelial progenitor cell proliferation. The Journal of biological chemistry 288, 
16085-16097. 
Kim, C.S., Jeon, S.Y., Min, Y.G., Rhyoo, C., Kim, J.W., Yun, J.B., Park, S.W., and Kwon, T.Y. (2000). Effects 
of beta-toxin of Staphylococcus aureus on ciliary activity of nasal epithelial cells. The Laryngoscope 110, 
2085-2088. 
Kitatani, K., Idkowiak-Baldys, J., and Hannun, Y.A. (2008). The sphingolipid salvage pathway in ceramide 
metabolism and signaling. Cellular signalling 20, 1010-1018. 
Klevens, R.M., Morrison, M.A., Nadle, J., Petit, S., Gershman, K., Ray, S., Harrison, L.H., Lynfield, R., 
Dumyati, G., Townes, J.M., et al. (2007). Invasive methicillin-resistant Staphylococcus aureus infections 
in the United States. Jama 298, 1763-1771. 
Kluytmans, J., van Belkum, A., and Verbrugh, H. (1997). Nasal carriage of Staphylococcus aureus: 
epidemiology, underlying mechanisms, and associated risks. Clinical microbiology reviews 10, 505-520. 
Ko, Y.P., Kuipers, A., Freitag, C.M., Jongerius, I., Medina, E., van Rooijen, W.J., Spaan, A.N., van Kessel, 
K.P., Hook, M., and Rooijakkers, S.H. (2013). Phagocytosis escape by a Staphylococcus aureus protein 
that connects complement and coagulation proteins at the bacterial surface. PLoS pathogens 9, 
e1003816. 
Kobayashi, K., Nagata, E., Sasaki, K., Harada-Shiba, M., Kojo, S., and Kikuzaki, H. (2013). Increase in 
secretory sphingomyelinase activity and specific ceramides in the aorta of apolipoprotein E knockout 
mice during aging. Biological & pharmaceutical bulletin 36, 1192-1196. 
Kohler, C., von Eiff, C., Liebeke, M., McNamara, P.J., Lalk, M., Proctor, R.A., Hecker, M., and Engelmann, S. 
(2008). A defect in menadione biosynthesis induces global changes in gene expression in Staphylococcus 
aureus. Journal of bacteriology 190, 6351-6364. 
Kolesnick, R.N., Goni, F.M., and Alonso, A. (2000). Compartmentalization of ceramide signaling: physical 
foundations and biological effects. Journal of cellular physiology 184, 285-300. 
Kollef, M.H., Shorr, A., Tabak, Y.P., Gupta, V., Liu, L.Z., and Johannes, R.S. (2005). Epidemiology and 
outcomes of health-care-associated pneumonia: results from a large US database of culture-positive 
pneumonia. Chest 128, 3854-3862. 
Konig, H., Ponta, H., and Herrlich, P. (1998). Coupling of signal transduction to alternative pre-mRNA 
splicing by a composite splice regulator. The EMBO journal 17, 2904-2913. 
Konopka, A., Zeug, A., Skupien, A., Kaza, B., Mueller, F., Chwedorowicz, A., Ponimaskin, E., Wilczynski, 
G.M., and Dzwonek, J. (2016). Cleavage of Hyaluronan and CD44 Adhesion Molecule Regulate Astrocyte 
Morphology via Rac1 Signalling. PloS one 11, e0155053. 
Kornhuber, J., Muller, C.P., Becker, K.A., Reichel, M., and Gulbins, E. (2014). The ceramide system as a 
novel antidepressant target. Trends in pharmacological sciences 35, 293-304. 
Kornhuber, J., Rhein, C., Muller, C.P., and Muhle, C. (2015). Secretory sphingomyelinase in health and 
disease. Biological chemistry 396, 707-736. 
Kubica, M., Guzik, K., Koziel, J., Zarebski, M., Richter, W., Gajkowska, B., Golda, A., Maciag-Gudowska, A., 
Brix, K., Shaw, L., et al. (2008). A potential new pathway for Staphylococcus aureus dissemination: the 
silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PloS one 3, e1409. 
100 
 
Kuwae, A., Momose, F., Nagamatsu, K., Suyama, Y., and Abe, A. (2016). BteA Secreted from the 
Bordetella bronchiseptica Type III Secetion System Induces Necrosis through an Actin Cytoskeleton 
Signaling Pathway and Inhibits Phagocytosis by Macrophages. PloS one 11, e0148387. 
Kwiecinski, J., Jacobsson, G., Karlsson, M., Zhu, X., Wang, W., Bremell, T., Josefsson, E., and Jin, T. (2013). 
Staphylokinase promotes the establishment of Staphylococcus aureus skin infections while decreasing 
disease severity. The Journal of infectious diseases 208, 990-999. 
Laarman, A.J., Ruyken, M., Malone, C.L., van Strijp, J.A., Horswill, A.R., and Rooijakkers, S.H. (2011). 
Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion. 
Journal of immunology 186, 6445-6453. 
Lafont, F., Tran Van Nhieu, G., Hanada, K., Sansonetti, P., and van der Goot, F.G. (2002). Initial steps of 
Shigella infection depend on the cholesterol/sphingolipid raft-mediated CD44-IpaB interaction. The 
EMBO journal 21, 4449-4457. 
Lang, P.A., Schenck, M., Nicolay, J.P., Becker, J.U., Kempe, D.S., Lupescu, A., Koka, S., Eisele, K., Klarl, B.A., 
Rubben, H., et al. (2007). Liver cell death and anemia in Wilson disease involve acid sphingomyelinase 
and ceramide. Nature medicine 13, 164-170. 
Lannergard, J., Cao, S., Norstrom, T., Delgado, A., Gustafson, J.E., and Hughes, D. (2011). Genetic 
complexity of fusidic acid-resistant small colony variants (SCV) in Staphylococcus aureus. PloS one 6, 
e28366. 
Lee, L.Y., Miyamoto, Y.J., McIntyre, B.W., Hook, M., McCrea, K.W., McDevitt, D., and Brown, E.L. (2002). 
The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated 
responses. The Journal of clinical investigation 110, 1461-1471. 
Legg, J.W., Lewis, C.A., Parsons, M., Ng, T., and Isacke, C.M. (2002). A novel PKC-regulated mechanism 
controls CD44 ezrin association and directional cell motility. Nature cell biology 4, 399-407. 
Li, X., Gulbins, E., and Zhang, Y. (2012). Oxidative stress triggers Ca-dependent lysosome trafficking and 
activation of acid sphingomyelinase. Cellular physiology and biochemistry : international journal of 
experimental cellular physiology, biochemistry, and pharmacology 30, 815-826. 
Lindsay, J.A., and Riley, T.V. (1994). Staphylococcal iron requirements, siderophore production, and iron-
regulated protein expression. Infection and immunity 62, 2309-2314. 
Lisanti, M.P., Sargiacomo, M., Graeve, L., Saltiel, A.R., and Rodriguez-Boulan, E. (1988). Polarized apical 
distribution of glycosyl-phosphatidylinositol-anchored proteins in a renal epithelial cell line. Proceedings 
of the National Academy of Sciences of the United States of America 85, 9557-9561. 
Lister, J.L., and Horswill, A.R. (2014). Staphylococcus aureus biofilms: recent developments in biofilm 
dispersal. Frontiers in cellular and infection microbiology 4, 178. 
Liu, D., and Sy, M.S. (1997). Phorbol myristate acetate stimulates the dimerization of CD44 involving a 
cysteine in the transmembrane domain. Journal of immunology 159, 2702-2711. 
Liu, G.Y. (2009). Molecular pathogenesis of Staphylococcus aureus infection. Pediatric research 65, 71R-
77R. 
Liu, L.F., Kodama, K., Wei, K., Tolentino, L.L., Choi, O., Engleman, E.G., Butte, A.J., and McLaughlin, T. 
(2015). The receptor CD44 is associated with systemic insulin resistance and proinflammatory 
macrophages in human adipose tissue. Diabetologia 58, 1579-1586. 
Llewelyn, M., and Cohen, J. (2002). Superantigens: microbial agents that corrupt immunity. The Lancet 
Infectious diseases 2, 156-162. 
Loffler, B., Hussain, M., Grundmeier, M., Bruck, M., Holzinger, D., Varga, G., Roth, J., Kahl, B.C., Proctor, 
R.A., and Peters, G. (2010). Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic 
factor for human neutrophils. PLoS pathogens 6, e1000715. 
Lokeshwar, V.B., and Bourguignon, L.Y. (1991). Post-translational protein modification and expression of 
ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma 
membrane biosynthesis. The Journal of biological chemistry 266, 17983-17989. 
101 
 
Lopes Pinheiro, M.A., Kroon, J., Hoogenboezem, M., Geerts, D., van Het Hof, B., van der Pol, S.M., van 
Buul, J.D., and de Vries, H.E. (2016). Acid Sphingomyelinase-Derived Ceramide Regulates ICAM-1 
Function during T Cell Transmigration across Brain Endothelial Cells. Journal of immunology 196, 72-79. 
Lovat, P.E., Corazzari, M., Goranov, B., Piacentini, M., and Redfern, C.P. (2004). Molecular mechanisms 
of fenretinide-induced apoptosis of neuroblastoma cells. Annals of the New York Academy of Sciences 
1028, 81-89. 
Lowy, F.D. (1998). Staphylococcus aureus infections. The New England journal of medicine 339, 520-532. 
Man, S.M., Ekpenyong, A., Tourlomousis, P., Achouri, S., Cammarota, E., Hughes, K., Rizzo, A., Ng, G., 
Wright, J.A., Cicuta, P., et al. (2014). Actin polymerization as a key innate immune effector mechanism to 
control Salmonella infection. Proceedings of the National Academy of Sciences of the United States of 
America 111, 17588-17593. 
Manago, A., Becker, K.A., Carpinteiro, A., Wilker, B., Soddemann, M., Seitz, A.P., Edwards, M.J., Grassme, 
H., Szabo, I., and Gulbins, E. (2015). Pseudomonas aeruginosa pyocyanin induces neutrophil death via 
mitochondrial reactive oxygen species and mitochondrial acid sphingomyelinase. Antioxidants & redox 
signaling 22, 1097-1110. 
Marathe, S., Schissel, S.L., Yellin, M.J., Beatini, N., Mintzer, R., Williams, K.J., and Tabas, I. (1998). Human 
vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications 
for early atherogenesis and ceramide-mediated cell signaling. The Journal of biological chemistry 273, 
4081-4088. 
Marimuthu, K., and Harbarth, S. (2014). Screening for methicillin-resistant Staphylococcus aureus ... all 
doors closed? Current opinion in infectious diseases 27, 356-362. 
Marrack, P., and Kappler, J. (1990). The staphylococcal enterotoxins and their relatives. Science 248, 
705-711. 
Maskalyk, J. (2002). Antimicrobial resistance takes another step forward. CMAJ : Canadian Medical 
Association journal = journal de l'Association medicale canadienne 167, 375. 
Maula, T., Kurita, M., Yamaguchi, S., Yamamoto, T., Katsumura, S., and Slotte, J.P. (2011). Effects of 
sphingosine 2N- and 3O-methylation on palmitoyl ceramide properties in bilayer membranes. 
Biophysical journal 101, 2948-2956. 
McCollister, B.D., Myers, J.T., Jones-Carson, J., Voelker, D.R., and Vazquez-Torres, A. (2007). Constitutive 
acid sphingomyelinase enhances early and late macrophage killing of Salmonella enterica serovar 
Typhimurium. Infection and immunity 75, 5346-5352. 
McDonald, B., and Kubes, P. (2015). Interactions between CD44 and Hyaluronan in Leukocyte Trafficking. 
Frontiers in immunology 6, 68. 
Melly, M.A., Thomison, J.B., and Rogers, D.E. (1960). Fate of staphylococci within human leukocytes. The 
Journal of experimental medicine 112, 1121-1130. 
Miletti-Gonzalez, K.E., Murphy, K., Kumaran, M.N., Ravindranath, A.K., Wernyj, R.P., Kaur, S., Miles, G.D., 
Lim, E., Chan, R., Chekmareva, M., et al. (2012). Identification of function for CD44 intracytoplasmic 
domain (CD44-ICD): modulation of matrix metalloproteinase 9 (MMP-9) transcription via novel 
promoter response element. The Journal of biological chemistry 287, 18995-19007. 
Misra, S., Hascall, V.C., Markwald, R.R., and Ghatak, S. (2015). Interactions between Hyaluronan and Its 
Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer. Frontiers in immunology 
6, 201. 
Mlynarczyk, A., Mlynarczyk, G., and Jeljaszewicz, J. (1998). The genome of Staphylococcus aureus: a 
review. Zentralblatt fur Bakteriologie : international journal of medical microbiology 287, 277-314. 
Mongodin, E., Bajolet, O., Cutrona, J., Bonnet, N., Dupuit, F., Puchelle, E., and de Bentzmann, S. (2002). 
Fibronectin-binding proteins of Staphylococcus aureus are involved in adherence to human airway 
epithelium. Infection and immunity 70, 620-630. 
102 
 
Montgomery, C.P., Boyle-Vavra, S., Adem, P.V., Lee, J.C., Husain, A.N., Clasen, J., and Daum, R.S. (2008). 
Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus 
pulsotypes USA300 and USA400 in a rat model of pneumonia. The Journal of infectious diseases 198, 
561-570. 
Montgomery, C.P., Boyle-Vavra, S., and Daum, R.S. (2010). Importance of the global regulators Agr and 
SaeRS in the pathogenesis of CA-MRSA USA300 infection. PloS one 5, e15177. 
Mori, T., Kitano, K., Terawaki, S., Maesaki, R., Fukami, Y., and Hakoshima, T. (2008). Structural basis for 
CD44 recognition by ERM proteins. The Journal of biological chemistry 283, 29602-29612. 
Mueller, N., Avota, E., Collenburg, L., Grassme, H., and Schneider-Schaulies, S. (2014). Neutral 
sphingomyelinase in physiological and measles virus induced T cell suppression. PLoS pathogens 10, 
e1004574. 
Murai, T. (2015). Lipid Raft-Mediated Regulation of Hyaluronan-CD44 Interactions in Inflammation and 
Cancer. Frontiers in immunology 6, 420. 
Nagano, O., and Saya, H. (2004). Mechanism and biological significance of CD44 cleavage. Cancer science 
95, 930-935. 
Nakamura, F., Amieva, M.R., and Furthmayr, H. (1995). Phosphorylation of threonine 558 in the 
carboxyl-terminal actin-binding domain of moesin by thrombin activation of human platelets. The 
Journal of biological chemistry 270, 31377-31385. 
Nakatsuji, T., Tang, D.C., Zhang, L., Gallo, R.L., and Huang, C.M. (2011). Propionibacterium acnes CAMP 
factor and host acid sphingomyelinase contribute to bacterial virulence: potential targets for 
inflammatory acne treatment. PloS one 6, e14797. 
Naor, D., Nedvetzki, S., Golan, I., Melnik, L., and Faitelson, Y. (2002). CD44 in cancer. Critical reviews in 
clinical laboratory sciences 39, 527-579. 
Naor, D., Sionov, R.V., and IshShalom, D. (1997). CD44: Structure, function, and association with the 
malignant process. Adv Cancer Res 71, 241-319. 
Neame, S.J., Uff, C.R., Sheikh, H., Wheatley, S.C., and Isacke, C.M. (1995). CD44 exhibits a cell type 
dependent interaction with triton X-100 insoluble, lipid rich, plasma membrane domains. Journal of cell 
science 108 ( Pt 9), 3127-3135. 
Newrzella, D., and Stoffel, W. (1992). Molecular cloning of the acid sphingomyelinase of the mouse and 
the organization and complete nucleotide sequence of the gene. Biological chemistry Hoppe-Seyler 373, 
1233-1238. 
Ng, T., Parsons, M., Hughes, W.E., Monypenny, J., Zicha, D., Gautreau, A., Arpin, M., Gschmeissner, S., 
Verveer, P.J., Bastiaens, P.I., et al. (2001). Ezrin is a downstream effector of trafficking PKC-integrin 
complexes involved in the control of cell motility. The EMBO journal 20, 2723-2741. 
Ni, X., and Morales, C.R. (2006). The lysosomal trafficking of acid sphingomyelinase is mediated by 
sortilin and mannose 6-phosphate receptor. Traffic 7, 889-902. 
Nicolson, G.L. (2014). The Fluid-Mosaic Model of Membrane Structure: still relevant to understanding 
the structure, function and dynamics of biological membranes after more than 40 years. Biochimica et 
biophysica acta 1838, 1451-1466. 
Nishifuji, K., Sugai, M., and Amagai, M. (2008). Staphylococcal exfoliative toxins: "molecular scissors" of 
bacteria that attack the cutaneous defense barrier in mammals. Journal of dermatological science 49, 
21-31. 
Normark, B.H., Normark, S., and Norrby-Teglund, A. (2004). Staphylococcal protein A inflames the lungs. 
Nature medicine 10, 780-781. 
Nouwen, J.L., Ott, A., Kluytmans-Vandenbergh, M.F., Boelens, H.A., Hofman, A., van Belkum, A., and 
Verbrugh, H.A. (2004). Predicting the Staphylococcus aureus nasal carrier state: derivation and 
validation of a "culture rule". Clinical infectious diseases : an official publication of the Infectious 
Diseases Society of America 39, 806-811. 
103 
 
Novick, R.P. (1991). Genetic systems in staphylococci. Methods in enzymology 204, 587-636. 
Novick, R.P. (2003). Autoinduction and signal transduction in the regulation of staphylococcal virulence. 
Molecular microbiology 48, 1429-1449. 
O'Brien, L.M., Walsh, E.J., Massey, R.C., Peacock, S.J., and Foster, T.J. (2002). Staphylococcus aureus 
clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal 
colonization. Cellular microbiology 4, 759-770. 
O'Neill, E., Pozzi, C., Houston, P., Humphreys, H., Robinson, D.A., Loughman, A., Foster, T.J., and O'Gara, 
J.P. (2008). A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding 
proteins, FnBPA and FnBPB. Journal of bacteriology 190, 3835-3850. 
O'Riordan, K., and Lee, J.C. (2004). Staphylococcus aureus capsular polysaccharides. Clinical microbiology 
reviews 17, 218-234. 
Ohata, H., Ishiguro, T., Aihara, Y., Sato, A., Sakai, H., Sekine, S., Taniguchi, H., Akasu, T., Fujita, S., 
Nakagama, H., et al. (2012). Induction of the stem-like cell regulator CD44 by Rho kinase inhibition 
contributes to the maintenance of colon cancer-initiating cells. Cancer research 72, 5101-5110. 
Okada, K., Ueshima, S., Tanaka, M., Fukao, H., and Matsuo, O. (2000). Analysis of plasminogen activation 
by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice. Blood 
coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 11, 645-655. 
Okamoto, I., Kawano, Y., Tsuiki, H., Sasaki, J., Nakao, M., Matsumoto, M., Suga, M., Ando, M., Nakajima, 
M., and Saya, H. (1999). CD44 cleavage induced by a membrane-associated metalloprotease plays a 
critical role in tumor cell migration. Oncogene 18, 1435-1446. 
Okamoto, I., Tsuiki, H., Kenyon, L.C., Godwin, A.K., Emlet, D.R., Holgado-Madruga, M., Lanham, I.S., 
Joynes, C.J., Vo, K.T., Guha, A., et al. (2002). Proteolytic cleavage of the CD44 adhesion molecule in 
multiple human tumors. The American journal of pathology 160, 441-447. 
Okayama, H., Kumamoto, K., Saitou, K., Hayase, S., Kofunato, Y., Sato, Y., Miyamoto, K., Nakamura, I., 
Ohki, S., Sekikawa, K., et al. (2009). CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for 
prediction of lymph node metastasis in primary gastric cancer. Oncology reports 22, 745-755. 
Olaku, V., Matzke, A., Mitchell, C., Hasenauer, S., Sakkaravarthi, A., Pace, G., Ponta, H., and Orian-
Rousseau, V. (2011). c-Met recruits ICAM-1 as a coreceptor to compensate for the loss of CD44 in Cd44 
null mice. Molecular biology of the cell 22, 2777-2786. 
Olson, M.E., Nygaard, T.K., Ackermann, L., Watkins, R.L., Zurek, O.W., Pallister, K.B., Griffith, S., 
Kiedrowski, M.R., Flack, C.E., Kavanaugh, J.S., et al. (2013). Staphylococcus aureus nuclease is an SaeRS-
dependent virulence factor. Infection and immunity 81, 1316-1324. 
Orian-Rousseau, V., Chen, L., Sleeman, J.P., Herrlich, P., and Ponta, H. (2002). CD44 is required for two 
consecutive steps in HGF/c-Met signaling. Genes & development 16, 3074-3086. 
Orian-Rousseau, V., Morrison, H., Matzke, A., Kastilan, T., Pace, G., Herrlich, P., and Ponta, H. (2007). 
Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-
actin. Molecular biology of the cell 18, 76-83. 
Orian-Rousseau, V., and Ponta, H. (2015). Perspectives of CD44 targeting therapies. Archives of 
toxicology 89, 3-14. 
Pal, S., Ganguly, K.K., and Chatterjee, A. (2013). Extracellular matrix protein fibronectin induces matrix 
metalloproteinases in human prostate adenocarcinoma cells PC-3. Cell communication & adhesion 20, 
105-114. 
Palmqvist, N., Patti, J.M., Tarkowski, A., and Josefsson, E. (2004). Expression of staphylococcal clumping 
factor A impedes macrophage phagocytosis. Microbes and infection 6, 188-195. 
Palyi-Krekk, Z., Barok, M., Kovacs, T., Saya, H., Nagano, O., Szollosi, J., and Nagy, P. (2008). EGFR and 
ErbB2 are functionally coupled to CD44 and regulate shedding, internalization and motogenic effect of 
CD44. Cancer letters 263, 231-242. 
104 
 
Parent, N., Scherer, M., Liebisch, G., Schmitz, G., and Bertrand, R. (2011). Protein kinase C-delta isoform 
mediates lysosome labilization in DNA damage-induced apoptosis. International journal of oncology 38, 
313-324. 
Parker, D., and Prince, A. (2012). Immunopathogenesis of Staphylococcus aureus pulmonary infection. 
Seminars in immunopathology 34, 281-297. 
Patti, J.M., Allen, B.L., McGavin, M.J., and Hook, M. (1994). MSCRAMM-mediated adherence of 
microorganisms to host tissues. Annual review of microbiology 48, 585-617. 
Peacock, S.J., Justice, A., Griffiths, D., de Silva, G.D., Kantzanou, M.N., Crook, D., Sleeman, K., and Day, 
N.P. (2003). Determinants of acquisition and carriage of Staphylococcus aureus in infancy. Journal of 
clinical microbiology 41, 5718-5725. 
Peng, H., Li, C., Kadow, S., Henry, B.D., Steinmann, J., Becker, K.A., Riehle, A., Beckmann, N., Wilker, B., Li, 
P.L., et al. (2015). Acid sphingomyelinase inhibition protects mice from lung edema and lethal 
Staphylococcus aureus sepsis. Journal of molecular medicine 93, 675-689. 
Perret, M., Badiou, C., Lina, G., Burbaud, S., Benito, Y., Bes, M., Cottin, V., Couzon, F., Juruj, C., 
Dauwalder, O., et al. (2012). Cross-talk between Staphylococcus aureus leukocidins-intoxicated 
macrophages and lung epithelial cells triggers chemokine secretion in an inflammasome-dependent 
manner. Cellular microbiology 14, 1019-1036. 
Perrotta, C., Bizzozero, L., Cazzato, D., Morlacchi, S., Assi, E., Simbari, F., Zhang, Y., Gulbins, E., Bassi, 
M.T., Rosa, P., et al. (2010). Syntaxin 4 is required for acid sphingomyelinase activity and apoptotic 
function. The Journal of biological chemistry 285, 40240-40251. 
Perrotta, C., Bizzozero, L., Falcone, S., Rovere-Querini, P., Prinetti, A., Schuchman, E.H., Sonnino, S., 
Manfredi, A.A., and Clementi, E. (2007). Nitric oxide boosts chemoimmunotherapy via inhibition of acid 
sphingomyelinase in a mouse model of melanoma. Cancer research 67, 7559-7564. 
Perrotta, C., Cervia, D., De Palma, C., Assi, E., Pellegrino, P., Bassi, M.T., and Clementi, E. (2015). The 
emerging role of acid sphingomyelinase in autophagy. Apoptosis : an international journal on 
programmed cell death 20, 635-644. 
Peschel, A., Jack, R.W., Otto, M., Collins, L.V., Staubitz, P., Nicholson, G., Kalbacher, H., Nieuwenhuizen, 
W.F., Jung, G., Tarkowski, A., et al. (2001). Staphylococcus aureus resistance to human defensins and 
evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane 
lipids with l-lysine. The Journal of experimental medicine 193, 1067-1076. 
Peschel, A., and Otto, M. (2013). Phenol-soluble modulins and staphylococcal infection. Nature reviews 
Microbiology 11, 667-673. 
Pewzner-Jung, Y., Ben-Dor, S., and Futerman, A.H. (2006). When do Lasses (longevity assurance genes) 
become CerS (ceramide synthases)?: Insights into the regulation of ceramide synthesis. The Journal of 
biological chemistry 281, 25001-25005. 
Pewzner-Jung, Y., Tavakoli Tabazavareh, S., Grassme, H., Becker, K.A., Japtok, L., Steinmann, J., Joseph, 
T., Lang, S., Tuemmler, B., Schuchman, E.H., et al. (2014). Sphingoid long chain bases prevent lung 
infection by Pseudomonas aeruginosa. EMBO molecular medicine 6, 1205-1214. 
Peyrani, P., and Ramirez, J. (2015). What is the best therapeutic approach to methicillin-resistant 
Staphylococcus aureus pneumonia? Current opinion in infectious diseases 28, 164-170. 
Pike, L.J. (2006). Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. 
Journal of lipid research 47, 1597-1598. 
Ponta, H., Sherman, L., and Herrlich, P.A. (2003). CD44: from adhesion molecules to signalling regulators. 
Nature reviews Molecular cell biology 4, 33-45. 
Pozzi, C., Lofano, G., Mancini, F., Soldaini, E., Speziale, P., De Gregorio, E., Rappuoli, R., Bertholet, S., 
Grandi, G., and Bagnoli, F. (2015). Phagocyte subsets and lymphocyte clonal deletion behind ineffective 
immune response to Staphylococcus aureus. FEMS microbiology reviews 39, 750-763. 
105 
 
Prevost, G., Cribier, B., Couppie, P., Petiau, P., Supersac, G., Finck-Barbancon, V., Monteil, H., and 
Piemont, Y. (1995). Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus 
ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infection and 
immunity 63, 4121-4129. 
Proctor, R.A., Kriegeskorte, A., Kahl, B.C., Becker, K., Loffler, B., and Peters, G. (2014). Staphylococcus 
aureus Small Colony Variants (SCVs): a road map for the metabolic pathways involved in persistent 
infections. Frontiers in cellular and infection microbiology 4, 99. 
Prosdocimi, M., and Bevilacqua, C. (2012). Exogenous hyaluronic acid and wound healing: an updated 
vision. Panminerva medica 54, 129-135. 
Qazi, S.N., Counil, E., Morrissey, J., Rees, C.E., Cockayne, A., Winzer, K., Chan, W.C., Williams, P., and Hill, 
P.J. (2001). agr expression precedes escape of internalized Staphylococcus aureus from the host 
endosome. Infection and immunity 69, 7074-7082. 
Qiu, H., Edmunds, T., Baker-Malcolm, J., Karey, K.P., Estes, S., Schwarz, C., Hughes, H., and Van Patten, 
S.M. (2003). Activation of human acid sphingomyelinase through modification or deletion of C-terminal 
cysteine. The Journal of biological chemistry 278, 32744-32752. 
Quintern, L.E., Schuchman, E.H., Levran, O., Suchi, M., Ferlinz, K., Reinke, H., Sandhoff, K., and Desnick, 
R.J. (1989). Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively 
processed transcripts. The EMBO journal 8, 2469-2473. 
Ragle, B.E., and Bubeck Wardenburg, J. (2009). Anti-alpha-hemolysin monoclonal antibodies mediate 
protection against Staphylococcus aureus pneumonia. Infection and immunity 77, 2712-2718. 
Ragle, B.E., Karginov, V.A., and Bubeck Wardenburg, J. (2010). Prevention and treatment of 
Staphylococcus aureus pneumonia with a beta-cyclodextrin derivative. Antimicrobial agents and 
chemotherapy 54, 298-304. 
Ranganath, P., Matta, D., Bhavani, G.S., Wangnekar, S., Jain, J.M., Verma, I.C., Kabra, M., Puri, R.D., 
Danda, S., Gupta, N., et al. (2016). Spectrum of SMPD1 mutations in Asian-Indian patients with acid 
sphingomyelinase (ASM)-deficient Niemann-Pick disease. American journal of medical genetics Part A 
170, 2719-2730. 
Recsei, P., Kreiswirth, B., O'Reilly, M., Schlievert, P., Gruss, A., and Novick, R.P. (1986). Regulation of 
exoprotein gene expression in Staphylococcus aureus by agar. Molecular & general genetics : MGG 202, 
58-61. 
Reinehr, R., Becker, S., Braun, J., Eberle, A., Grether-Beck, S., and Haussinger, D. (2006). Endosomal 
acidification and activation of NADPH oxidase isoforms are upstream events in hyperosmolarity-induced 
hepatocyte apoptosis. The Journal of biological chemistry 281, 23150-23166. 
Resh, M.D. (1999). Fatty acylation of proteins: new insights into membrane targeting of myristoylated 
and palmitoylated proteins. Biochimica et biophysica acta 1451, 1-16. 
Ridley, A.J., and Hall, A. (1992). The small GTP-binding protein rho regulates the assembly of focal 
adhesions and actin stress fibers in response to growth factors. Cell 70, 389-399. 
Ridley, A.J., Paterson, H.F., Johnston, C.L., Diekmann, D., and Hall, A. (1992). The small GTP-binding 
protein rac regulates growth factor-induced membrane ruffling. Cell 70, 401-410. 
Ridley, M. (1959). Perineal carriage of Staph. aureus. British medical journal 1, 270-273. 
Rietveld, A., Neutz, S., Simons, K., and Eaton, S. (1999). Association of sterol- and 
glycosylphosphatidylinositol-linked proteins with Drosophila raft lipid microdomains. The Journal of 
biological chemistry 274, 12049-12054. 
Roca, F.J., and Ramakrishnan, L. (2013). TNF dually mediates resistance and susceptibility to 
mycobacteria via mitochondrial reactive oxygen species. Cell 153, 521-534. 
Rochfort, K.D., Collins, L.E., Murphy, R.P., and Cummins, P.M. (2014). Downregulation of blood-brain 
barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: 
consequences for interendothelial adherens and tight junctions. PloS one 9, e101815. 
106 
 
Rooijakkers, S.H., van Kessel, K.P., and van Strijp, J.A. (2005). Staphylococcal innate immune evasion. 
Trends in microbiology 13, 596-601. 
Rose, F., Dahlem, G., Guthmann, B., Grimminger, F., Maus, U., Hanze, J., Duemmer, N., Grandel, U., 
Seeger, W., and Ghofrani, H.A. (2002). Mediator generation and signaling events in alveolar epithelial 
cells attacked by S. aureus alpha-toxin. American journal of physiology Lung cellular and molecular 
physiology 282, L207-214. 
Ruvolo, P.P. (2003). Intracellular signal transduction pathways activated by ceramide and its metabolites. 
Pharmacological research 47, 383-392. 
Salgado-Pabon, W., and Schlievert, P.M. (2014). Models matter: the search for an effective 
Staphylococcus aureus vaccine. Nature reviews Microbiology 12, 585-591. 
Sandhoff, R. (2010). Very long chain sphingolipids: tissue expression, function and synthesis. FEBS letters 
584, 1907-1913. 
Scheibner, K.A., Lutz, M.A., Boodoo, S., Fenton, M.J., Powell, J.D., and Horton, M.R. (2006). Hyaluronan 
fragments act as an endogenous danger signal by engaging TLR2. Journal of immunology 177, 1272-1281. 
Schissel, S.L., Jiang, X., Tweedie-Hardman, J., Jeong, T., Camejo, E.H., Najib, J., Rapp, J.H., Williams, K.J., 
and Tabas, I. (1998a). Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can 
hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. 
The Journal of biological chemistry 273, 2738-2746. 
Schissel, S.L., Keesler, G.A., Schuchman, E.H., Williams, K.J., and Tabas, I. (1998b). The cellular trafficking 
and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid 
sphingomyelinase gene. The Journal of biological chemistry 273, 18250-18259. 
Schommer, N.N., Muto, J., Nizet, V., and Gallo, R.L. (2014). Hyaluronan breakdown contributes to 
immune defense against group A Streptococcus. The Journal of biological chemistry 289, 26914-26921. 
Schrager, H.M., Alberti, S., Cywes, C., Dougherty, G.J., and Wessels, M.R. (1998). Hyaluronic acid capsule 
modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus 
to CD44 on human keratinocytes. The Journal of clinical investigation 101, 1708-1716. 
Schramm, M., Herz, J., Haas, A., Kronke, M., and Utermohlen, O. (2008). Acid sphingomyelinase is 
required for efficient phago-lysosomal fusion. Cellular microbiology 10, 1839-1853. 
Schuchman, E.H. (2007). The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-
Pick disease. Journal of inherited metabolic disease 30, 654-663. 
Schuchman, E.H., Levran, O., Pereira, L.V., and Desnick, R.J. (1992). Structural organization and complete 
nucleotide sequence of the gene encoding human acid sphingomyelinase (SMPD1). Genomics 12, 197-
205. 
Schuchman, E.H., Suchi, M., Takahashi, T., Sandhoff, K., and Desnick, R.J. (1991). Human acid 
sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively 
spliced cDNAs. The Journal of biological chemistry 266, 8531-8539. 
Schulz, A.M., Stutte, S., Hogl, S., Luckashenak, N., Dudziak, D., Leroy, C., Forne, I., Imhof, A., Muller, S.A., 
Brakebusch, C.H., et al. (2015). Cdc42-dependent actin dynamics controls maturation and secretory 
activity of dendritic cells. The Journal of cell biology 211, 553-567. 
Screaton, G.R., Bell, M.V., Jackson, D.G., Cornelis, F.B., Gerth, U., and Bell, J.I. (1992). Genomic structure 
of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. 
Proceedings of the National Academy of Sciences of the United States of America 89, 12160-12164. 
Sechi, A.S., Wehland, J., and Small, J.V. (1997). The isolated comet tail pseudopodium of Listeria 
monocytogenes: a tail of two actin filament populations, long and axial and short and random. The 
Journal of cell biology 137, 155-167. 
Shaykhiev, R., Behr, J., and Bals, R. (2008). Microbial patterns signaling via Toll-like receptors 2 and 5 
contribute to epithelial repair, growth and survival. PloS one 3, e1393. 
107 
 
Sherman, L., Sleeman, J., Herrlich, P., and Ponta, H. (1994). Hyaluronate receptors: key players in growth, 
differentiation, migration and tumor progression. Current opinion in cell biology 6, 726-733. 
Sherman, L.S., Rizvi, T.A., Karyala, S., and Ratner, N. (2000). CD44 enhances neuregulin signaling by 
Schwann cells. The Journal of cell biology 150, 1071-1084. 
Shivanna, V., Kim, Y., and Chang, K.O. (2015). Ceramide formation mediated by acid sphingomyelinase 
facilitates endosomal escape of caliciviruses. Virology 483, 218-228. 
Shompole, S., Henon, K.T., Liou, L.E., Dziewanowska, K., Bohach, G.A., and Bayles, K.W. (2003). Biphasic 
intracellular expression of Staphylococcus aureus virulence factors and evidence for Agr-mediated 
diffusion sensing. Molecular microbiology 49, 919-927. 
Siegelman, M.H., DeGrendele, H.C., and Estess, P. (1999). Activation and interaction of CD44 and 
hyaluronan in immunological systems. Journal of leukocyte biology 66, 315-321. 
Siegrist, M.S., Aditham, A.K., Espaillat, A., Cameron, T.A., Whiteside, S.A., Cava, F., Portnoy, D.A., and 
Bertozzi, C.R. (2015). Host actin polymerization tunes the cell division cycle of an intracellular pathogen. 
Cell reports 11, 499-507. 
Sieprawska-Lupa, M., Mydel, P., Krawczyk, K., Wojcik, K., Puklo, M., Lupa, B., Suder, P., Silberring, J., 
Reed, M., Pohl, J., et al. (2004). Degradation of human antimicrobial peptide LL-37 by Staphylococcus 
aureus-derived proteinases. Antimicrobial agents and chemotherapy 48, 4673-4679. 
Silva, L.C., de Almeida, R.F., Castro, B.M., Fedorov, A., and Prieto, M. (2007). Ceramide-domain 
formation and collapse in lipid rafts: membrane reorganization by an apoptotic lipid. Biophysical journal 
92, 502-516. 
Simonis, A., Hebling, S., Gulbins, E., Schneider-Schaulies, S., and Schubert-Unkmeir, A. (2014). 
Differential activation of acid sphingomyelinase and ceramide release determines invasiveness of 
Neisseria meningitidis into brain endothelial cells. PLoS pathogens 10, e1004160. 
Simons, K., and Ikonen, E. (1997). Functional rafts in cell membranes. Nature 387, 569-572. 
Singer, A.J., and Talan, D.A. (2014). Management of skin abscesses in the era of methicillin-resistant 
Staphylococcus aureus. The New England journal of medicine 370, 1039-1047. 
Singer, S.J., and Nicolson, G.L. (1972). The fluid mosaic model of the structure of cell membranes. 
Science 175, 720-731. 
Skaar, E.P., Humayun, M., Bae, T., DeBord, K.L., and Schneewind, O. (2004). Iron-source preference of 
Staphylococcus aureus infections. Science 305, 1626-1628. 
Skoudy, A., Mounier, J., Aruffo, A., Ohayon, H., Gounon, P., Sansonetti, P., and Tran Van Nhieu, G. (2000). 
CD44 binds to the Shigella IpaB protein and participates in bacterial invasion of epithelial cells. Cellular 
microbiology 2, 19-33. 
Slauch, J.M. (2011). How does the oxidative burst of macrophages kill bacteria? Still an open question. 
Molecular microbiology 80, 580-583. 
Sleeman, J.P., Kondo, K., Moll, J., Ponta, H., and Herrlich, P. (1997). Variant exons v6 and v7 together 
expand the repertoire of glycosaminoglycans bound by CD44. The Journal of biological chemistry 272, 
31837-31844. 
Song, L., Hobaugh, M.R., Shustak, C., Cheley, S., Bayley, H., and Gouaux, J.E. (1996). Structure of 
staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 274, 1859-1866. 
Soong, G., Martin, F.J., Chun, J., Cohen, T.S., Ahn, D.S., and Prince, A. (2011). Staphylococcus aureus 
protein A mediates invasion across airway epithelial cells through activation of RhoA GTPase signaling 
and proteolytic activity. The Journal of biological chemistry 286, 35891-35898. 
Stamenkovic, I., Aruffo, A., Amiot, M., and Seed, B. (1991). The hematopoietic and epithelial forms of 
CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. The 
EMBO journal 10, 343-348. 
Stancevic, B., and Kolesnick, R. (2010). Ceramide-rich platforms in transmembrane signaling. FEBS letters 
584, 1728-1740. 
108 
 
Staneva, G., Momchilova, A., Wolf, C., Quinn, P.J., and Koumanov, K. (2009). Membrane microdomains: 
role of ceramides in the maintenance of their structure and functions. Biochimica et biophysica acta 
1788, 666-675. 
Suga, N., Sugimura, M., Koshiishi, T., Yorifuji, T., Makino, S., and Takeda, S. (2012). Heparin/heparan 
sulfate/CD44-v3 enhances cell migration in term placenta-derived immortalized human trophoblast cells. 
Biology of reproduction 86, 134, 131-138. 
Taher, T.E., van der Voort, R., Smit, L., Keehnen, R.M., Schilder-Tol, E.J., Spaargaren, M., and Pals, S.T. 
(1999). Cross-talk between CD44 and c-Met in B cells. Current topics in microbiology and immunology 
246, 31-37; discussion 38. 
Takahashi, I., Takahashi, T., Mikami, T., Komatsu, M., Ohura, T., Schuchman, E.H., and Takada, G. (2005). 
Acid sphingomyelinase: relation of 93lysine residue on the ratio of intracellular to secreted enzyme 
activity. The Tohoku journal of experimental medicine 206, 333-340. 
Talan, D.A., Krishnadasan, A., Gorwitz, R.J., Fosheim, G.E., Limbago, B., Albrecht, V., Moran, G.J., and 
Group, E.M.I.N.S. (2011). Comparison of Staphylococcus aureus from skin and soft-tissue infections in US 
emergency department patients, 2004 and 2008. Clinical infectious diseases : an official publication of 
the Infectious Diseases Society of America 53, 144-149. 
Tchikov, V., Bertsch, U., Fritsch, J., Edelmann, B., and Schutze, S. (2011). Subcellular 
compartmentalization of TNF receptor-1 and CD95 signaling pathways. European journal of cell biology 
90, 467-475. 
Teder, P., Vandivier, R.W., Jiang, D., Liang, J., Cohn, L., Pure, E., Henson, P.M., and Noble, P.W. (2002). 
Resolution of lung inflammation by CD44. Science 296, 155-158. 
Teichgraber, V., Ulrich, M., Endlich, N., Riethmuller, J., Wilker, B., De Oliveira-Munding, C.C., van 
Heeckeren, A.M., Barr, M.L., von Kurthy, G., Schmid, K.W., et al. (2008). Ceramide accumulation 
mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nature medicine 14, 382-
391. 
Thakker, M., Park, J.S., Carey, V., and Lee, J.C. (1998). Staphylococcus aureus serotype 5 capsular 
polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model. 
Infection and immunity 66, 5183-5189. 
Thomer, L., Schneewind, O., and Missiakas, D. (2013). Multiple ligands of von Willebrand factor-binding 
protein (vWbp) promote Staphylococcus aureus clot formation in human plasma. The Journal of 
biological chemistry 288, 28283-28292. 
Tolg, C., McCarthy, J.B., Yazdani, A., and Turley, E.A. (2014). Hyaluronan and RHAMM in wound repair 
and the "cancerization" of stromal tissues. BioMed research international 2014, 103923. 
Tomita, T., and Kamio, Y. (1997). Molecular biology of the pore-forming cytolysins from Staphylococcus 
aureus, alpha- and gamma-hemolysins and leukocidin. Bioscience, biotechnology, and biochemistry 61, 
565-572. 
Ton-That, H., Faull, K.F., and Schneewind, O. (1997). Anchor structure of staphylococcal surface proteins. 
A branched peptide that links the carboxyl terminus of proteins to the cell wall. The Journal of biological 
chemistry 272, 22285-22292. 
Tong, S.Y., Davis, J.S., Eichenberger, E., Holland, T.L., and Fowler, V.G., Jr. (2015). Staphylococcus aureus 
infections: epidemiology, pathophysiology, clinical manifestations, and management. Clinical 
microbiology reviews 28, 603-661. 
Torres, V.J., Attia, A.S., Mason, W.J., Hood, M.I., Corbin, B.D., Beasley, F.C., Anderson, K.L., Stauff, D.L., 
McDonald, W.H., Zimmerman, L.J., et al. (2010). Staphylococcus aureus fur regulates the expression of 
virulence factors that contribute to the pathogenesis of pneumonia. Infection and immunity 78, 1618-
1628. 
Torres, V.J., Pishchany, G., Humayun, M., Schneewind, O., and Skaar, E.P. (2006). Staphylococcus aureus 
IsdB is a hemoglobin receptor required for heme iron utilization. Journal of bacteriology 188, 8421-8429. 
109 
 
Traber, K.E., Lee, E., Benson, S., Corrigan, R., Cantera, M., Shopsin, B., and Novick, R.P. (2008). agr 
function in clinical Staphylococcus aureus isolates. Microbiology 154, 2265-2274. 
Tsukamoto, S., Hirotsu, K., Kumazoe, M., Goto, Y., Sugihara, K., Suda, T., Tsurudome, Y., Suzuki, T., 
Yamashita, S., Kim, Y., et al. (2012). Green tea polyphenol EGCG induces lipid-raft clustering and 
apoptotic cell death by activating protein kinase Cdelta and acid sphingomyelinase through a 67 kDa 
laminin receptor in multiple myeloma cells. The Biochemical journal 443, 525-534. 
Tsukita, S., Oishi, K., Sato, N., Sagara, J., Kawai, A., and Tsukita, S. (1994). ERM family members as 
molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. The 
Journal of cell biology 126, 391-401. 
Tsukita, S., and Yonemura, S. (1999). Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) 
proteins. The Journal of biological chemistry 274, 34507-34510. 
Turner, M.D., Nedjai, B., Hurst, T., and Pennington, D.J. (2014). Cytokines and chemokines: At the 
crossroads of cell signalling and inflammatory disease. Biochimica et biophysica acta 1843, 2563-2582. 
Umeda, A., Ikebuchi, T., and Amako, K. (1980). Localization of bacteriophage receptor, clumping factor, 
and protein A on the cell surface of Staphylococcus aureus. Journal of bacteriology 141, 838-844. 
Umeda, A., Ueki, Y., and Amako, K. (1987). Structure of the Staphylococcus aureus cell wall determined 
by the freeze-substitution method. Journal of bacteriology 169, 2482-2487. 
Utermohlen, O., Herz, J., Schramm, M., and Kronke, M. (2008). Fusogenicity of membranes: the impact 
of acid sphingomyelinase on innate immune responses. Immunobiology 213, 307-314. 
Utermohlen, O., Karow, U., Lohler, J., and Kronke, M. (2003). Severe impairment in early host defense 
against Listeria monocytogenes in mice deficient in acid sphingomyelinase. Journal of immunology 170, 
2621-2628. 
van Blitterswijk, W.J., van der Luit, A.H., Veldman, R.J., Verheij, M., and Borst, J. (2003). Ceramide: 
second messenger or modulator of membrane structure and dynamics? The Biochemical journal 369, 
199-211. 
van der Windt, G.J., Hoogendijk, A.J., de Vos, A.F., Kerver, M.E., Florquin, S., and van der Poll, T. (2011). 
The role of CD44 in the acute and resolution phase of the host response during pneumococcal 
pneumonia. Laboratory investigation; a journal of technical methods and pathology 91, 588-597. 
van Meer, G., Stelzer, E.H., Wijnaendts-van-Resandt, R.W., and Simons, K. (1987). Sorting of 
sphingolipids in epithelial (Madin-Darby canine kidney) cells. The Journal of cell biology 105, 1623-1635. 
van Meer, G., Voelker, D.R., and Feigenson, G.W. (2008). Membrane lipids: where they are and how they 
behave. Nature reviews Molecular cell biology 9, 112-124. 
Varshney, P., Yadav, V., and Saini, N. (2016). Lipid rafts in immune signalling: current progress and future 
perspective. Immunology 149, 13-24. 
Vazquez, C.L., Rodgers, A., Herbst, S., Coade, S., Gronow, A., Guzman, C.A., Wilson, M.S., Kanzaki, M., 
Nykjaer, A., and Gutierrez, M.G. (2016). The proneurotrophin receptor sortilin is required for 
Mycobacterium tuberculosis control by macrophages. Scientific reports 6, 29332. 
Veiga, M.P., Arrondo, J.L., Goni, F.M., and Alonso, A. (1999). Ceramides in phospholipid membranes: 
effects on bilayer stability and transition to nonlamellar phases. Biophysical journal 76, 342-350. 
Viana, I.M., de Almeida, M.E., Lins, M.P., dos Santos Reis, M.D., de Araujo Vieira, L.F., and Smaniotto, S. 
(2015). Combined effect of insulin-like growth factor-1 and CC chemokine ligand 2 on angiogenic events 
in endothelial cells. PloS one 10, e0121249. 
Vigetti, D., Karousou, E., Viola, M., Deleonibus, S., De Luca, G., and Passi, A. (2014). Hyaluronan: 
biosynthesis and signaling. Biochimica et biophysica acta 1840, 2452-2459. 
von Bismarck, P., Winoto-Morbach, S., Herzberg, M., Uhlig, U., Schutze, S., Lucius, R., and Krause, M.F. 
(2012). IKK NBD peptide inhibits LPS induced pulmonary inflammation and alters sphingolipid 
metabolism in a murine model. Pulmonary pharmacology & therapeutics 25, 228-235. 
110 
 
von Eiff, C., Becker, K., Machka, K., Stammer, H., and Peters, G. (2001). Nasal carriage as a source of 
Staphylococcus aureus bacteremia. Study Group. The New England journal of medicine 344, 11-16. 
Wahe, A., Kasmapour, B., Schmaderer, C., Liebl, D., Sandhoff, K., Nykjaer, A., Griffiths, G., and Gutierrez, 
M.G. (2010). Golgi-to-phagosome transport of acid sphingomyelinase and prosaposin is mediated by 
sortilin. Journal of cell science 123, 2502-2511. 
Wang, Q., Teder, P., Judd, N.P., Noble, P.W., and Doerschuk, C.M. (2002). CD44 deficiency leads to 
enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice. The American 
journal of pathology 161, 2219-2228. 
Wang, Y., Yago, T., Zhang, N., Abdisalaam, S., Alexandrakis, G., Rodgers, W., and McEver, R.P. (2014). 
Cytoskeletal regulation of CD44 membrane organization and interactions with E-selectin. The Journal of 
biological chemistry 289, 35159-35171. 
Wasserstein, M.P., and Schuchman, E.H. (1993). Acid Sphingomyelinase Deficiency. In GeneReviews(R), 
R.A. Pagon, M.P. Adam, H.H. Ardinger, S.E. Wallace, A. Amemiya, L.J.H. Bean, T.D. Bird, C.T. Fong, H.C. 
Mefford, R.J.H. Smith, et al., eds. (Seattle (WA)). 
Weg-Remers, S., Ponta, H., Herrlich, P., and Konig, H. (2001). Regulation of alternative pre-mRNA 
splicing by the ERK MAP-kinase pathway. The EMBO journal 20, 4194-4203. 
Wertheim, H.F., Melles, D.C., Vos, M.C., van Leeuwen, W., van Belkum, A., Verbrugh, H.A., and Nouwen, 
J.L. (2005a). The role of nasal carriage in Staphylococcus aureus infections. The Lancet Infectious 
diseases 5, 751-762. 
Wertheim, H.F., Verveer, J., Boelens, H.A., van Belkum, A., Verbrugh, H.A., and Vos, M.C. (2005b). Effect 
of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy 
adults. Antimicrobial agents and chemotherapy 49, 1465-1467. 
Wertheim, H.F., Vos, M.C., Ott, A., van Belkum, A., Voss, A., Kluytmans, J.A., van Keulen, P.H., 
Vandenbroucke-Grauls, C.M., Meester, M.H., and Verbrugh, H.A. (2004). Risk and outcome of 
nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364, 703-
705. 
Wertheim, H.F., Walsh, E., Choudhurry, R., Melles, D.C., Boelens, H.A., Miajlovic, H., Verbrugh, H.A., 
Foster, T., and van Belkum, A. (2008). Key role for clumping factor B in Staphylococcus aureus nasal 
colonization of humans. PLoS medicine 5, e17. 
Wilke, G.A., and Bubeck Wardenburg, J. (2010). Role of a disintegrin and metalloprotease 10 in 
Staphylococcus aureus alpha-hemolysin-mediated cellular injury. Proceedings of the National Academy 
of Sciences of the United States of America 107, 13473-13478. 
Williams, R.E. (1963). Healthy carriage of Staphylococcus aureus: its prevalence and importance. 
Bacteriological reviews 27, 56-71. 
Wong, M.L., Xie, B., Beatini, N., Phu, P., Marathe, S., Johns, A., Gold, P.W., Hirsch, E., Williams, K.J., 
Licinio, J., et al. (2000). Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a 
possible link between inflammatory cytokines and atherogenesis. Proceedings of the National Academy 
of Sciences of the United States of America 97, 8681-8686. 
Xiong, Z.J., Huang, J., Poda, G., Pomes, R., and Prive, G.G. (2016). Structure of Human Acid 
Sphingomyelinase Reveals the Role of the Saposin Domain in Activating Substrate Hydrolysis. Journal of 
molecular biology 428, 3026-3042. 
Xu, X., Bittman, R., Duportail, G., Heissler, D., Vilcheze, C., and London, E. (2001). Effect of the structure 
of natural sterols and sphingolipids on the formation of ordered sphingolipid/sterol domains (rafts). 
Comparison of cholesterol to plant, fungal, and disease-associated sterols and comparison of 
sphingomyelin, cerebrosides, and ceramide. The Journal of biological chemistry 276, 33540-33546. 
Yamaoka, S., Miyaji, M., Kitano, T., Umehara, H., and Okazaki, T. (2004). Expression cloning of a human 
cDNA restoring sphingomyelin synthesis and cell growth in sphingomyelin synthase-defective lymphoid 
cells. The Journal of biological chemistry 279, 18688-18693. 
111 
 
Yatomi, Y., Ruan, F., Hakomori, S., and Igarashi, Y. (1995). Sphingosine-1-phosphate: a platelet-activating 
sphingolipid released from agonist-stimulated human platelets. Blood 86, 193-202. 
Yu, H., Zeidan, Y.H., Wu, B.X., Jenkins, R.W., Flotte, T.R., Hannun, Y.A., and Virella-Lowell, I. (2009). 
Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis. 
American journal of respiratory cell and molecular biology 41, 367-375. 
Yu, Q., and Stamenkovic, I. (2000). Cell surface-localized matrix metalloproteinase-9 proteolytically 
activates TGF-beta and promotes tumor invasion and angiogenesis. Genes & development 14, 163-176. 
Yun, Y.S., Min, Y.G., Rhee, C.S., Jung, I.H., Koh, Y.Y., Jang, T.Y., and Jung, D.H. (1999). Effects of alpha-
toxin of Staphylococcus aureus on the ciliary activity and ultrastructure of human nasal ciliated epithelial 
cells. The Laryngoscope 109, 2021-2024. 
Zebrakovska, I., Masa, M., Srp, J., Horn, M., Vavrova, K., and Mares, M. (2011). Complex modulation of 
peptidolytic activity of cathepsin D by sphingolipids. Biochimica et biophysica acta 1811, 1097-1104. 
Zeidan, Y.H., and Hannun, Y.A. (2007). Activation of acid sphingomyelinase by protein kinase Cdelta-
mediated phosphorylation. The Journal of biological chemistry 282, 11549-11561. 
Zeidan, Y.H., and Hannun, Y.A. (2010). The acid sphingomyelinase/ceramide pathway: biomedical 
significance and mechanisms of regulation. Current molecular medicine 10, 454-466. 
Zeidan, Y.H., Jenkins, R.W., and Hannun, Y.A. (2008a). Remodeling of cellular cytoskeleton by the acid 
sphingomyelinase/ceramide pathway. The Journal of cell biology 181, 335-350. 
Zeidan, Y.H., Wu, B.X., Jenkins, R.W., Obeid, L.M., and Hannun, Y.A. (2008b). A novel role for protein 
kinase Cdelta-mediated phosphorylation of acid sphingomyelinase in UV light-induced mitochondrial 
injury. FASEB journal : official publication of the Federation of American Societies for Experimental 
Biology 22, 183-193. 
Zhang, C., and Li, P.L. (2010). Membrane raft redox signalosomes in endothelial cells. Free radical 
research 44, 831-842. 
Zhang, Y., Li, X., Becker, K.A., and Gulbins, E. (2009). Ceramide-enriched membrane domains--structure 
and function. Biochimica et biophysica acta 1788, 178-183. 
Zhang, Y., Li, X., Carpinteiro, A., Goettel, J.A., Soddemann, M., and Gulbins, E. (2011). Kinase suppressor 
of Ras-1 protects against pulmonary Pseudomonas aeruginosa infections. Nature medicine 17, 341-346. 
Zhang, Y., Li, X., Carpinteiro, A., and Gulbins, E. (2008). Acid sphingomyelinase amplifies redox signaling 
in Pseudomonas aeruginosa-induced macrophage apoptosis. Journal of immunology 181, 4247-4254. 
Zhang, Y., Li, X., Grassme, H., Doring, G., and Gulbins, E. (2010). Alterations in ceramide concentration 
and pH determine the release of reactive oxygen species by Cftr-deficient macrophages on infection. 
Journal of immunology 184, 5104-5111. 
Zhang, Y., Yao, B., Delikat, S., Bayoumy, S., Lin, X.H., Basu, S., McGinley, M., Chan-Hui, P.Y., Lichenstein, 
H., and Kolesnick, R. (1997). Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 89, 63-72. 
 
 
  
112 
 
Publications, Posters and Presentations 
Publications 
Peng H, Li C, Kadow S, Henry BD, Steinmann J, Becker KA, Riehle A, Beckmann N, 
Wilker B, Li PL, Pritts T, Edwards MJ, Zhang Y, Gulbins E, Grassmé H. Acid 
sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus 
aureus sepsis. J Mol Med (Berl), 2015 
Li C, Peng H, Japtok L, Seitz A, Riehle A, Wilker B, Soddemann M, Kleuser B, Edwards 
M, Lammas D, Zhang Y, Gulbins E, Grassme H. Inhibition of neutral sphingomyelinase 
protects mice against systemic tuberculosis. Front Biosci (Elite Ed), 2016 
Fahsel B, Kemper H, Mayeres J, Li C, Wilker B, Keitsch S, Kohnen M, Caldwell C, 
Fraunholz M, Edwards M, Grassmé H, Gulbins E, Seitz A. Staphylococcus aureus 
alpha-toxin disrupts endothelial tight junctions via acid sphingomyelinase, ceramide and 
p38K, In press, 2016 
Li C, Wu Y, Riehle A, Kamler M, Gulbins E, Grassmé H. Staphylococcus aureus 
survives in cystic fibrosis macrophages forming a reservoir for chronic pneumonia. 
Infect & Imm, in revision, 2016 
Li C, Wu Y, Riehle A, Orian-Rousseau V, Gulbins E, Grassmé H. Regulation of 
Staphylococcus aureus infection of macrophages by CD44 and acid sphingomyelinase. 
Plos Pathogens, submitted, 2016 
Li C, Gulbins E, Grassmé H. Acid sphingomyelinase in host bacteria interaction. In 
submission, 2016 
 
 
 
113 
 
Posters and Presentations  
Li C, Gulbins E, Grassmé H. Regulation of the cytoskeleton by ceramide upon 
Staphylococcus aureus infection. Poster, Tag der Forschung der Medizinischen Fakultät, 
Essen, Nov. 21, 2014 
Li C, Gulbins E, Grassmé H. Regulation of the cytoskeleton by ceramide upon 
Staphylococcus aureus infection. Poster and Presentation, 3rd International Meeting of 
German Society for Cell Biology on Actin Dynamics, Regensburg, Germany, May 2-5, 
2015 
Li C, Gulbins E, Grassmé H. Regulation of the cytoskeleton by ceramide upon 
Staphylococcus aureus infection. Poster, Sphingolipids in infection and beyond, 
Wuerzburg, Germany, June 25-26, 2015 
Li C, Gulbins E, Grassmé H. Acid sphingomyelinase regulates infection of 
macrophages with Staphylococcus aureus - Application to the pathogenesis of cystic 
fibrosis. Poster, Tag der Forschung der Medizinischen Fakultät, Essen, Nov. 20, 2015 
Li C, Wu Y, Gulbins E, Grassmé H Inhibition of neutral sphingomyelinase protects mice 
against systemic tuberculosis. Presentation, Forschergruppen Meeting (FOR2123), 
Wuerzburg, Germany, Feb. 4, 2016 
  
114 
 
Acknowledgements 
I am very grateful to Prof. Dr. Erich Gulbins, for giving me the opportunity to do my PhD 
in his laboratory under his scientific guidance and professional support.  
I deeply appreciate Dr. Heike Grassmé for her dedicated personal and academic 
support throughout my study. 
I am grateful to all my colleagues. I would like to thank Dr. Katrin Becker-Flegler for her 
help and enthusiasm for research. I thank all my other colleagues and former 
colleagues: Nadine Beckmann, Salina Begum, Dr. Alexander Carpinteiro, Hannelore 
Disselhoff, Bärbel Edelmann, Gabi Hessler, Karen Hung, Dr. Stephanie Kadow, 
Stefanie Karnebeck, Simone Keitsch, Anne Koch, Claudine Kühn, Melanie Kramer, Jie 
Ma, Helga Pätsch, Bärbel Pollmeier, Bettina Peter, Carolin Sehl, Deepa Sharma, 
Matthias Soddemann, Shari Tavakoli, Elisa Venturini, Yuqing Wu, Barbara Wilker, for 
being much more than just co-workers. My particular thanks go to Siegfried Moyrer for 
his constant help throughout these years. 
I would thank all my friends for their friendship and support. 
Most importantly, I would like to thank my parents, sisters, my wife, and my son Aisen. 
They helped me pass all challenges and complete this work.  
 
  
115 
 
Erklärung: 
Hiermit erkläre ich, gem. § 6 Abs. 2, g der Promotionsordnung der Fakultät für Biologie 
zur Erlangung der Dr. rer. nat., dass ich das Arbeitsgebiet, dem das Thema „Regulation 
of Staphylococcus aureus infection of macrophages by CD44 and acid 
sphingomyelinase“ zuzuordnen ist, in Forschung und Lehre vertrete und den Antrag von 
Cao Li befürworte. 
Essen, den ________________________________ 
Prof. Dr. E. Gulbins - Unterschrift d. wissenschaftl. Betreuers 
Mitglied der Universität Duisburg-Essen 
 
Erklärung: 
Hiermit erkläre ich, gem. § 7 Abs. 2, d und f der Promotionsordnung der Fakultät für 
Biologie zur Erlangung des Dr. rer. nat., dass ich die vorliegende Dissertation 
selbständig verfasst und mich keiner anderen als der angegebenen Hilfsmittel bedient 
habe und alle wörtlich oder inhaltlich übernommenen Stellen als solche gekennzeichnet 
habe. 
Essen, den ______________________________ 
Unterschrift des/r Doktoranden/in 
 
Erklärung: 
Hiermit erkläre ich, gem. § 7 Abs. 2, e und g der Promotionsordnung der Fakultät für 
Biologie zur Erlangung des Dr. rer. nat., dass ich keine anderen Promotionen bzw. 
Promotionsversuche in der Vergangenheit durchgeführt habe, dass diese Arbeit von 
keiner anderen Fakultät abgelehnt worden ist, und dass ich die Dissertation nur in 
diesem Verfahren einreiche. 
Essen, den ______________________________ 
Unterschrift des/r Doktoranden/in 
